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Paramecium bursaria chlorella virus (PBCV-1), a member of the family 
Phycodnaviridae, is a large dsDNA, plaque-forming virus that infects the unicellular 
green alga Chlorella NC64A. The 331 kb PBCV-1 genome is predicted to encode 365 
proteins and 11 tRNAs. To follow global transcription during PBCV-1 replication, a 
microarray containing 50-mer probes to the PBCV-1 365 protein-encoding genes (CDS) 
was constructed. Competitive hybridization experiments were conducted employing 
cDNAs from poly A-containing RNAs obtained from cells at seven time points after 
virus infection.  The results led to the following conclusions: i) the PBCV-1 replication 
cycle is temporally programmed and regulated; ii) 360 (99%) of the arrayed PBCV-1 
CDSs were expressed at some time in the virus life cycle in the laboratory; iii) 227 (62%) 
of the CDSs were expressed before virus DNA synthesis begins; iv) these 227 CDSs were 
grouped into two classes: 127 transcripts disappeared prior to initiation of virus DNA 
synthesis (considered early) and 100 transcripts were still detected after virus DNA 
synthesis begins (considered early/late); v) 133 (36%) of the CDSs were expressed after 
virus DNA synthesis begins (considered late); vi) expression of most late CDSs  is 
inhibited by adding the DNA replication inhibitor, aphidicolin, prior to virus infection. 
This study provides the first comprehensive evaluation of virus gene expression during 
the PBCV-1 lifecycle.   
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1CHAPTER I 
INTRODUCTION AND BACKGROUND 
1. OVERVIEW 
The traditional concept that viruses are strictly submicroscopic entities with 
minimal genomes has changed. To date, many large DNA viruses infecting a wide range 
of hosts have been characterized: they are ubiquitous in nature, exhibit extraordinary 
diversity in genome structure and composition, and in some instances, their genomes 
overlap those of the smallest bacteria (e.g., ~1.2-Mb amoeba virus vs. ~0.5-Mb 
Mycoplasma genitalium) [1, 2]. Among these viruses, the Phycodnaviridae family 
encompasses a morphologically similar but genetically diverse group of icosahedral 
double-stranded DNA (dsDNA) viruses that infect eukaryotic algal hosts from marine 
and freshwater environments [3]. Members of this group, as implied by the family name, 
are strictly DNA viruses that infect certain types of algae [4]. The phycodnaviruses are 
now recognized as key elements in the ecology of aqueous environments, playing a 
significant role in the dynamics of algal blooms, nutrient cycling, algal community 
structure, and possibly gene transfer between organisms [3, 5, 6, 7, 8, 9]. 
 Current estimates indicate that there are approximately 100,000 to several million 
species of algae; however only ~40,000 have been identified [10].  In addition, at any one 
time, as many of 20% of the photosynthetic microorganisms in the ocean (including 
prokaryotes) are infected with a virus [11]. From this perspective, if one considers that 
2only 150 phycodnaviruses have been partially characterized and approximately 100 
others have been mentioned in the literature, it indicates there is a vast array of algal 
viruses yet to be discovered [10]. At present, the phycodnaviruses are divided into six 
genera based on their host range: Chlorovirus, which includes the type-species 
Paramecium bursaria chlorella virus-1 (PBCV-1), Coccolithovirus, Phaeovirus,
Prasinovirus, Prymnesiovirus, and Raphidovirus [3, 4]. These divisions are supported by 
phylogenetical analysis using the DNA polymerase gene and fragments and whole gene 
sequences of the major capsid protein as markers (Fig. 1) [12]. The Chloroviruses are the 
only viruses that infect freshwater algae, while other members of the family are found in 
marine environments. The genomes of ten phycodnaviruses, represented by four genera 
(Chlorovirus, Coccolithovirus, Phaeovirus, and Prasinovirus) have been sequenced and 
their genomes range in size from 154 kb to 406 kb [10, 13, 14, 15]. However, this range 
is even larger since a virus infecting the microalga Pyramimonas orientalis with a 
genome of ~ 560 kb has been described [16]. Genome comparison between Chlorovirus,
Coccolithovirus and Phaeovirus members revealed that from a pool of approximately 
1000 genes, only 14 are shared among them. This suggests extraordinary viral diversity 
within the group and also indicates that group divergence was not a recent event [10]. 
 The phycodnaviruses are closely related to other large DNA viruses that infect a 
wide range of eukaryotic hosts including protists (mimivirus) and metazoans (poxviruses, 
African swine fever virus, and iridoviruses). Collectively, these viruses are referred to as 
Nucleo Cytoplasmic Large DNA Viruses (NCLDVs) with respect to their large size and 
replication site.  The genome size of members of this group ranges from 100 kb to 1.2 
Mb. They have nine common genes (core genes) involved in metabolic processes and  
3Figure 1. Phylogenetic tree based on alignment of DNA PolB protein sequences from 
the Phycodnaviridae family and mimivirus. Only the conserved region of the protein 
was used. The tree was rooted using homologous sequences from two iridoviruses FV-3 
and LCDV-1. Group A, clade of virus sequences with unknown hosts; group B, clade 
containing viruses infecting Pyramimonas orientalis; group C, different clusters of 
sequences from the metagenome survey Previous identified operational taxonomic unit 
4(OTUs) are indicated by name and GenBank accession number, while sequences 
obtained from the Sargasso Sea metagenome are indicated by accession number alone. 
Sequences reported in this study are marked in bold. Nodes with >75% bootstrap values 
are marked by black dots, while actual bootstrap values are shown for nodes with values 
between 50 and 75%. Currently assigned genus names are shown to the right of the tree. 
The scale bar indicates the number of amino acid substitutions per residue. Adapted from 
[12]. 
virus structure and they are thought to be monophyletic [17]. In addition, NCLDVs carry 
a diverse assemblage of not only prokaryotic and eukaryotic, but also archaeal, gene 
homologs. This high degree of genome diversity suggests that NCLDVs have an ancient 
origin, possibly predating the divergence of the three kingdoms of life [18]. Interestingly, 
sequence analysis, where available, indicates that NCLDV genomes are only distantly 
related to their host genome, contradicting the concept that frequent horizontal gene 
exchange occurs between virus and host.
 Starting with a short description of the algal host and the discovery of algal 
viruses, this chapter will then focus on the virus Paramecium bursaria chlorella virus 1 
(PBCV-1), the subject of this research. PBCV-1 general characteristics, the protein-
encoding genes (CDSs), and advances in the understanding of the infection cycle are 
reviewed. A comparison of PBCV-1 with other sequenced chloroviruses and a brief 
overview of other algal host systems will conclude the first chapter.   
52. THE ALGAL HOST CHLORELLA NC64A 
 Algae are one of the most important primary producers on Earth with a dominant 
impact on global productivity and biogeochemical cycling [19]. They are common in 
nature and can be found mostly in aquatic environments but also in terrestrials’ habitats. 
Algae constitute a diverse group of photosynthetic organisms, ranging from the most 
simple cell structure to large spreading seaweeds belonging to different phylogenetic 
groups and many taxonomic divisions. Algae constitute part of the phytoplankton 
responsible for the release of large amounts of oxygen into the atmosphere and account 
for over 50% of the fixed carbon on the planet. Because most algae require only light, 
simple salts, and a nitrogen source for growth, they are potential producers of proteins, 
carbohydrates, and fats for feeding humans and animals [20]. Furthermore, algae are a 
source of useful compounds such as E-carotene, alginic acid, carrageen, and agar. They 
are also used to remove heavy metals from wastewaters [21]. In addition, there is also a 
growing economical interest to use algae as a source for renewable biofuels as an 
alternative to fossil fuel [22, 23].
 Algae are currently classified in the Kingdom Protist. Cyanobacteria, or blue-
green algae, were traditionally considered to be algae; however, they were removed from 
this group because of their prokaryotic cell structure. The diversity within this group of 
organisms can be seen with: (i) the structure and composition of the cell wall (e.g., some 
algae have predominantly cellulosic cell walls and others have chitinaceous or silicacious 
wall; (ii) the characteristics of stored polysaccharides and lipids (e.g., starch, oil 
droplets); (iii) and the pigment molecules associated with light-harvesting antenna 
6complexes that drive photosynthetic electron transport (e.g., green algae have 
chlorophylls a and b and various carotenoids, red algae have phycobiliproteins, and 
diatoms and dinoflagellates have xanthophylls) [19].
 The genus Chlorella (Phylum Chlorophyta, Class Trebouxiophyceae) consists of 
small, spherical, unicellular green algae. Algae originally included in this genus (>100) 
are very heterogeneous; the GC composition of the genomic DNA from different species 
ranges from 43 to 79% [24]. The cell wall composition, containing a variety of 
polysaccharides and a small amount of protein and lipids, varies as well. This diversity is 
confirmed by recent molecular taxonomy analysis showing that many of the isolates 
originally classified as Chlorella species are in fact dispersed over two classes of 
chlorophytes, the Trebouxiophyceae and the Chlorophyceae [26, 27]. One such study 
suggests that only three Chlorella species should be included in the “true” Chlorella
genus, i.e., C. sorokiniana, C. lobophoro, and C. vulgaris str. Beijerinck [28]. 
Figure 2. P. bursaria with endosymbiotic algae. 
7Most Chlorella species are free-living, however, Chlorella sp. NC64A is a 
hereditary endosymbiont of the ciliate Paramecium bursaria (Fig. 2). Although they both 
retain the ability to grow independently, algal-free P. bursaria are rare in natural 
environments [29]. “Green” P. bursaria have several hundred Chlorella cells enclosed 
individually in the perialgal vacuole in the cytoplasm of the protozoan. Interestingly, 
timing in cell divisions for both algae and host is well coordinated and synchronized 
according to environmental conditions. The successful interaction is established by 
mutual symbiosis: (i) the host provides nitrogen components and CO2 to the algae and 
offers protection against viruses; (ii) the algae supply the host not only with 
photosynthetic products, maltose and oxygen, but also have a photoprotective role. In 
addition, P. bursaria grows better in the presence of algae and photosynthetic products of 
Chlorella are related to expression of circadian rhythms in the host [29]. 
 The genome of Chlorella sp. NC64A has recently been sequenced (G. Blanc et 
al., manuscript in preparation). The 46.2 Mb genome is predicted to encode 9, 791 
protein-encoding genes (CDSs) that are presumably distributed among 13 chromosomes. 
Chlorella NC64A has a nuclear genome with a high GC content (67%). It also contains a 
circular chloroplast DNA (~124 kb, 34% GC) and a partially sequenced circular 
mitochondrial DNA (~68 kb, 29% GC). Furthermore, Chlorella NC64A as well as other 
Chlorella species were previously thought to be non-motile and only reproduce 
asexually. However, gene annotation reveals the presence of a significant subset of 
proteins found in flagella and all the known meiosis-specific proteins. As expected, the 
genome content also shows adaptation to endosymbiosis with the presence of many cell 
8transporters and several families of proteins containing protein-protein interaction 
domains (Blanc et al., manuscript in preparation). 
3. THE DISCOVERY OF ALGAL VIRUSES 
The first report of virus infecting algae occurred in the Russian literature between 
1950s and 1966, where the authors describe the lysis of a free-living green alga, 
Chlorella pyrenoidosa [30, 31, 32, 33]. However, they acknowledged the fact that cells 
were contaminated with bacteria, and in fact, many of the reported viruses may have been 
bacteriophages. In the 1970s, several independent reports described the presence of 
viruses or virus-like particles (VLP) in algae: (i) viruses infecting Sirodotia tenuissima, a 
red algae [34]; (ii) viruses infecting Oedogonum sp., a green alga [35]; (iii) viruses 
infecting Chorda tomentosa, a brown alga [36], and (iv) viruses infecting the 
coccolithophore Emiliania huxleyi [37]. The first virus to eventually be classified as a 
phycodnavirus was isolated from the marine unicellular alga Micromonas pusilla in 1979 
[38]. These early observations were not further pursued by virologists for several reasons 
that include: (i) evidence for the presence of viruses in algae was solely microscopic and 
many times it corresponded to a single observation; (ii) in some cases, algae were field-
collected and they were no longer available for study; (iii) cultures were not axenic; (iv) 
technical problems regarding virus isolation (e.g., low concentration); (v) the inability to 
culture the host [20].
 In 1978, Kawakami and Kawakami [39] described virus-like particles in 
Chlorella isolated from the protozoan Paramecium bursaria. However, the virus particles 
9were neither isolated nor characterized. The beginning of algal virology as a field 
occurred in the early 1980s, when Van Etten and Meints [40] characterized a large virus 
with polyhedron structure present in the isolated symbiotic alga Chlorella isolated from 
Hydra viridis. They reported that the virus lysed the whole algal population in 24 h and 
virus particles were absent in endosymbiotic Chlorella. Further characterization 
determined that the virus possessed a 250 kb dsDNA with at least 19 structural proteins, 
including a 46 kDa major capsid protein. Six other hydra Chlorella viruses were isolated 
within a short time concurrently with the isolation of a virus from symbiotic Chlorella
from Paramecium bursaria, named Paramecium bursaria chlorella virus-1 (PBCV-1) 
[41, 42]. Initial restriction fragment analysis of all the chloroviruses revealed four 
different types of isolates and show no correlation between genomic composition and 
geographical origin of the viruses. Hydra Chlorella virus showed a very different DNA 
pattern from PBCV-1. Taking advantage of the fact that paramecium free-Chlorella can 
be grown in culture along with technical difficulties in isolating Chlorella from Hydra,
made the laboratory concentrate all the efforts in the study of the virus PBCV-1 [20]. 
 After testing many symbiotic and free-living Chlorella, three isolates supported 
PBCV-1 growth: NC64A, ATCC 30562, and N1a. Koch’s postulates for the virus were 
fulfilled and plaque-assay in lawns of NC64A was developed providing a sensitive 
bioassay for studies and is still used today. Subsequently, many viruses infecting 
Chlorella NC64A, called NC64A viruses, have been discovered from freshwater 
collected around the globe. 
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To date, viruses infecting endosymbiotic Chlorella (also referred to as 
chloroviruses) in association with Paramecium bursaria, Hydra viridis, and
Acanthocystis turfacea have been reported [43]. Chlorella NC64A and Chlorella Pbi are 
symbionts of P. bursaria, and their viruses are called NC64A viruses and Pbi viruses, 
respectively. Sequenced NC64A viruses are PBCV-1 and NY-2A, and sequenced Pbi 
viruses are MT325 and FR383 [44, 45]. Recently, a chlorovirus infecting Chlorella
isolated from the helizoon A. turfacea was sequenced and characterized and is referred to 
as ATCV-1 [46]. A comparative analysis of PBCV-1 and these other chloroviruses will 
be described later in this chapter.  
4. PARAMECIUM BURSARIA CHLORELLA VIRUS -1
Paramecium bursaria chlorella virus-1 (PBCV-1) is the prototype of the 
Phycodnaviridae family, a group of large, icosahedral, plaque-forming, dsDNA viruses 
that infect certain freshwater chlorella-like green algae. PBCV-1 infects Chlorella 
NC64A, a natural endosymbiont green alga of the protozoa Paramecium bursaria.
PBCV-1 has a linear 330,744 bp non-permutated dsDNA genome with a GC content of 
approximately 40%. The ends of the PBCV-1 genome form a hairpin loop-like structure 
consisting of a 35 nucleotide-long region that is covalently closed and unevenly base-
paired [47]. The 35-nucleotides are complementary when the sequences are inverted. 
Adjacent to the hairpin ends are identical 2221 bp repeats that possibly house the 
initiation point for DNA replication site [48]. The PBCV-1 genome also contains 
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methylated nucleotides (1.9% of the cytosines are m5C and 1.5% of the adenines are 
m6A) [20, 49, 50].
4.1. PBCV-1 structure 
PBCV-1 has a multilayer structure, with an outer glycoprotein capsid that 
surrounds a lipid bilayer membrane and a dsDNA genome [51, 52]. Vp54, a glycoprotein 
and the major component of the capsid, represents about 40% by weight of the total 
protein content in the virus. The crystal structure of Vp54 showed that the subunit 
consists of two 8-stranded, antiparallel E-barrel, “jelly-roll” domains. The monomeric 
VP54 forms a trimeric capsomer (a “major capsomer”), which has pseudo-6-fold 
symmetry, relating the jelly-roll structures [52].
 Using cryoelectron microscopy (cryoEM) and assuming icosahedral symmetry 
[51], it has been shown that the virion has a diameter ranging from 1.650 Å, measured 
along the 2-fold and 3-fold axes, and  1,900 Å, measured along the 5-fold axes. The 
PBCV-1 glycoprotein shell is composed of 20 triangular units, or “trisymmetrons”, and 
12 pentagonal caps, or “pentasymmetrons” at the 5-fold vertices. Each trisymmetron and 
pentasymmetron consists of a pseudohexagonal array of 66 and 30 trimeric casomers, 
respectively. The triangulation number (T) is 169d (h = 7, k = 8), where T represents the 
number of jelly rolls in the icosahedral asymmetric unit [53].
 Recent 5-fold symmetry, 3D reconstruction analyses indicate that PBCV-1 has a 
quasiicosahedral structure, which means it does not have a perfect icosahedral 
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conformation. Instead, it has a unique vertex composed of special capsomers (Fig. 3) 
[53]. The unique vertex contains a pocket on the inside and a cylindrical spike structure 
on the outside of the capsid (Fig. 3). While this pocket is predicted to house enzymes to 
be used in the initial stages of the infection (i.e., cell wall degrading enzymes), the spike 
might be used to puncture the host cell, similar to the ones described in some 
bacteriophages [53]. The spike is too narrow for DNA to pass through it.
Figure 3. The 5-fold-averaged cryoEM structure of PBCV-1 viewed down a quasi-2-
fold axis. (A) Hexagonal arrays of major capsomers form trisymmetrons and 
pentasymmetrons (yellow). The unique vertex with its spike structure is at the top. 
Capsomers in neighboring trisymmetrons are related by a 60° rotation, giving rise to the 
boundary between trisymmetrons. (B) Central cross-section of the cryoEM density. (Scale 
bar: 500 Å.) (C) The same view as in B but colored radially, with red density being 
within 680 Å, yellow between 680 and 745 Å, green between 745 and 810 Å, light blue 
between 810 and 880 Å, and dark blue greater than 880 Å. Note the typical lipid low-
density gap surrounding the red nucleocapsid density. Figure from [53]. 
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4.2. PBCV-1 CDSs 
 Initial sequencing of the PBCV-1 genome revealed 697 potential open reading 
frames (ORFs), of which 373 were predicted to be protein-encoding genes (CDSs) [54, 
55, 56, 57, 58]. A CDS is defined here as a gene sequence flanked by start and stop 
codons that presumably codes for a protein, as opposed to tRNAs genes. The following 
criteria were used to define a CDS: (i) minimal size of 65 codons or more initiated by an 
ATG site; (ii) the largest CDS was chosen when CDSs overlapped; (iii) the putative 
promoter region (50 nucleotides upstream of the start codon) is AT-rich (>70%). The 
total number of CDSs from PBCV-1 has changed since the first publication describing 
the sequence because of sequencing mistakes. Now, the following CDSs are considered 
to be a single CDS: A92/93L, A111/114R, A122/123R, A140/145R, A181/182, 
A189/192, A219/222/226R, and A554/556/557L. The former annotation number is 
maintained to avoid confusion. It is possible that other CDSs will be detected with the 
upcoming re-sequencing of PBCV-1 and other chloroviruses. In addition, sequence 
comparisons with other chloroviruses help to identify sequencing mistakes. Currently, 
PBCV-1 is predicted to encode 365 CDSs [59]. The CDS density is 1.11 CDS/kb, which 
is similar to that reported for other large DNA viruses (e.g., Ostreococcus tauri virus-5 is 
1.45 CDS/kb and Feldmania sp. virus-1 is 0.968 CDS/kb) [13, 15].
PBCV-1 CDSs are evenly distributed on both strands of the virus genome and 
intergenic space is minimal (>100 nucleotides). The exception is a 1788 nucleotide 
region near the middle of the genome that contains many stop codons and harbors 11 
tRNA genes. In addition, this area has 900 nucleotides that are GC rich (>60%) and the 
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observed-to-expected ratio of CpG dinucleotides is 1.45, characteristics of a CpG island.  
The 2221 bp inverted terminal repeat region contains 4 duplicated CDSs [55, 60]. 
 Approximately 35% of the PBCV-1 CDSs have a match in the public databases 
and these can be classified into a cluster of orthologous groups (COG) according to their 
putative functions. The CDSs resemble genes from all three domains of life, with the 
majority being bacterial-like. Prokaryotic CDSs tend to be clustered in islands towards 
the extremity of the virus genome and are co-localized with bacterial-like insertion 
sequences [18]. The functions of at least 44 PBCV-1 recombinant proteins have been 
characterized and show the expected activity [61]. Interestingly, a few PBCV-1 proteins 
revealed unusual characteristics. For example, some proteins are bifunctional (e.g., 
dCMP deaminase can also function as a dCTP deaminase) [62]; other virus-encoded 
enzymes have extremely high activity (e.g., virus topoisomerase II activity is 30x faster 
than human topoisomerase II) [63, 64]; and a few PBCV-1 proteins were the first 
characterized from a virus (e.g. K+ ion channel protein) [65]. A detailed description of 
PBCV-1 CDSs according to their COG as well as highlights of current research will be 
presented. A review of PBCV-1 infection cycle will follow.  
DNA replication, recombination, and repair 
 It is assumed that early PBCV-1 CDSs are transcribed in the nucleus, translated in 
the cytoplasm, and the proteins then return to the nucleus to initiate virus DNA synthesis 
(60-90 min p.i.) [66]. Large DNA viruses are known to code for most of the machinery 
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needed for viral DNA replication. Thus, PBCV-1 encodes 18 CDSs involved in DNA 
replication, recombination, and repair.  
 For the DNA replication process, PBCV-1 encodes a DNA polymerase G family 
protein (A185R) that contains a proof-reading 3’-5’ exonuclease domain [67]. This gene 
has a 101-nucleotide (nt) intron that is spliceosomal-processed [68].  This presence of this 
intron was recently confirmed by the transcriptome sequencing of infected Chlorella
NC64A at 20 min p.i. (G. M. Yanai-Balser, unpublished results). PBCV-1 also encodes 
two sliding clamp processivity factor proteins (PCNA) (A193L and A574L). It is unlikely 
that they are a result of gene duplication as they have low similarity at the amino acid 
level (26%) and more closely resemble PCNAs from other organisms than with each 
other. PCNAs not only interact with enzymes involved in DNA replication but also with 
enzymes involved in DNA repair and post-replicative processing such as DNA 
methyltransferases and DNA transposases [69]. Since PBCV-1 encodes proteins involved 
with DNA repair, DNA methylation, and transposases, it is possible that the two PCNAs 
serve different roles in PBCV-1 replication.  
 PBCV-1 also encodes a replication factor C (RFC) (A417L), a protein complex 
required for the ATP-dependent loading of PCNA onto DNA in eukaryotes and archaea 
[70, 71]. RFCs from eukaryotes and the corresponding protein (called J-complex) in 
bacteria are heteropentamers, whereas RFC from archaea are heterodimers [72, 73]. 
PBCV-1’s RFC resembles the archaea protein.  
 Other proteins possibly involved directly in DNA replication include an ATP-
dependent DNA ligase (A544R), an RNase H (A399R), and a type II DNA 
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topoisomerase (A583L). The PBCV-1 topoisomerase II is smaller than other 
characterized topoisomerase II enzymes and it has a 30x greater DNA cleavage 
processivity than human topoisomerase IIa [64]. The viral enzyme lacks a nuclear 
localization signal and PSORT analysis predicted that the virus topoisomerase II resides 
in the cytoplasm. Assuming this is true and viral DNA replication occurs in the host cell 
nucleus, this suggests the enzyme has a role in DNA packaging which does occur in the 
cytoplasm [61]. 
 PBCV-1 also encodes an archaeo-like DNA primase (A468R) that initiates 
synthesis of new DNA strands by synthesizing short RNA oligomers on ssDNA [74]. In 
addition, this primase displays amino acid sequence similarity to a specific class of 
trifunctional primase/helicase/origin recognition proteins (M. Griep, personal 
communication). The helicase portion of the viral protein resembles the superfamily III 
helicases. A DNA binding protein (A437L) is located in the virion and is predicted to aid 
in neutralizing virus dsDNA.  
 PBCV-1 encodes a 5’-3’ exonuclease homolog (A166R), which is probably 
involved in DNA recombination and it is known to be functional. In a study using 
temperature-sensitive mutants, it was established that genetic recombination occurs in 
PBCV-1 at a frequency of ~2% [75]. Finally, the virus has a CDS encoding a homolog of 
the bacteriophage T4 pyrimidine dimer-specific glycosylase (PDG). This is a well 
characterized DNA repair enzyme involved in pyrimidine photodimer excision [76]. 
Comparative studies revealed that PBCV-1 PDG cleaves both cys-syn and trans-syn II
cyclobutane pyrimidine dimers, whereas the T4 enzyme only cleaves the cis-syn form. 
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PBCV-1 PDG also excises two other monomeric products induced by UV radiation or 
hydroxylradicals, 4,6-diamino-5-formamidopyrimidine and 2,6 diamino-4-hydroxy-5-
formamidopyrimidine [77]. Moreover, PBCV-1 PDG is more processive than the T4 
enzyme and is the first trans-syn II specific glycosylase identified to date.
DNA restriction/modification
PBCV-1 and other chloroviruses genomes have varying amounts of methylated 
nucleotides. Cytosine methylation (m5C) can range from 0.12% to 47.5% of the total 
cytosine and adenine methylation (m6A) varies from 1.5% to 37%.  The finding that 
methylated bases occur at specific DNA sequences led to the discovery of virus encoded 
restriction/modification (R/M) systems [49, 50].  DNA methyltransferases (MTases) 
protect the DNA from cleavage by methylating one of the bases in the same nucleotide 
sequence, and DNA restriction endonuclease (REases) recognize and cleave specific 
nucleotide sequences.  The number of virus-encoded MTases and REases varies among 
the different chloroviruses.  About 25% of the virus-encoded DNA MTases have a 
companion REases.  
PBCV-1 has two R/M systems: (i) the CviAI R/M system, which consists of the 
REase R.CviAI (A252R) (cleaves /GATC, but not GmATC sites) and the adenine MTase 
M.CviAI (A251R) (methylates GATC sequences) [78], (ii) the CviAII system consists of 
R.CviAII (A579L) (cleaves C/ATG, but not CmATG) and the adenine MTase M.CviAII 
(A581R) (methylates CATG sequences) [79]. In addition to these two R/M systems, 
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PBCV-1 also encodes three other MTases (A517L, A530R, A683L) but they lack a 
companion REase [61].  
Until recently, the biological function of the virus encoded R/M systems was 
unknown. However, analysis of host chromosomal DNA in PBCV-1-infected cells using 
pulsed-field gel electrophoresis revealed that host chromosomes were degraded within 
minutes after PBCV-1 infection (2-5 min p.i.).  The DNA degradation was impervious to 
protein synthesis inhibitors or UV inactivation of virus particles, indicating that a virion 
packaged protein, probably is the cause.  Mass spectrometry analysis of PBCV-1 virion 
revealed that the two PBCV-1 REases were present in the virion but not their companion 
MTases (D. Dunigan, manuscript in preparation).  Nuclease activities, including those of 
the two known REases and an uncharacterized general nuclease(s), were detected in 
disrupted PBCV-1 particles.  This nuclease(s) degraded host and virus DNA in vitro,
however, it did not degrade virus DNA in vivo, suggesting differential intracellular 
trafficking of the virion-associated nucleases [80]. 
Nucleotide metabolism 
 Host chromosome degradation starts 2-5 min after PBCV-1 infection [80]. Virus 
DNA replication begins 60-90 min p.i. and by 4 h p.i., the total DNA in the cell increases 
at least four to five-fold [61]. With a ~330 kb genome, PBCV-1 requires a large quantity 
of dNTPs for replication that cannot be accounted for by simply recycling 
deoxynucleotides from degraded host DNA. To guarantee a supply of deoxynucleotides 
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in non-proliferating host cells, large DNA viruses frequently encode nucleotide synthesis 
enzymes. PBCV-1 genome encodes 11 CDSs involved in nucleotide metabolism and 
many of them have been functionally characterized.  
 Most PBCV-1 nucleotide enzymes are directed to the de novo dTTP synthesis 
pathway (Fig. 4) by producing key intermediates in dTTP formation [62]. PBCV-1 
encodes: (i) the two subunits for ribonucleotide reductase (A476R and A629R), which is 
responsible for the reduction of UDP or UTP to dUDP and dUTP, respectively (Fig 4A); 
(ii) the first known bifunctional dCMP deaminase (A596R) that deaminates dCMP into 
dUMP and also deaminates dCTP to dUTP (Fig. 4B and C, respectively) [62]; (iii) the 
deoxyuridine triphosphatase (dUTPase) (A551L) that catalyzes the hydrolysis of dUTP to 
dUMP and PPi. PBCV-1 dUTPase forms a trimer and has properties similar to dUPTases 
from eukaryotes, bacteria and other viruses (Fig 4D) [81]; (iv) a FAD-dependent 
thymidylate synthase X (ThyX) (A674R) (Fig 4E). This was unexpected because most 
organisms have the homodimeric thymidylate A (ThyA) enzyme. However, the PBCV-1 
enzyme resembles the homotetramer ThyX, common in pathogenic bacteria. While ThyA 
uses the substrate methylenetrtrahydrofolate as both methylene donor and reductant, 
ThyX uses it only as methylene donor. The PBCV-1 recombinant protein converts dUMP 
to dTMP more efficiently than other characterized ThyXs [82].
Recombinant proteins from most of these enzymes involved in nucleotide 
synthesis were functionally characterized, except for ribonucleotide reductase. It is not 
surprising that many PBCV-1 nucleotide CDSs encode enzymes involved in the three 
pathways that lead to dUMP production, possibly as a means to compensate for 
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differences in DNA content of the host (PBCV-1 genome is 40% GC and host Chlorella
NC64A nuclear genome is 67% GC. 
Figure 4. The three known pathways for synthesis of dUMP, an intermediate in dTTP 
synthesis. The enzymes shown in the diagram in red are encoded by chlorovirus PBCV-1. 
Asterisks indicate enzymes known to be functional. Adapted from [62]. 
In addition, PBCV-1 encodes an aspartate transcarbamylase (ATCase) (A169R), a 
key regulatory enzyme that controls the de novo biosynthetic pathway of pyrimidines. 
PBCV-1 ATCase resembles several plant ATCases including the catalytic domain; 
however, it lacks the regulatory domain [83]. Recently, the PBCV-1 glutaredoxin 







to ribonucleotide reductase [84]. PBCV-1 glutaredoxin contains an unusual monothiol 
active site rather than the typical dithiol active site. 
 Other PBCV-1 enzymes predicted to be involved in nucleotide metabolism 
include deoxynucleoside kinase (A416R), thioredoxin (A427L), cytosine deaminase 
(A200R), and NTP pyrophosphohydrolase (A326L).
Transcription
  A whole genome transcription analysis using microarrays has been done for 
PBCV-1 virus and details about the time of expression of each CDS will be discussed in 
Chapter II. PBCV-1 gene expression is temporally regulated and the first viral transcripts 
are detected 5-10 min p.i. and chloroplast, but not cytoplasmic, rRNA degradation begins 
about 30 min p.i. [85].  Virus infection rapidly inhibits most host transcription. The virus 
has at least two ways to inhibit host transcription: (i) by host chromosome degradation 
using viral encoded restriction endonucleases, and (ii) by methylating histone H3 at 
Lys27 using a viral encoded vSET (A625L) [86]. PBCV-1 vSET is a small 120 amino 
acid proteins that contains a nuclear localization signal and is known to trigger gene 
silencing in eukaryotes. Both restriction endonuclease(s) and vSET are packaged in the 
PBCV-1 virion (Dunigan, manuscript in preparation).
 A few PBCV-1 CDSs can overlap or possibly form polycistronic transcripts. The 
virus can also post-transcriptionally modify mRNAs since introns are present in at least 
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two PBCV-1 CDSs (DNA polymerase [A185R] and TFIIS [A125L]). Transcripts also 
often extend beyond the translational stop codon [87, 88, 89] and this is confirmed by the 
preliminary analysis of a recent transcriptome-sequencing project (Yanai-Balser, 
unpublished). Recently, three putative promoter sequences were identified for PBCV-1 
CDSs and their relationship with time of expression will be reported in Chapter III.  
 PBCV-1 encodes many genes involved in transcription; however, it still depends 
on host transcription machinery because it does not encode a recognizable RNA 
polymerase or a subunit of it. No RNA polymerase activity was detected in purified 
PBCV-1 virions. The lack of a virus-encoded RNA polymerase suggests that infecting 
viral DNA must go the cell nucleus and a host RNA polymerase initiates viral 
transcription, possibly in conjunction with virus-packaged transcription factors. 
Consistent with this possibility, PBCV-1 encodes at least three transcription factor-like 
elements: (i) TFIIB (A107L); (ii) TFIID (A552R); (iii) TFIIS (A125L). 
 Other PBCV-1 CDSs involved in transcription are two enzymes involved in 
forming the mRNA cap structure, RNA triphosphatase (A449R) [90] and RNA 
guanylyltransferase (A103R) [91]. The size, amino acid sequence, and biochemical 
properties of the PBCV-1 capping enzymes resemble yeast-capping enzymes more than 
poxvirus and African swine fever virus multifunctional RNA capping enzymes [92, 93].  
 PBCV-1 also encodes an active RNAse III (or ribonuclease III) (A464R), which 
is a multifunctional, ubiquitous enzyme present in prokaryotic and eukaryotic organisms.  
RNAse III is involved in the processing of cellular and viral precursor RNAs to produce 
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mature functional rRNAs, mRNA, and tRNAs. It is also involved in the degradation of 
specific mRNAs and recognizes dsRNA structures and cleaves them at specific sites. 
Orthologs of this enzyme also participate in gene inactivation by RNA interference and in 
gene regulation during development. PBCV-1 RNAse III resembles bacterial enzymes 
both in size and its activity is presumably responsible for processing either virus mRNAs 
or tRNAs [94]. According to Nishida et al. (1999) [95] tRNAs from the chlorovirus 
CVK2 are transcribed as a polycystronic message at early and late times after infection 
and are aminoacetylated in vivo [95].
 Lastly, PBCV-1 encodes three proteins that contain sequence elements of 
superfamily II helicases (A153R, A241R, 363R) that are probably involved in 
transcription. A CDS for a SWI/SNF helicase (A548L) and a SWI/SNF chromatin 
remodeling complex (A189/192R) are also present in the PBCV-1 genome.  
    
Protein synthesis, modification, and degradation 
 PBCV-1 infection inhibits host protein synthesis and some early virus proteins 
appear within 15 min p.i. Viral proteins are synthesized on the cytoplasmic ribosomes 
and not on organellar ribosomes since cycloheximide, not chloramphenical, inhibits viral 
replication [96]. The mechanisms which allow the virus to take over the host translational 
machinery forcing it to translate virus mRNAs are not known.
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 PBCV-1 codon usage is biased to codons ending in A/U (63%) over those ending 
in C/G (37%). This bias is expected since PBCV-1 DNA is 40% GC, whereas host 
nuclear DNA is 67% GC (Blanc et al, manuscript in preparation). Therefore, finding that 
PBCV-1 encodes 11 tRNA genes is not surprising, as viral tRNAs might overcome codon 
usage barriers that exist between virus and its host ensuring virus maximal replication 
potential. Some chloroviruses encode as many as 16 tRNAs [95, 97]. There is a strong 
correlation between the abundance of virus-encoded tRNAs and the virus gene codon 
usage.  The virus encoded tRNAs contain internal A and B boxes characteristic of RNA 
polymerase III promoter elements, suggesting that tRNAs might be transcribed 
individually by RNA polymerase III. However, as mentioned previously, chlorovirus 
tRNA genes are transcribed as a large precursor RNA and processed via intermediates to 
mature tRNA at both early and late stages of virus replication. Some, if not all, of the 
tRNAs are aminoacetylated in vivo, suggesting they probably function in viral protein 
synthesis [95].
 The chloroviruses were the first viruses reported to encode a translation 
elongation factor enzyme (EF-3) [98]. The putative protein from PBCV-1 (A666L) is 
similar to EF-3 from fungi, which is known to stimulate EF-1D-depending binding of 
aminoacyl-tRNA to the A site of the ribosome. Like fungal EF-3 proteins, the PBCV-1 
protein has an ABC transporter family motif and two ATP/GTP-binding site motifs. 
Possibly, the virus-encoded EF-3 in combination with the viral tRNAs alter the host 
protein synthetic machinery to preferentially translate viral mRNAs.
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 Including glycosylation (discussed in the Sugar Metabolism section), PBCV-1 
encodes several enzymes involved in post-translational modification. Like several large 
dsDNA viruses, PBCV-1 encodes an ERV/ALR protein that functions as a protein thiol 
oxireductase (465R) [99]. PBCV-1 also encodes a putative protein disulfide isomerase 
(A448L) and a prolyl 4-hydroxylase (A85R) that converts Pro-containing peptides into 
hydroxyl-Pro-containing peptides and was functionally characterized [100]. As many as 8 
putative protein kinases are present in the PBCV-1 genome and will be described in the
Signaling section. 
 PBCV-1 encodes two putative proteins that interact with ubiquitin, a ubiquitin C-
terminal hydrolase (A105L) and a Skp1 protein (A39L). This last protein belongs to the 
SFC-E3 ubiquitin ligase family that target cell cycle and other regulatory factors for 
degradation. Other PBCV-1 CDSs possibly involved with protein degradation are a zinc 
metallopeptidase (A604L) and a ATPase (AAA+ class) (A44L).
Signaling
PBCV-1 was the first virus discovered to encode a functional K+ channel protein. 
The 94-amino acid protein (called Kcv) produces a K+ selective and slightly voltage-
sensitive conductance in Xenopus oocytes [65], mammalian HEK293 (human embryonic 
kidney cells) [101] and Chinese-hamster ovary cells [102]. Kcv has minimal structure: 
the channel monomer consists of two transmembrane domains (TM), a pore loop, and a 
12 amino acid-long cytoplasmic N-terminus. Like other K+ channels, PBCV-1 Kcv forms 
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a functional tetramer and electrophysiology experiments established that it has many 
properties similar to more complex K channels, including gating, selectivity, sensitivity 
to voltage, and susceptibility to channel blockers. 
 The biological function of PBCV-1 Kcv is hypothesized to be involved in host 
membrane depolarization upon infection [103]. Virus attaches and degrades the Chlorella
host cell wall, which is followed by fusion of the viral internal membrane and the host 
membrane. This facilitates entry of the viral DNA and virion-associated proteins into the 
cell, leaving an empty virus capsid on the outside. Rapid depolarization of the host 
membrane occurs and results in an immediate loss of K+ from the host, a process which 
energetically favors ejection of viral DNA into the host [104]. Virus competition assays 
indicated that host membrane depolarization might also prevent the infection of the host 
by another virus [105]. 
 Additional PBCV-1 signaling proteins include eight Ser/Thr protein kinases (PK) 
(A34R, A248R, A277L, A278L, A282L, A289L, A614L, A617R). A Ser/Thr PK 
(A248R) is adjacent to the Kcv CDS (A250R). Some of the PKs are clustered in the 
PBCV-1 genome and recombinant proteins from all of them have been biochemically 
tested and shown to be functional (P. Valbuzzi, unpublished results). 
Cell wall degradation 
 Recent genomic analysis of virus the host, Chlorella NC64A, indicates it encodes 
a complex array of synthesizing and modifying polysaccharides (Blanc et al., manuscript 
27 
in preparation). Surprisingly, genes involved in the synthesis of cellulose and hemi-
cellulose, major components of the primary cell wall of green plants, are absent. Instead, 
paralogs for chitin synthase and 25 paralogs for chitin deacetylase (which converts chitin 
into chitosan) are present. Two chitinase- encoding genes (plant and bacterial types) and 
four chitosanase genes for the degradation of chitin and chitosans are also present. As 
mentioned previously, the cell wall of Chlorella species, including Chlorella NC64A,
contains glucosamine polymers. 
 Consequently, to be able to penetrate the host, PBCV-1 and other chloroviruses 
have CDSs involved with chitin and chitosan degradation, including two chitinases 
(A181/182R, A260R), a chitosanase (A292L), a E-1,3-glucanase (A94L), and E and D 1,4 
linked glucuronic lyase (A215L). Recombinant proteins produced from these five genes 
have the expected enzyme activities [106, 107, 108, 109, 110, 111, 112].  All of these 
proteins, except for the E-1,3-glucanase, are expressed late; however, none of them are 
packaged in the virion (Dunigan, manuscript in preparation).  The chitosanase CDS was 
studied in another chlorovirus, CVK2, and it is transcribed late and encodes two proteins 
with chitinase activity (37 kDa and 65 kDa). The larger protein is packaged in nascent 
virions, whereas the smaller one occurs only in infected cells [112]. Interestingly, PBCV-
1 contains the same chitinase CDS flanked by two CDSs common to CVK2. 
 Phylogenetic analysis of chitosanase and chitin synthase from the host Chlorella 
NC64A and PBCV-1 indicate the sequences are evolutionary related. However, no direct 
evidence for gene exchange was obtained. The fact that higher plants do not have gene 
families encoding enzymes involved in either chitin or chitosanase synthesis suggests that 
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the host genes involved in chitin metabolism might have come from the viruses, 
contradicting the concept that viruses always acquire genes from their hosts.  
Sugar metabolism 
 The PBCV-1 genome encodes several enzymes involved in nucleotide sugar 
metabolism including two enzymes from the highly conserved pathway that converts 
GDP-D-mannose to GDP-L-fucose: (i) GDP-D-mannose 4,6 dehydratase (GMD) 
(A118R) and (ii) the bifunctional GDP-4-keto-6-deoxy-D-mannose epimerase/reductase 
(GMER) (A295L). Experiments with recombinant GMD and GMER established that 
both virus proteins have properties comparable to human and bacterial enzymes, however 
PBCV-1 GMD is more stable than GMDs from other organisms. In addition to the 
dehydratase activity, the PBCV-1 GMD also catalyzes NADPH-dependent reduction of 
the intermediate GDP-4-keto-6-deoxy-D-mannose, forming GDP-D-rhamnose. As a 
consequence, in vitro reconstruction of the biosynthetic pathway using PBCV-1 GMD 
and GMER produces both GDP-L-fucose and GDP-D-rhamnose in the presence of 
NADPH [113].  
 Fucose and rhamnose are present in the glycans attached to the virus major capsid 
protein, Vp54. However, uninfected Chlorella NC64A cell walls contain rhamnose and 
trace amounts of fucose [114], suggesting that the virus-encoded pathway could 
circumvent a limited supply of GDP-sugars by the host.  Other genes involved in sugar 
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metabolism are D-lactate-dehydrogenase (A53R) and fructose-2,6-biphosphatase 
(A297L) but their functions have not been tested. 
- Protein glycosylation
 Structural proteins of many viruses, including herpesviruses, poxviruses, and 
paramyxoviruses, as well chloroviruses, are glycosylated. Typically, viral proteins are 
glycosylated by host-encoded glycosyltransferases located in the endoplasmic reticulum 
(ER) and Golgi, and then transported to a host membrane [115, 116]. Nascent viruses 
acquire the glycoprotein(s) and only become infectious by budding through the 
membrane, usually as they are released from the cell. Consequently, the glycan portion of 
virus glycoproteins is host-specific.
 Several observations indicate that chloroviruses differ from the above scenario: (i) 
PBCV-1 Vp54, the major capsid protein located on the viral surface, is one of the three 
glycosylated viral proteins. The glycan portion of Vp54 contains several neutral sugars 
that contribute to the protease resistance and antigenicity of the virus [117]. Polyclonal 
antibodies to wild-type PBCV-1 and its antigenic variants do not react with many other 
independent virus isolates that infect Chlorella NC64A. (ii) Vp54 crystal structure 
revealed four N-linked glycosylation sites and two O-linked oligosaccharides. However, 
the four glycosylated Asn resides are not located in consensus sequences typical of 
eukaryotic N-linked glycans [52]. (iii) PBCV-1 encodes most, if not all, 
glycosyltransferases involved in constructing the glycans attached to Vp54 (A64R, 
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A111/114R, A219/222/226R, A473L, and A546L). None of these have an identifiable 
signal peptide that would target them to the ER. Furthermore, cellular protein localization 
analysis using PSORT predicts that all of these proteins, except for A473L which is 
predicted to localize in a membrane, are cytoplasmic.     
- Host cell surface changes
 PBCV-1 is unusual because it encodes the enzyme hyaluronan synthase (HAS) 
(A98R) that synthesizes hyaluronan (or hyaluronic acid) [118, 119]. Hyaluronan is a 
ubiquitous constituent of the extracellular matrix in vertebrates, and consists of ~20,000 
alternating E-1,4-glucuronic acid and E-1,3-N-acetylglucosamine residues [120]. 
Hyaluronan synthesis occurs at the plasma membrane and is simultaneously extruded 
through the membrane to the exterior of the cell. Previously, hyaluronan was thought to 
occur only in vertebrates and a few pathogenic bacteria, where it forms an extracellular 
capsule, presumably to avoid the immune system [120, 121].
 PBCV-1 also encodes two enzymes involved in the biosynthesis of hyaluronan 
precursors, glutamine:fructose-6-phosphate amidotransferase also known as glucosamine 
synthase (A100R) and UDP-glucose-dehydrogenase (UDP-GlcDH) (A609L) [121]. All 
three CDSs are expressed early during PBCV-1 infection. These results let to the 
discovery that hyaluronan lyase-sensitive hair-like fibers begin to accumulate on the 
surface of PBCV-1 infecting host cells by 15 min p.i. and by 4 h p.i. the infected cells are 
covered with a dense fibrous hyaluronan network [119].
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 HAS is present in many, but not all, chloroviruses isolated from diverse 
geographical regions [119]. Surprisingly, many chloroviruses that lack HAS have a gene 
encoding a functional chitin synthase (CHS). Furthermore, cells infected with these 
viruses produce chitin fibers on their external surface [122]. Chitin, an insoluble linear 
homopolymer of E-1,4-linked-N-acetyl-glucosamine residues, is a commom component 
of insect exoskeletons, shells of crustaceans, fungal and algal cell walls [123]. A few 
chloroviruses contain both HAS and CHS CDSs, and form both hyaluronan and chitin on 
the surface of their infected cells [122, 124]. Finally, a few chloroviruses probably lack 
both genes because no extracellular polysaccarides are formed on the surface of infected 
cells [119]. The fact that many chloroviruses require a huge expenditure of ATP for their 
synthesis, are important in the virus life cycle. However, at present this function(s) is 
unknown.
Lipid metabolism 
PBCV-1 encodes six enzymes involved in lipid metabolism. A patatin-like protein 
(A173L) is present in the virus genome. Patatins are plant storage glycoproteins that have 
lipolytic activity and they are thought to serve as a defense against plant parasites and 
they have been shown to participate in plant signal transduction. Many bacteria also 
encode patatin-like proteins [125]. In addition, two acetyltransferases (A254R and 
A654L), a glycerophosphoryl diesterase (A49L), a lysophospholipase (A271L), and a 
lipoprotein lipase (A402R) are also encoded by PBCV-1.
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Integration and Transposition 
 PBCV-1 has a large number of CDSs involved with genome integration and 
transposition: seven GIY-YIG endonucleases (A539R, A351L, A134L, A287R, A315L, 
A495R, A651L), six HNH endonucleases (A478L, A354R, A422R, A490L, A267L, 
A87R), and two transposases (A625R, A366L). Currently, the functions of these CDSs 
are unknown. 
Structural proteins 
 SDS-PAGE mass-spectrometry revealed ~130 proteins associated with the 
PBCV-1 virion (Dunigan et al., unpublished results). At least 9 CDSs are predicted to 
serve a structure role in the virion. They include the major capsid protein (A430L), 
A140/145R, 189/192R, A363R, A384L, A540L, A558L, A561L, A622L. Homologs of 
all of these proteins are present in the virions of other chloroviruses.  
Polyamine biosynthetic enzymes 
 Polyamines are small cationic organic molecules that are known to have an 
important role in the replication of many viruses. They are present (as putrescine, 
spermidine and spermine) in large amounts in the capsid of some viruses, where they can 
neutralize up to 50% of the viral nucleic acid. In some instances, virus infection can 
result in an increase in polyamines in the host cell and inhibition of polyamine synthesis 
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can interfere with virus replication. In contrast, host polyamines can also confer 
resistance to some viruses. All of these reports have assumed that polyamines are made 
by the host cells. PBCV-1 is unusual because it encodes four enzymes for the polyamine 
biosynthesis: (i) ornithine decarboxylase (ODC) (A207R), which converts ornithine to 
putrescine, but can also use arginine as a substrate. Because of its dual function and 
because it shows higher activity with arginine, currently the virus ODC is reclassified as 
ODC/ADC (A207R) [126]. The virus also encodes two enzymes necessary to produce 
putrescine from agmatine: (ii) agmatine iminohydrolase (A638R) and (iii) N-
carbamoylputrescine amidohydrolase (A78R). In addition, PBCV-1 encodes (iv) 
homospermidine synthase (HSS) (A237R) [127] that synthesizes the rare polyamine 
homospermidine from two molecules of putrescine. Because spermidine synthase is 
lacking, the end product of the pathway in the virus is likely homospermidine. All of 
these four recombinant polyamine enzymes were functional [126, 127, 128].  
 The importance of polyamines in PBCV-1 pathogenesis remains unclear since the 
host cell also produces polyamines. Little change occurs in either polyamine 
concentration or in composition (putrescine, cadaverine, spermidine, and 
homospermidine are present) during the first hour of virus infection [127]. However, by 
240 min p.i., the concentration of putrescine increases about 3.5-fold, whereas the other 
polyamines decrease. The net result is that polyamine concentration decreases slightly 
during virus replication. Also, it is unlikely that polyamines play a role in neutralizing 
virus DNA because the number of polyamine molecules per PBCV-1 virion is so low that 
they can only neutralize ~0.2% of the virus phosphate residues. Furthermore, the 
physiological significant of the polyamines in the PBCV-1 particles must be limited 
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because they are only loosely associated with the virions (they can be replaced by Tris or 
displaced by washing the particles in a polyamine-free buffer without affecting virus 
infectivity [127].
4.3. Current infection cycle 
PBCV-1 binds to the host cell and specifically attaches to the cell wall probably at 
a unique vertex [53]. Following attachment, virus punctures a hole in the cell wall and 
cell membrane using a spike-like structure. It has been suggested that the spike is then 
released because of the lower density linking the spike and the unique vertex [53]. Host 
cell wall degrading enzymes possibly located in the virus “pocket” [53] at the unique 
vertex are released and the host cell wall is degraded at the point of contact (Fig. 4A).  
 The virus internal membrane fuses with host plasma membrane, causing a K+
efflux possibly mediated by viral K+ ion channel (Kcv) [104]. H+ flux and H2O flux occur 
as well causing host membrane depolarization. It is suspect that this depolarization might 
prevent other viruses from attaching to the cell [105]. Secondary active transport of the 
cells is also rapidly inhibited by infection [129]. Finally, viral DNA along with DNA-
associated proteins are ejected into the cell leaving an empty capsid outside (Fig. 4B).
Host chromosome degradation caused by restriction endonucleases packaged in 
the virion occurs within 2-5 min p.i. [80]. We predict that the DNA and virus-associated 
proteins goes quickly to the nucleus and commandeer the host transcription machinery; 
the first viral transcripts can be detected at 5-10 min p.i.  
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Figure 5. Infection of Chlorella strain NC64A by PBCV-1. A. Digestion of the wall at 
the point of attachment (1-3 min p.i.) . B. The contents of the virus are released into the 
cell (3-5 min p..i). C. Cytoplasmic virus assembly centers at 3-5 h p.i. D. Release of 
progeny virus by lysis of host cell at 6-8 h p.i. 
 Virus DNA replication begins between 60-90 min p.i. At 240 min, cells are 
covered with hyaluronan [120]. Virus assembly occurs at 3-5 h p.i. in localized regions of 
the cytoplasm called virus assembly centers (Fig 4C). Finally, at 6-8h p.i., host cell lysis 
occurs and release of progeny virions (Fig. 4D). Typically, about 1000 particles per cell 




5. OTHER CHLOROVIRUSES 
Five additional chlorovirus genomes have been sequenced: NY-2A and AR158 
that infect Chlorella NC64A (same host for PBCV-1); MT325 and FR483 that infect 
Chlorella Pbi, and ATCV-1, that infects Chlorella SAG 3.83. Both NC64A and Pbi are 
normal endosymbionts of the protozoa P. bursaria, while SAG 3.83 is an endosymbiont 
of the heliozoon Acanthocystis turfacea [44, 45, 46]. Chlorovirus genomes have CDSs 
distributed evenly on both strands and have minimal intergenic space; the GC content is 
host-specific. The main genomic features for each new chlorovirus can be seen in 
TABLE 1 in comparison to the prototype PBCV-1.  
Table 1. Comparison of sequenced chlorella virus genomesa
Virus Hostb Genome (bp) CDSs tRNA genes GC (%) 
PBCV-1 NC64A 330,743 365 11 40 
NY-2A NC64A 368,683 404 7 40.7 
AR158 NC64A 344,690 360 6 40.7 
MT325 Pbi 314,335 331 10 45.3 
FR483 Pbi 321,240 335 9 44.6 
ATCV-1 SAG 3.83 288,047 329 11 49.4 
a Adapted from [46] 
b Specific Chlorella strains
Most CDSs involved in the main metabolic functions (i.e., DNA replication  and 
nucleotide biosynthesis) are conserved among chloroviruses (~80%). Despite the strong 
conservation each virus has unique features. For example, (i) NY-2A has the largest 
genome and it is also heavily methylated: 45% of cytosines are 5-methylcytosine (5mC) 
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and 37% of the adenines are N6-methyladenine (6mA) compared to 1.9% 5mC and 1.5% 
6mA in PBCV-1. In addition, two NY-2A CDSs encode inteins (the first detected in 
chloroviruses), the large subunit of ribonucleotide reductase and a superfamily II 
helicase. (ii) AR158 is the only NC64A virus that does not encode a full-length K+ ion 
channel protein (Kcv). (iii) MT325 is the first virus to encode a water channel, an 
aquaglyceroporin (AQV). The K+ ion channel (Kcv) from MT325 differs in structure 
from PBCV-1 Kcv [130]. (iv) The virus FR483 lacks both AQV and Kcv, but it encodes 
a putative potassium ion transporter protein and an alkyl sulfatase [45]. (v) Like PBCV-1, 
ATCV-1 also encodes GDP-D-mannose 4,6 dehydratase (GMD) and functional studies 
revealed it has the expected dehydratase activity but lacks the additional reductase 
activity present in the PBCV-1 encoded enzyme [131].  (vi) The ATCV-1-Kcv is the 
smallest functional K+ ion channel reported to date (82 amino acids) and is more 
permeable to K+ than Rb+, which differs from PBCV-1 Kcv [132].  
 NC64A viruses have three types of introns in their CDSs. PBCV-1 and NY2-A 
have a self-splicing intron in a transcription factor TFIIS-like CDS [44, 56]. A 
spliceosomal-processed intron is present in the DNA polymerase gene and a 81-
nucleotide spliceossomal-processed intron exists in the pyrimidine dimmer-specific 
glycosylase gene from some viruses [111]. However, initial analyses of Pbi virus 
genomes did not detect any intron or inteins in their CDSs, although a single tRNA in 
MT235 and FR483 contains an intron [45].
Considerable variation occurs in chlorovirus genomes and the total number of 
genes in the chlorovirus gene pool exceeds that of a single isolate. In addition, not all 
38 
PBCV-1 genes are required for virus replication, since PBCV-1 mutants with large 
deletions (27-37 kb) [133] can replicate in Chlorella. Large insertions also occur in some 
chloroviruses, for example, the virus CVK2 contains an extra 22 kb insert [95, 134]. The 
different sizes and diversity of the chlorella virus genomes suggest that dynamic and 
frequent rearrangements of virus genomes occur in natural environments.  
6. NATURAL HISTORY OF CHLOROVIRUSES 
 Even after almost 30 years of study, the natural history of chlorella viruses is still 
poorly understood. At present, chloroviruses have been isolated from three different 
Chlorella:   (i) Chlorella NC64A (host for the sequenced PBCV-1, NY-2A, and AR158), 
(ii) Chlorella Pbi (host for MT235 and FR383), and (iii) Chlorella SAG 3.93 (host for 
ATCV-1). Chlorella NC64A and Pbi are natural endosymbionts of the protozoan 
Paramecium bursaria. Chlorella SAG 3.83 is a natural endosymbiont of the heliozoon 
Acanthocystis turfacea.
Chlorella NC64A and Pbi were originally isolated from American and European 
strains of P. bursaria, respectively. Although NC64A and Pbi viruses have similar 
morphology and biological and biochemical properties, viruses infecting Chlorella 
NC64A cannot infect or attach to Chlorella Pbi. The component sugars in the cell walls 
of the two Chlorella differ considerably [135] and it was predicted that host receptor for 
the viruses could also be the recognition factor for the paramecia. However, this is not 
true since both Chlorella can establish symbiotic relationships with paramecium isolated 
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from American and European waters. A. turfacea virus was isolated from Chlorella from 
a German freshwater pond. Furthermore, viruses of the more recently discovered 
Chlorella SAG 3.83 endosymbiont of A. turfacea also only attach to and infect this 
Chlorella isolate. 
Chlorella NC64A viruses have been isolated from freshwater collected all over 
the world: the United States [136, 137, 138], Japan, Brazil [139], Australia (Van Etten 
and J Rohozinski, unpublished), China [140], Argentina and Israel (Y Zhang, M Nelson, 
JL Van Etten, unpublished), South Korea, and Italy [20]. Chlorella Pbi viruses were 
originally collected in Europe [141], and more recently in Australia, Canada, and the 
northern United States (Minnesota, Wisconsin, and Montana) or at higher elevations in 
the western United States (M. Nelson, unpublished results). Some water samples from 
Nebraska (United States) and Australia contained both NC64A and Pbi viruses (J. Van 
Etten, and J. Rohozinski, unpublished; M. Nelson, unpublished). The most important 
factors influencing the distribution of NC64A and Pbi viruses are probably latitude and 
altitude.
Chlorella virus titers in indigenous water vary from 1-100 plaque-forming units 
(PFU) per ml, but titer as high as 1 x 105 PFU/ml have been obtained. The concentration 
of chlorella viruses fluctuates with the seasons, with the highest titers found in late spring 
[139, 142]. A water sample collected through ice had a titer of >1000 PFU/ml (M. 
Nelson, unpublished). 
 It is not known whether Chlorella NC64A and Pbi viruses replicate exclusively in 
the Chlorella free of the paramecium or whether they have another host(s). In fact, it is 
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not even known if the symbiotic Chlorella are free living in natural environments. A 
single paramecium can contain up to 1000 Chlorella cells; if each infected Chlorella can 
produce ~250 infectious viruses, then, it is predicted that Chlorella cells released from a 
single paramecium could produce up to 250,000 virus particles. This could explain the 
high virus titers occasionally observed.
The occasional high titers in indigenous water are also surprising because viruses 
are constantly exposed to solar radiation, that damages viral DNA and inactivates viruses. 
Inactivation of bacteriophages and cyanophages occurs at rates of 0.4 to 0.8 per hour in 
full sunlight [143, 144]. Chlorella viruses have adapted to solar radiation by having 
access to two independent DNA repair systems [76]. PBCV-1 uses a (i) pyrimidine 
dimmer-specific glycosylase that initiates UV-induced thymidine dimer repair, which 
functions in the light and in the dark; and (ii) host photolyase to repair UV-induced 
thymidine dimers (also called host cell reactivation) [76]. PBCV-1 also encodes a 
putative Cu/Zn superoxide dismutase that could help protect DNA from reactive oxygen 
species.
 Plaque-forming viruses are specific to certain species of Chlorella, since attempts 
to find viruses infecting other Chlorella hosts or the green alga, e.g., Chlamydomonas
reinardt, have been unsuccessful. It is possible that some viruses might exist in a 
lysogeny state with their hosts, but no evidence for lysogeny has been detected for 
chloroviruses.  
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7. OTHER ALGAL VIRUSES 
 Perhaps the next best studied algal virus is the coccolithovirus that infects the 
unicellular free-living calcifying Emiliania huxleyi, which is best known for forming 
large costal and open ocean algal blooms. Much of the appreciation for aquatic viruses 
came with the identification of the Emiliania huxleyi virus (EhV-1), partially responsible 
for the termination of E. huxleyi blooms. EhV-1 has a 407 kb circular genome (40% GC) 
that encodes 472 protein-encoding genes, of which 14% have a match in the public 
database [145]. The virus particle is a 160-200 nm icosahedron and the genome encodes 
for some unusual genes involved in sphingolipid biosynthesis, two desaturases, and eight 
proteases, but more importantly, encodes for 6 subunits of the RNA polymerase, which is 
lacking in PBCV-1. Upon infection, EhV-1 capsid remains at the cell surface, and it is 
speculated that binding occurs in the underlying plasma membrane of the host [146]. 
Interestingly, shell-less algae (haploid) are resistant to virus infection [147] and during 
release, EhV-1 buds through the membrane in an animal-like cell extrusion [146].
 Another well characterized phycodnavirus belongs to the genus Phaeovirus. To 
date, eight classes of brown algae (macroalgae) are reported to be infected by viruses 
[15], however only two phaeovirus genomes have been sequenced: the 335 kb
Ectocarpus siliculosus virus (EsV-1) [13] and the smaller genome (158 kb) of Feldmania 
sp. virus (FsV) [15]. The viruses in this group are probably the most diverse in terms of 
genome size (ranging from 150-335 kb) and they can infect more than one host from 
different families. This last factor probably reflects the unusual life style of these viruses 
that unlike the other phycodnavirus members that are lytic, integrates its genome into the 
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host genome and live in lysogeny. EsV-1 is the type-species of the group and perhaps the 
best characterized Phaeovirus. EsV-1 infects only free-swimming wall-less gametes or 
spores and after infection, virus DNA integrates to the host genome. The host exhibits no 
symptoms of infection, except for a partial or total inhibition of sexual reproduction, and 
the virus genome can be transmitted by mitosis. EsV-1 controls the host by only 
expressing genes in reproductive organ cells, where the virus disintegrates the organelles 
and forms a dense pack of virus particles. Upon certain environmental stimuli, EsV-1 
induces lysis which releases spores and gametes, guaranteeing synchronous infection 
[13]. The FsV has two genome sizes, 158 kb and 178 kb that co-occur. Although the two 
genomes present similar restriction fragments and integration sites, they integrate in 
distinct regions in the host genome.     
 EsV-1 also encodes for a K+ ion channel that structurally resembles PBCV-1 Kcv 
and eukaryotic K+ channels. Despite their similarity, the EsV-1 protein (named Kesv), is 
sorted to the mitochondria whereas PBCV-1 Kcv goes to the plasma membrane. Mutation 
analysis revealed that the N-terminus and structural features in the second transmembrane 
domain are responsible for the mitochondrial signal in Kesv [148].
 Recently, two viruses infecting the green alga Ostreococcus tauri, (OtV-5 and 
OtV-1), currently unclassified in the Phycodaviridae family, were isolated and their 
genomes sequenced [14, 149]. The host O. tauri is the smallest free-living, 
photosynthetic marine eukaryote, whose genome has also been sequenced [150]. OtV-5 
and OtV-1 have a linear dsDNA genome (186 kb and 191 kb, respectively) and show 
high level of colinearity.  Their genomes are predicted to encode 268 and 232 CDSs, 
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respectively. O. tauri lacks a cell wall and when it is attacked by high amounts of OtV-5 
(high multiplicity of infection) not all cells become infected, suggesting either host 
resistance or a lack of virus receptor in the host cell membrane. This indicates that 
attachment is specific and a crucial step during infection. A 50 nm space can be 
microscopically observed between the virus and the host cell membrane and may indicate 
the presence of an envelope around host plasma membrane.  The OtV-5 burst size (25 
virus particles/cell) is smaller than that observed in other phycodnaviruses. OtV-5 
encodes for DNA methyltransferases but not the companion restriction endonuclease as 
identified in PBCV-1, and during the lytic infection cycle the host chromosome remains 
intact [14].  
It seems that algal virus diversity is even more spectacular than previously 
thought as shown by additional virus characterizations. In 2003, Tai and colleagues [151] 
reported the first single-stranded RNA (ssRNA) virus infecting the raphytophyte 
Heterosigma akashiwo and in 2004, another ssRNA virus infecting the marine diatom 
Rhisozolenia sp. [152]. In the same year, a double-stranded RNA (dsRNA) virus (24.6 
kb) infecting the prasinophyte Micromonas pusilla was reported by Brussaard et al. 
(2004) [153]. Later in 2005, a virus infecting Chaeotocerus salsugenum, a marine diatom, 
has an intriguing genome type: the genome is composed of a 6-kb closed circle ssDNA 
with a 1-kb linear, partially paired ssDNA [154]. Finally, in 2008, Tomaru et al. [155] 
reported a ssDNA virus that seems to have a fragmented genome in the marine diatom 
Chaetocerus debilis. Furthermore, ssRNA and dsDNA viruses infecting dinoflagellates 
(Dinophyceae), and additional dsDNA viruses infecting prymnesiophytes 
(Haptophyceae) and Pelagophyceae were recently identified [156].  
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 Collectively, algal viruses infect a wide range of hosts and presents a remarkable 
variety in size (25 to above 220 nm), genome type (dsDNA, ssDNA, dsRNA, ssRNA), 
genome structure (linear, circular, fragmented), and genome size (4.4 to above 500 kb) 
[156].  The diversity of algal viruses described so far is impressive considering this field 
is only in the beginning.
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 MICROARRAY ANALYSIS OF CHLORELLA VIRUS 
PARAMECIUM BURSARIA CHLORELLA VIRUS-1 
TRANSCRIPTION 
1. OVERVIEW 
Paramecium bursaria chlorella virus 1 (PBCV-1), the prototype of the genus 
Chlorovirus (family Phycodnaviridae), is a large, icosahedral (190 nm in diameter), 
plaque-forming virus that infects the unicellular, eukaryotic green alga Chlorella NC64A. 
The PBCV-1 virion has a lipid membrane located inside an outer glycoprotein capsid.  
The 330-kb genome is a linear, non-permutated, dsDNA molecule with covalently closed 
hairpin ends that has approximately 365 protein encoding genes (CDS), as well as 11 
tRNA encoding genes (reviews [1, 2, 3]).  The CDSs are evenly distributed on both 
strands and intergenic space is minimal (typically less than 100 nucleotides); the 
exception is a 1788 bp sequence in the middle of the genome that encodes the tRNA 
genes.  Approximately 35% of the 365 PBCV-1 gene products resemble proteins in the 
public databases. 
PBCV-1 initiates infection by attaching rapidly and specifically to the cell wall of 
its host [4, 5], probably at a unique virus vertex [6, 7].  Attachment is immediately 
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followed by host cell wall degradation by a virus-packaged enzyme(s) at the point of 
contact.  Following wall degradation, the viral internal membrane presumably fuses with 
the host membrane causing host membrane depolarization [8], potassium ion efflux [9], 
and increase in the cytoplasm pH [10].  These events are predicted to facilitate entry of 
the viral DNA and virion-associated proteins into the cell.  PBCV-1 lacks a gene 
encoding a recognizable RNA polymerase or a subunit of it and RNA polymerase activity 
is not detected in PBCV-1 virions.  Therefore, viral DNA and virion-associated proteins 
are predicted to migrate to the nucleus and early viral transcription is detected 5-10 min 
post-infection (p.i.), presumably by commandeering a host RNA polymerase(s) (possibly 
RNA polymerase II) [11, 12].  Virus DNA synthesis begins 60-90 min p.i., followed by 
virus assembly at 3-5 h p.i. in localized regions of the cytoplasm, called virus assembly 
centers [4].  At 6-8 h p.i., virus-induced host cell lysis occurs resulting in release of 
progeny virions (~1,000 viruses/cell of which ~25% are infectious).  These events are 
depicted in Fig. 1. 
To initiate PBCV-1 transcription, the host RNA polymerase(s), possibly in 
combination with a virus transcription factor(s), must recognize virus DNA promoter 
sequences.  Recently, three short nucleotide sequences were identified in putative virus 
promoter regions (150 bp upstream and 50 bp downstream of the ATG translation site) 
that are conserved in PBCV-1 and other Chlorovirus members [13]. PBCV-1 CDSs are 
not spatially clustered on the genome by either temporal or functional class suggesting 
that transcription regulation must occur via cis- and possible trans-acting regulatory 
elements.  
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Figure 1. Timeline representing the PBCV-1 lifecycle in Chlorella NC64A. Numbers 
represent minutes after infection.  CDSs expressed before viral DNA synthesis begins 
were classified as early (black arrow), CDSs expressed after DNA synthesis begins were 
classified as late (white arrow), and CDSs expressed before and after DNA synthesis 
begins were classified as early/late (arrow with diagonal lines).  Electron micrographs A 
and B were reproduced from [5] and micrographs C and D were reproduced from [4] 
with permission. 
To understand the dynamics of PBCV-1 global gene expression during virus 
replication, we constructed a microarray containing 50-mer probes to each of the 365 
PBCV-1 CDSs.  cDNAs from poly A-containing RNAs isolated from cells at seven times 
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after PBCV-1 infection were competitively hybridized against a reference sample on the 
microarray. To further delineate early and late gene expression, cells were treated with 
the DNA replication inhibitor, aphidicolin, prior to infection.  The results provide the first 
comprehensive transcriptional map of the virus genome, conferring insights about the 
characterization of each PBCV-1 CDS, the majority of which have unknown functions.  
In addition, the microarray data suggest that viral DNA replication plays a significant role 
in the temporal regulation of gene expression. 
2. MATERIALS AND METHODS 
2.1. RNA isolation and drug treatment.  Chlorella NC64A cells (1 x 108 cells/ml) were 
infected with PBCV-1 at a multiplicity of infection of 5 to ensure synchronous infection.  
Uninfected cells and cells at 20, 40, 60, 90, 120, 240 and 360 min p.i. were harvested by 
centrifugation (4,000 rpm) for 5 min at 4ºC and disrupted with glass beads (0.25-0.30 mm 
in diameter) using a bead beater (Disruptor Genie, Scientific Industries, Bohemia, NY) in 
the presence of Trizol (Invitrogen, Carlsbad, CA).  RNAs were isolated using the 
Absolutely RNA Miniprep Kit (Stratagene, La Jolla, CA) according to the manufacturer’s 
instructions.  RNA integrity was verified in denaturing 1% agarose gels by monitoring 
host cytoplasmic and chloroplast ribosomal RNAs. Total RNA was quantified with a 
NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE).  
To determine the effect of virus DNA synthesis on virus gene expression, 
aphidicolin (20 Pg/ml) was added to the cells 15 min prior to infection and samples were 
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collected at the same times after infection as described above.  Control samples were 
obtained from infected non-treated cells at the same times. Preliminary experiments to 
determine optimal drug dosage and time of application indicated that 20 Pg/ml of 
aphidicolin completely inhibits DNA synthesis in 15 min. 
2.2. Microarray construction and hybridization.  The PBCV-1 genome is predicted to 
have 365 CDSs and 11 tRNA encoding genes. The tRNAs sequences were not included 
in the microarrays. Fifty-mer probes representing each CDS in the PBCV-1 genome were 
designed and synthesized by MWG Biotech (Ebersberg, Germany) (20-80% GC, 60-80º 
C melting temperature).  A table with the probes’ sequences is in Supplement 1.  Probes 
were spotted onto CMT-GAPS silane-coated slides (Corning, Lowell, MA) using 
Omnigrid 100 (Genomic Solutions, Ann Arbor, MI) according to manufacturer’s 
instructions.  Probes were printed in quadruplicates on every slide. For each time point, 
20 Pg of total RNA was reverse-transcribed using oligo(dT) as a primer and cDNAs were 
labeled with either Cy3 or Cy5-dUTP (GE Healthcare, Piscataway, NJ) using the 
SuperScript Indirect cDNA Labeling System (Invitrogen) following the supplier’s 
directions.  The reference sample, for the time course experiments, consisted of a pool of 
transcripts obtained by mixing equal amounts of total RNA from each time point. 
Competitive hybridization experiments were conducted for each sample against the 
reference sample [14, 15, 16]. For the aphidicolin experiments, a direct comparison was 
carried out with each treated sample versus the corresponding non-treated infected 
control.
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Labeled cDNAs were resuspended in pre-heated (68ºC) 40 Pl of Ambion 
hybridization buffer #2 (Ambion, Austin, TX).  Arrays were hybridized (42ºC) for 16 
hours in a Corning hybridization chamber (Corning, Lowell, MA).  Slides were washed 
twice (42ºC) in 2x SSC (1x SSC is 0.15 M sodium chloride, 0.015 M sodium citrate), 
0.5% SDS for 15 min followed by two washes in 0.5x SSC, 0.5% SDS for 15 min.  Slides 
were then dried with low-speed centrifugation and subjected to fluorescence detection 
with an Axon 4000B scanner (Molecular Devices, Sunnyvale, CA).
2.3. Microarray analysis. Results from three independent experiments were analyzed 
using the GenePix Pro v.6.0 software (Molecular Devices) and TIGR microarray 
software suite (TM4) [17].  Several transformations were performed to eliminate low 
quality data, to normalize the measured intensities using the Lowess algorithm, and to 
regulate the standard deviation of the intensity of the Cy5/Cy3 ratio across blocks. CDSs 
that displayed statistically significant modulation were identified by a one-way analysis 
of variance (ANOVA), using P values of <0.01 as a cutoff.  For the aphidicolin 
experiments, Significant Analysis of Microarray (SAM) [18] was used to identify CDSs  
with statistically significant changes in expression in comparison to a non-treated 
infected sample (False discovery rate  5%).  CDSs with similar expression profiles were 
grouped into different clusters with a K-means algorithm using Euclidean distance and 50 
maximum iterations. PBCV-1 microarray data sets were deposited at NCBI’s Gene 
Omnibus Express (GEO) under the accession number GSE18421.
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Figure 2. Heatmap illustrating the expression of 360 PBCV-1 CDSs during the 
infection cycle. cDNAs from each time point were labeled with Cy5 and the reference 
control was labeled with Cy3. Color code represents the log2 (Cy5/Cy3) ratio for each 
time point.  CDSs with similar expression profiles were grouped into three classes 
representing early, early/late, and late using K-means algorithm.  Each column 
corresponds to the time point when total RNA was collected (numbers represent minutes 
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after infection). Each row represents a different CDS in PBCV-1. A list of all of the CDSs 
is available in Supplement 2.
3. RESULTS AND DISCUSSION 
3.1. Microarray quality check. To evaluate our probes, equal amounts of PBCV-1 
genomic DNA (2 Pg) were labeled in two independent reactions with either Cy3-dCTP or 
Cy5-dCTP (GE Healthcare) using random primers (Invitrogen).  The two reactions were 
then competitively hybridized with the probes in the microarray.  No difference was 
detected in hybridization of the two DNA samples on all spots (results not shown) 
indicating the probes were specific and also excluding any preferential hybridization to 
one of the dyes.  In addition, to check for host cross-hybridization, PBCV-1 DNA (2 Pg) 
was labeled with Cy3-dCTP and host Chlorella NC64A DNA (2 Pg) with Cy5-dCTP.  
Only two PBCV-1 CDSs (A260R and A625R) hybridized with host DNA; however, 
these two CDSs are false-positives since recently available Chlorella NC64A genome 
sequence did not have detectable homologous sequences.
3.2. PBCV-1 transcription program.  RNAs were isolated from infected cells at 20, 40, 
60, 90, 120, 240, and 360 min p.i.  Competitive hybridization results from each time 
point against the RNA reference pool revealed that transcripts of 360 (99%) of the 365 
PBCV-1 CDSs display statistically significant variation in at least one of the 
experimental time points (Fig. 2).  CDSs A60L, A328L, A482R, and A646L did not pass 
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statistical tests in the time course experiment. CDS A689L was not spotted onto the array 
because it was accidentally omitted during the probe synthesis.  The gene expression 
analysis was based on relative levels, rather than absolute levels of expression.  Mapping 
the PBCV-1 transcription pattern to the genome revealed no large regions that were 
biased as to time of expression, indicating that gene expression in PBCV-1 is mostly 
controlled by multiple initiation sites (Fig. 3).  However, a few early or late CDSs 
clustered in small regions of the genome as can be seen in shaded areas in Fig. 3.  
Interestingly, these small regions are also clustered and conserved in another sequenced 
chlorovirus (NY-2A) that infects the same host Chlorella (results not shown).  Unlike the 
phage T4 genome, where most late CDSs are located in contiguous regions on the same 
DNA strand [19], PBCV-1 expression did not show a strong strand-specific bias.  In 
addition, there is no relationship between time of expression and G+C content of the 
genome (Fig. 3).  
 Classification of PBCV-1 CDSs was based on when the transcript was detected by 
the microarray.  Globally, the 360 statistically significant CDSs were grouped into three 
classes (Fig. 4): i) 227 (62%) of the CDSs were expressed before viral DNA synthesis 
begins at 60-90 min p.i.;  ii) these 227 CDSs were divided into two classes: transcripts of 
127 CDSs disappeared prior to initiation of virus DNA synthesis (considered early) while 
transcripts of 100 CDSs were still detected after virus DNA synthesis begins (considered 
early/late);  iii) transcripts of 133 (37%) CDSs were detected after virus DNA synthesis 
begins (considered late).  Functional categorization of PBCV-1 CDSs was reported 
elsewhere [20] and functional distribution compared to each transcriptional category is 
summarized in Fig. 4 and 5.  Forty-four of the PBCV-1 encoded proteins have been 
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expressed and recombinant proteins shown to be functional enzymes.  These are 
indicated with an asterisk in Fig. 5.  The functions of the remaining CDSs are either 
putative or unknown. 
A previously described putative promoter sequence (AATGACA) and a similar 
sequence (ATGACAA) [13, 11] were detected in 50 early or early/late PBCV-1 CDSs. 
However, promoter sequences for most early, early/late, and late CDSs remain 
unidentified.
3.3. Early CDSs.  One hundred and twenty-seven (35%) of the 360 PBCV-1 CDSs were 
expressed early, 20-60 min p.i. (Supplement 2).  Sixty-one percent of the early CDSs 
have no known function.  Many of the early CDSs are predicted to encode the machinery 
for the virus to begin DNA replication.  In fact, PBCV-1 encodes seven proteins involved 
in DNA replication, recombination and repair that were expressed early including: į
DNA polymerase (A185R), superfamily III helicase (A456L), DNA topoisomerase II 
(A583L), RNAse H (A399R), and PCNA (A574L).  A pyrimidine dimer-specific 
glycosylase (A50L), a well-characterized DNA repair enzyme involved in pyrimidine 
photodimer excision [21], was also expressed early.  Additional PBCV-1 encoded 
proteins involved in virus DNA synthesis and DNA recombination were in the early/late 
class including, DNA primase (A468R), a 5’-3’ exonuclease (A166R) and a second 
PCNA (A193L).  The PBCV-1 genome contains methylated nucleotides, both N6-
methylated adenine and 5-methylcytosine [22].  Therefore, it is not surprising that the 
virus encodes three functional DNA methyltransferases that were transcribed early – two 
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enzymes that form N6-methyladenine (A251R and A581R) and one that forms 5-
methylcytosine (A517L). 
 PBCV-1 DNA synthesis also requires large quantities of deoxynucleotide 
triphosphates (dNTPs) that cannot be accounted for simply by recycling 
deoxynucleotides from host DNA.  By 4 h p.i., the total amount of DNA in the cell 
increases 4-fold due to viral DNA synthesis [23].  To guarantee a supply of dNTPs in 
non-proliferating host cells, large DNA viruses, including PBCV-1, encode proteins 
involved in dNTP biosynthesis: dUTP pyrophosphatase (A551L), thioredoxin (A427L), 
thymidylate synthase X (A674R), and cytosine deaminase (A200R) CDSs were 
transcribed early.  Additional dNTP synthesizing CDSs in the early/late class included 
aspartate transcarbamylase (A169R), both subunits of ribonucleotide reductase (A476R 
and A629R), glutaredoxin (A438L), and dCMP deaminase (A596R). 
 Several PBCV-1 CDSs predicted to encode proteins involved in transcription 
were also expressed early.  These proteins include three putative transcription factors, 
TFIIB (A107L), TFIID (A552R), TFIIS (A125L), two helicases, SWI/SNF helicase 
(A548L) and superfamily II helicase (A241R), and RNAse III (A464R).  The genes for 
two enzymes involved in mRNA capping, an RNA triphosphatase (A449R) and a 
guanylyltransferase (A103R) were also transcribed early.  The products of at least some 
of these early CDSs are undoubtedly involved in the switching of virus early gene 
transcription to late gene transcription.   
77 
Figure 3.  Mapping of the PBCV-1 transcriptome.  Blue arrows: early CDSs; green 
arrows: early/late CDSs; red arrows: late CDSs. Arrow points to transcription direction. 
Shaded areas indicate small transcription CDS clusters that are also conserved in 
another chlorovirus (NY-2A), except for the areas marked with asterisks.  Middle circle 
shows G+C content of the genome.  Note that the PBCV-1 genome is linear and a 
circular map was generated for illustration purposes only.
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A few PBCV-1 enzymes involved in protein synthesis and protein degradation 
were transcribed early including translation elongation factor-3 (A666L), ubiquitin C-
terminal hydrolase (A105L), Skp1 protein (A39L), SCF-E3 ubiquitin ligase (A481L), a 
zinc metallopeptidase (A604L), and an ATPase (AAA + class) (A44L). 
 Unlike other viruses, PBCV-1 encodes at least part, if not all, of the machinery 
required to glycosylate its major capsid protein [19], including five glycosyltransferases 
[24, 25, 26].  Furthermore, glycosylation of the virus major capsid protein probably 
occurs independently of the host endoplasmic reticulum-Golgi system [19].  All of the 
glycosyltransferase CDSs were expressed early (A64R, A111/114R, A219/222/226R, 
A473L, A546L).
 The chlorella viruses are also unusual because they encode enzymes involved in 
sugar metabolism.  Two PBCV-1 encoded enzymes synthesize GDP-L-fucose from 
GDP-D-mannose, GDP-D-mannose dehydratase (A118R), and fucose synthase (A295L) 
[27, 28] and three enzymes, glucosamine synthetase (A100R), UDP-glucose 
dehydrogenase (A609L), and hyaluronan synthase (A98R), contribute to the synthesis of 
hyaluronan, a linear polysaccharide composed of alternating E1,4-glucuronic acid and 
E-1,3-N-acetylglucosamine residues [29, 30].  The CDSs for these five enzymes were 
expressed early.
3.4. Early/Late CDSs.  One hundred (27%) CDSs were classified as early/late, 67 (67%) 
of which have unknown function (Supplement 2).  This class contains CDSs that were 
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expressed before 60 min p.i., but whose transcripts were also present after PBCV-1 DNA 
synthesis begins.  At least three mechanisms can lead to classification of CDSs into the 
early/late class: (i) the CDSs were transcribed both before and after viral DNA replication 
begins;  (ii) the CDSs were only transcribed prior to initiation of virus DNA synthesis but 
complete degradation of their transcripts only occurred after DNA synthesis begins;  (iii) 
the CDSs encode polycistronic mRNAs, e.g., one could have a dicistronic mRNA in 
which one CDS is required for an early function and the other CDS is required for a late 
function.  To add to the complexity, ~30 transcripts were detected early, disappeared and 
then reappeared as late transcripts (these CDSs are marked in Supplement 2).  A similar 
phenomenon has been reported in transcriptional studies with the bacteriophage T4 [15] 
and Red Sea bream iridovirus [31]. 
In addition to the early/late CDSs described in the preceding section, the most 
striking feature of this early/late class was the presence of many genes encoding proteins 
associated with genome integration, including 5 GIY-YIG endonucleases (A134L, 
A287R, A315L, A495R, A651L) and 4 HNH endonucleases (A354R, A422R, A478L, 
A490L).  Also, one of the two transposases (A366L) coded by PBCV-1, was expressed 
early/late. The functions of these proteins in the PBCV-1 life cycle are unknown.  
3.5. Late CDSs.  One hundred and thirty-three (37%) of the 360 CDSs were classified as 
late CDSs (Supplement 2), 74% of which have no match in the public databases.  The 
expectation is that most late CDS products are involved in either virus capsid assembly, 
DNA packaging, virus release, or are packaged in the virus particles.  Indeed, SDS-
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PAGE mass spectrometry proteomic analysis of purified virions indicated that 118 
PBCV-1 gene products were detected in the virions (Dunigan et al., unpublished results).  
Of these 118 proteins, 83 had their corresponding CDS transcribed late, 29 were 
transcribed early/late, while only 6 virion-associated proteins were expressed early. 
At least 9 late CDSs are predicted to have their gene products serving a purely 
structural role in the virion including the major capsid protein A430L [32] and 
A140/145R, which is associated with the unique vertex of the virus [7].  Other putative 
structural proteins are A189/192R, A363R, A384L, A540L, A558L, A561L, A622L.  
Homologs of all these proteins are present in all of the chloroviruses (Dunigan et al., 
unpublished results).  In addition to structural proteins, a DNA binding protein (A437L), 
predicted to aid in neutralization of the virus dsDNA, was in the virion and its gene 
transcribed late. 
Several CDSs encoding proteins with putative enzyme functions were expressed 
late and their gene products were packaged in the PBCV-1 virion.  Presumably these 
enzymes are released into the cell during virus infection and aid in establishing infection.  
These proteins include an ATPase (A561L), a superfamily II helicase (A363R), a 
SWI/SNF chromatin remodeling complex subunit (A189/192R), and a SET domain-
containing histone 3, Lys27 methyltransferase (named vSET) (A612L).  The vSET 
protein is predicted to aid in the rapid inhibition of host transcription during virus 
infection [33].  Two site-specific (restriction) endonucleases (A252 and A579L) were 
also expressed as late CDSs and their proteins are packaged in the virion. The restriction 
endonucleases are involved in host chromosome degradation, which begins within a few 
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minutes after virus infection [34].  Thus, PBCV-1 has at least two avenues to inhibit host 
transcription and subvert the host RNA polymerase (presumably RNA polymerase II) for 
virus transcription: virus packaged restriction endonucleases and a vSET histone 3, Lys27 
methyltransferase.   
Five of the 8 PBCV-1 encoded Ser/Thr protein kinase CDSs were expressed late 
(A34R, A277L, A278L, A282L and A614L).  With the exception of A277L, the other 
four kinases were packaged in the virion (Dunigan et al., unpublished results).  A dual 
specific phosphatase (A305L) was also expressed late and the protein is present in the 
virion.  These results indicate that PBCV-1 has the potential to release several protein 
kinase/phosphatase proteins into the cell during infection; these enzymes are probably 
involved in regulatory mechanisms. 
PBCV-1 encodes five proteins that degrade polysaccharides, and presumably 
some of these encoded proteins are involved in host cell wall degradation either during 
virus entry or in aiding lysis of the cell wall during virus release.  With the exception of ȕ
1,3-glucanase (A94L) that was expressed early, the remaining 4 CDSs were transcribed 
late.  The late CDSs encode a ȕ and Į 1,4-linked glucuronic lyase (A215L), two 
chitinases (A260R and A181/182R) and one chitosanase (A292L).
 Finally, 49 late gene products were not detected in the virion. Fifteen of these 
proteins have a putative function, for example a DNA packaging ATPase (A392R) that is 
predicted to be involved in packaging DNA into the virion.  Interestingly, some CDSs 
that were expected to be transcribed early because of their putative involvement in the 
DNA replication, were transcribed late. These CDSs encode a replication factor C protein 
82 
(A417L) (RFC), which is similar to one of the two RFCs proteins in Archaea, an ATP-
dependent DNA ligase (A544R), and a deoxynucleoside kinase (A416R). However, none 
of these proteins were detected in the virion (Dunigan et al., unpublished results). 
3.6. Aphidicolin treatment. To confirm the early and late classification of PBCV-1 
CDSs, aphidicolin was used to block viral DNA synthesis. The drug was added to the 
culture 15 min prior to the addition of PBCV-1 and cells were harvested at the same 
times after infection used in the previous experiments (20, 40, 60, 90, 120, 240, 360 min 
p.i.).  Each sample was analyzed using the corresponding infected non-treated sample as 
a control. 
Expression of 179 (49%) CDSs was inhibited by aphidicolin (Supplement 2). Of 
these 179, 14 were expressed early, 57 were expressed early/late, and 108 were expressed 
late.  This experiment established that transcription of most late CDSs relies on the 
synthesis of viral DNA.  In contrast, expression of 181 CDSs was not affected by 
aphidicolin. Of these 181, 113 were early, 43 were early/late, and 25 were late.  Three 
CDSs (A328R, A482R, A464L) were not previously classified as early, early/late or late 
because they did not pass statistical tests. However, they were expressed in the presence 
of aphidicolin, which indicates that these CDSs might be early. Collectively, expression 
of most early CDSs was not affected by aphidicolin and expression of late CDSs was 
inhibited by the drug. We have no explanation why 14 early CDSs and 57 early/late 
CDSs were affected by aphidicolin nor do we know why 25 late CDSs were not affected 
by aphidicolin. 
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Figure 4.  A. PBCV-1 global expression pattern.  B. Distribution of CDSs according to 
their putative function and time of expression. CDS products with unknown function are 
not listed in this graph. 
3.7. Verification of the microarray results.  Three independent sets of experiments 
support the microarray results. i) Recombinant proteins from 19 PBCV-1 CDSs have 
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been biochemically characterized previously and their genes northern blotted to 
determine when they were expressed.  Sixteen of these results completely agree with the 
microarray experiments.  The other three northern analyses were similar, but not 
identical, with the microarray analyses.  One is a glycosyltransferase (A64R), which 
northern analysis indicated is expressed from 45-360 min p.i. [25], whereas the 
microarray analysis indicated that the CDS was expressed only between 40-60 min p.i.  
The second CDS is a chitinase (A181/182R), which northern results indicate transcription 
occurs between 30-360 min p.i. [35], whereas, the microarray analysis showed the 
transcript was present from 60-360 min p.i.  The third CDS is a dCMP deaminase 
(A596R), which northern analysis indicated expression occurs from 30-120 min p.i. [36]; 
the microarray experiments detected the transcript at 40-60 min p.i. and then again from 
240-360 min p.i.  This discontinuity in expression has also been observed with a few 
other virus CDSs and it has been observed in both northern blots and in the microarray 
results (e.g., homospermidine synthase (A207R) [37]). It is important to note that the 
microarrays measured relative levels of the transcript and this fact could explain the few 
differences mentioned above.  
ii) The 46.2 Mb genome of the PBCV-1 host, Chlorella NC64A was recently 
sequenced to 9-fold coverage (http://genome.jgipsf.org/ChlNC64A_1/ChlNC64A_1.
info.html).  This prompted us to initiate a transcriptome analysis of Chlorella NC64A and 
PBCV-1 infected cells by shotgun sequencing cDNA derived from poly A+ RNA using a 
new high throughput sequencing instrument.  To date, we have two sets of sequences, 
one from uninfected Chlorella NC64A and one from cells at 20 min p.i.  We compared 
the 20 min p.i. viral microarray results with the infected 20 min p.i. viral transcriptome 
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sequencing results.  Of the 172 CDSs detected by the microarray analysis at 20 min p.i., 
expression of 159 CDSs (92%) were detected in the transcriptome study using a 200-fold 
coverage cutoff (Yanai-Balser et al., unpublished results).
iii) Kawasaki et al. (2004) [11] identified 22 immediate-early PBCV-1 CDSs 
(expressed at 5-10 min p.i.).  Our microarray results indicated that 20 of these 22 CDSs 
were expressed early.  CDS A689L was not present in our array, and CDS A312L was 
classified as early/late and was not detected at 20 min p.i., which is the earliest time point 
in the present study. In the later case, the difference could be due to the relative 
measurement of the transcript. 
3.8. Do late PBCV-1 mRNAs have a poly A tail?   Both the microarray results and the 
preliminary transcriptome sequencing of PBCV-1 depended on cDNA synthesis using a 
oligo dT primer.  We mention this issue for two reasons.  First, about 20 years ago we 
conducted a set of pulse-labeling experiments where PBCV-1 infected cells were 
incubated with H3-adenine for 30 min periods [38].  Poly A+ and poly A- RNAs were 
separated on an oligo dT-cellulose column and the radioactivity determined.  The results 
indicated that 22-26% of the radioactivity eluted in the poly A+ fraction from cells 
infected from 0-30 min and from 30-60 min p.i.  In contrast, 6.1%, 4.5% and 2.5% of the 
radioactivity eluted in the poly A+ fractions at 60-90, 90-120 and 120-240 min p.i., 
respectively.  Therefore, we suggested that PBCV-1 early mRNAs probably contain poly 
A tails and late mRNAs might lack them.  However, there are other explanations for 
these earlier results, e.g., the pool size of unlabeled adenine certainly increases 
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dramatically during infection, consequently, there could be a large dilution effect on the 
added H3-adenine compared to the controls.  In addition, we now know that PBCV-1 
infection leads to rapid depolarization of the host plasma membrane, which causes an 
immediate decrease in adenine transport into the infected cell [10].  Both of these issues 
undoubtedly influenced our previous results. 
Second, a report by Kawasaki et al. (2004) [11] also suggests that there may be a 
shift in poly A+ RNAs during chlorella virus replication. Twenty-two PBCV-1 
immediate-early CDSs were analyzed and the transcripts gradually decreased in size after 
20 min p.i., suggesting weakening or cessation of poly A polymerase activity.
The current manuscript provides evidence that most, if not all, PBCV-1 mRNAs 
have a poly A tail because expression of 99% of the PBCV-1 CDSs was detected in our 
microarray experiments.  Furthermore, many of the CDSs we identified were clearly 
expressed late and packaged in the virion.
3.9. PBCV-1 transcription is complex.  As mentioned above, we and others have 
characterized several individual PBCV-1 gene products.  In most of these reports, a 
northern analysis was conducted when studying a specific CDS.  The transcription 
patterns of ~50% of these CDSs are more complicated than just obtaining a single 
hybridizing RNA band of the predicted size at specific times.  That is, full-length gene 
DNA probes often hybridize to mRNA transcripts that are 40-60% larger than the CDS 
itself, suggesting that PBCV-1 might have polycistronic mRNAs.  In addition, some 
probes not only hybridize to mRNAs of the expected size, but they also hybridize to 
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larger mRNAs at other times in the virus replication cycle.  These complex patterns occur 
even with ssDNA probes (e.g., the potassium ion channel CDS, kcv) [39].  One difference 
between the previous northern analyses and the microarray results is that hybridization to 
total RNA was used in the northern analyses and in the research described in this paper 
the cDNAs were synthesized from poly A+ RNAs. 
We examined four of the CDSs that produced larger transcripts than expected to 
determine if expression of their flanking CDSs were identical in the microarray 
experiments to the target CDS, possibly suggesting a polycistronic mRNA.  A common 
expression pattern was obtained for two of the four CDSs. The RNAse III (A464R) 
mRNA has a predicted size of 825 nucleotides (nts).  However, in a northern blot the 
RNAse III hybridizing band is ~1,300 nts. Its two adjacent CDSs are 204 nts (A462R) 
and 354 nts (A465R), and like A464R, both of them are expressed early.  The combined 
sizes of them with the RNAse III CDS are compatible with either a dicistronic or even a 
tricistronic mRNA.  The other example is the potassium ion channel CDS (kcv, A250R)
that northern analysis indicated has a complex expression pattern, at early times A250R is 
expressed as a large message and at late stages as a monocistronic mRNA [39].  
However, when the early transcript for this CDS was mapped, the start and the stop sites 
were within the adjacent CDSs, so A250R is clearly not a polycistronic mRNA.  The 
CDSs surrounding the other two CDSs with larger transcripts than expected, fucose 
synthase (A295L) and dCMP deaminase (A596R), were expressed at different times than 
the target CDS.  
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Figure 5. Heatmap showing distribution of selected CDSs according to their putative 
functional class.  cDNAs from each time point were labeled with Cy5 and the reference 
control was labeled with Cy3.  Color code represents the log2 (Cy5/Cy3) ratio for each 
time point.  Each column corresponds to the time point when total RNA was collected 
(numbers represent minutes after infection). Each row represents a different PBCV-1 
CDS.  Recombinant proteins have been characterized for the CDSs marked with an 
asterisk.
It is clear that a detailed transcription analysis using a high throughput sequencing 
system of PBCV-1 infected cells will be required to precisely determine promoter and 
terminator sites, as well as splicing regions of PBCV-1 transcription.  This analysis 
should include the use of random primers in addition to oligo dT primers, and also allow 
the detection of PBCV-1 encoded small RNAs. 
3.10. Microarray results with other large dsDNA viruses. PBCV-1 expressed 99% of 
its CDSs at some point in the virus life cycle during infection in laboratory conditions.  
Similar results were obtained for other large DNA viruses such as vaccinia and 
monkeypox viruses in which ~95% of their CDSs are expressed in cell cultures [40, 41].  
Transcription analysis using microarrays was also performed with two marine fish 
iridoviruses: (i) Singapore grouper iridovirus expressed 97% of its CDSs in cell culture 
[42] and (ii) Red Sea bream iridovirus expressed 96% of its CDSs during in vitro
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infection [32].  Therefore, it appears that most CDSs are expressed in these large dsDNA 
viruses, even in laboratory conditions.
The temporal categorization of the transcripts in large viruses varies.  Different 
studies classify virus transcripts in different ways, usually subdividing early CDSs into 
more specific categories. For example, Red Sea bream iridoviruses has ~9% of its CDSs 
classified as immediate-early, ~43% classified as early, and ~41% classified as late [32]. 
T4 bacteriophage transcripts are divided into immediate-early (42%), delayed early 
(~12%), middle early (21%), and late (~22%) [15]. Poxvirus transcription occurs in the 
cytoplasm of the infected cell and is programmed by a virus-encoded RNA polymerase 
and time-specific transcription factors to generate three transcription categories: early, 
intermediate, and late [43].  Using tiling array technology, a recent study reveals 
immediate-early transcripts in vaccinia [41]. An additional microarray-based 
classification of vaccinia and monkeypox virus gene expression divided the virus CDSs 
into early and late categories only (~50% of the CDSs in each class). The method used in 
this later study categorized CDSs according to the time the transcript is first detected, so 
the intermediate class (expressed early and late) was not distinguished, implying that this 
class was a subgroup of the early CDSs [42]. For PBCV-1, we classified a portion of the 




For the first time, a global mRNA transcription profile was conducted for a 
chlorella virus.  The PBCV-1 life cycle is temporally programmed. This regulation is 
controlled by a precise gene expression pattern, where the time of transcription is dictated 
by initiation of viral DNA replication, which begins 60-90 min p.i.  Early CDSs were 
transcribed between 20-60 min p.i, and products of the majority of the early CDSs are 
responsible for providing the machinery for viral DNA replication.  Late CDSs were 
transcribed after 60 min p.i., and most of them were dependent on initiation of viral DNA 
synthesis, since aphidicolin blocked the expression of most late CDSs.  Products of many 
late CDSs serve either a structural role or were packaged in the virion, presumably to aid 
in virus infection.  Forty-six percent of the early transcripts were still detected after DNA 
synthesis begins and were called early/late CDSs, indicating a complex mechanism for 
mRNA maturation and degradation. Some of these early/late CDSs may only be 
synthesized early, but their transcripts were not degraded until after DNA synthesis 
begins. However, this scenario probably does not apply to all early/late CDSs because 
several early-late CDS products were packaged in the virion.  These CDSs may also be 
transcribed as late CDSs.
This study reveals that PBCV-1 gene expression time is independent of GC 
content, as well as the transcription direction and CDS location in the genome. It is 
anticipated that the temporal transcription map will provide clues to the functions of the 
large category of viral proteins whose functions are not yet known and to the events that 
must be orchestrated for a successful viral infection. 
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5. SUPPLEMENT 
























































































































































































































































































































































































5.2. Supplement 2.  List of PBCV-1 CDSs with expression profile 







A002L  NP_048350 E Yes Unknown function Uncategorized 
A003R NP_048351 E Yes Unknown function Uncategorized 
A005R NP_048353 E Yes Unknown function Uncategorized 
A007L  NP_048355 E Yes Unknown function Uncategorized 
A008L  NP_048356 E Yes Unknown function Uncategorized 
A009R NP_048357 E Yes Unknown function Uncategorized 
A010R  NP_048358 L No Unknown function Uncategorized 
A011L NP_048359 L No Unknown function Uncategorized 
A014R NP_048362 L Yes Unknown function Uncategorized 
A018L  NP_048366 L No Unknown function Uncategorized 
A025L  NP_048373 L No Unknown function Uncategorized 
A029L NP_048377 L No Unknown function Uncategorized 
A034Ra  NP_048382 L Yes Ser/Thr protein kinase Signaling 
A035L  NP_048383 L No Unknown function Uncategorized 
A037L  NP_048385 E Yes Unknown function Uncategorized 
A039L NP_048387 E Yes SKP-1 Protein Protein Synthesis, Modification, and Degradation 
A041R   NP_048389 L No Unknown function Uncategorized 
A044L  NP_048392 E Yes ATPase (AAA + class) Protein Synthesis, Modification, and Degradation 
A048R  NP_048396 EL Yes Unknown function Uncategorized 
A049Lb NP_048397 EL Yes Glycerophosphoryl diesterase Lipid Metabolism 
A050La NP_048398 E Yes Pyrimidine dimer-specific glycosylase DNA Replication, Recombination, and Repair 
A051L   NP_048399 L No Unknown function Uncategorized 
A053Ra NP_048401 E Yes D-lactate dehydrogenase Sugar  Metabolism 
A057R  NP_048405 E Yes Unknown function Uncategorized 
A060L NP_048408 N/A N/A Unknown function Uncategorized 
A061L NP_048409 L No O-methyltransferase Miscellaneous 
A063L  NP_048411 L No Unknown function Uncategorized 
A064R NP_048412 E Yes Glycosyltransferase Sugar Metabolism 
A067R  NP_048415 E Yes Unknown function Uncategorized 
A071R  NP_048419 EL No Unknown function Uncategorized 
A075L  NP_048423 EL Yes Unknown function Uncategorized 
A077L  NP_048425 E Yes Unknown function Uncategorized 
A078Ra NP_048426 E Yes N-carbomoylputrescine amidohydrolase Miscellaneous 
A079R  NP_048427 E Yes Unknown function Uncategorized 
A081L  NP_048429 E No Unknown function Uncategorized 
A084L  NP_048432 E Yes Unknown function Uncategorized 
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A085Ra NP_048433 L No Prolyl-4-hydroxylase Protein Synthesis, Modification, and Degradation 
A087R NP_048435 E Yes HNH endonuclease Integration and Transposition 
A088R  NP_048436 E Yes Unknown function Uncategorized 
A089Rb NP_048437 EL Yes Unknown function Uncategorized 
A090R  NP_048438 EL No Unknown function Uncategorized 
A092/93Lb  NP_048441 EL No Unknown function Uncategorized 
A094La NP_048442 E Yes Beta-1,3-glucanase Cell Wall Degradation 
A098Ra NP_048446 E Yes Hyaluronan synthase Sugar Manipulation 
A100Ra NP_048448 E Yes Glucosamine synthetase Sugar Manipulation 
A103Ra NP_048451 E Yes mRNA guanylyltransferase Transcription 
A105L NP_048453 E Yes Ubiquitin C-terminal hydrolase Protein Synthesis, Modification, and Degradation 
A107L  NP_048455 E Yes Trancription factor TFIIB Transcription 
A109L  NP_048457 EL Yes Unknown function Uncategorized 
A111/114R NP_048459 E Yes Fucosyl-Glycosyltransferase Sugar Manipulation 
A118Ra NP_048466 EL No GDP-D-mannose dehydratase Sugar Manipulation 
A121R  NP_048469 EL No Unknown function Uncategorized 
A122/123R
NP_048470 
NP_048471 L Yes Unknown function Uncategorized 
A125L NP_048472 E Yes Transcription factor TFIIS Transcription 
A127R   NP_048475 L No Unknown function Uncategorized 
A129R  NP_048477 EL Yes Unknown function Uncategorized 
A130Rb NP_048478 EL Yes Unknown function Uncategorized 
A131L  NP_048479 E Yes Unknown function Uncategorized 
A133R  NP_048481 E Yes Unknown function Uncategorized 
A134L NP_048482 EL No GIY-YIG endonuclease Integration and Transposition 
A135L  NP_048483 L Yes Unknown function Uncategorized 
A137R  NP_048485 E Yes Unknown function Uncategorized 
A138R  NP_048486 EL Yes Unknown function Uncategorized 
A139L   NP_048487 L No Unknown function Uncategorized 
A140/145Rb  NP_048488 EL No Unknown function Uncategorized 
A148R  NP_048496 L No Unknown function Uncategorized 
A150L  NP_048498 E No Unknown function Uncategorized 
A151R  NP_048499 E Yes Unknown function Uncategorized 
A153R  NP_048501 EL No Superfamily II helicase Transcription 
A154L  NP_048502 EL No Unknown function Uncategorized 
A157Lb NP_048505 EL No Unknown function Uncategorized 
A158L  NP_048506 E No Unknown function Uncategorized 
A161R  NP_048509 E Yes Unknown function Uncategorized 
A162L  NP_048510 E No Unknown function Uncategorized 
A163R NP_048511 EL No Unknown function Uncategorized 
A165L   NP_048513 EL No Unknown function Uncategorized 
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A166Ra NP_048514 EL No Exonuclease DNA Replication, Recombination, and Repair 
A168R NP_048516 L No Unknown function Uncategorized 
A169Ra NP_048517 EL No  Aspartate transcarbamylase Nucleotide metabolism 
A171R  NP_048519 E Yes Unknown function Uncategorized 
A173L NP_048521 E Yes Patatin-like phospholipase Lipid Manipulation 
A175R  NP_048523 EL Yes Unknown function Uncategorized 
A177R  NP_048525 EL No Unknown function Uncategorized 
A180R NP_048528 E Yes Fibronectin binding protein Miscellaneous 
A181/182Ra NP_048529 L No Chitinase Cell Wall Degradation 
A185R NP_048532 E Yes DNA Pol DNA Replication, Recombination, and Repair 
A189/192R NP_048536 L Yes SWI/SNF chromatin remodeling complex Transcription 
A193L NP_048540 EL No PCNA DNA replication, Recombination, and Repair 
A196L  NP_048543 L No Unknown function Uncategorized 
A199R  NP_048546 L No Unknown function Uncategorized 
A200R NP_048547 E Yes Cytosine deaminase Nucleotide Metabolism 
A201L   NP_048548 EL No Unknown function Uncategorized 
A202L  NP_048549 EL Yes Unknown function Uncategorized 
A203R NP_048550 L No Unknown function Uncategorized 
A205R   NP_048552 L No Unknown function Uncategorized 
A207Ra,b NP_048554 EL No Ornithine/Arginine decarboxylase Miscellaneous 
A208R  NP_048555 E Yes Unknown function Uncategorized 
A213L   NP_048560 EL Yes Unknown function Uncategorized 
A214L  NP_048561 E Yes Unknown function Uncategorized 
A215La NP_048562 L No Beta and Alpha 1,4 linked glucoronic lyase  Cell Wall Degradation 
A217Lb NP_048564 EL No Monoamine oxidase Miscellaneous 
A219/222/226R NP_048569 E Yes Glycosyltransferase Sugar Manipulation 
A227L   NP_048575 L No Unknown function Uncategorized 
A229L  NP_048577 L Yes Unknown function Uncategorized 
A230R NP_048578 L No Unknown function Uncategorized 
A231Lb   NP_048579 EL No Unknown function Uncategorized 
A233R  NP_048581 L No Unknown function Uncategorized 
A234L  NP_048582 EL No Unknown function Uncategorized 
A237Ra NP_048585 L No Homospermidine synthase Miscellaneous 
A239L  NP_048587 E Yes Unknown function Uncategorized 
A241R  NP_048589 E Yes Superfamily II helicase Transcription 
A243R  NP_048591 EL No Unknown function Uncategorized 
A245Ra NP_048593 L No Cu/Zn-Superoxide Dismutase Miscellaneous 
A246R NP_048594 L No Pathogenesis-related protein Miscellaneous 
A247R  NP_048596 E No Unknown function Uncategorized 
A248Ra NP_048597 E Yes Ser/Thr protein kinase Signaling 
A250Ra,b NP_048599 EL Yes Potassium channel protein Signaling 
105 
A251Ra NP_048600 E Yes Adenine methyltransferase DNA Restriction/Modification 
A252Ra NP_048602 L No DNA restriction endonuclease DNA Restriction/Modification 
A253R  NP_048604 E Yes Unknown function Uncategorized 
A254R  NP_048605 L No Acetyltransferase Lipid Manipulation 
A256L  NP_048607 EL Yes Unknown function Uncategorized 
A257L  NP_048608 E Yes Unknown function Uncategorized 
A259L  NP_048610 E Yes Unknown function Uncategorized 
A260Ra NP_048613 L Yes Chitinase Cell Wall Degradation 
A261R  NP_048615 EL Yes Unknown function Uncategorized 
A262L  NP_048616 L Yes Unknown function Uncategorized 
A263L   NP_048617 L No Unknown function Uncategorized 
A265L  NP_048619 EL Yes Unknown function Uncategorized 
A267L  NP_048621 E No HNH endonuclease Integration and Transposition 
A271Lb NP_048625 EL Yes Lysophospholipase Lipid Metabolism 
A273L   NP_048627 L No Unknown function Uncategorized 
A274R  NP_048628 EL No Unknown function Uncategorized 
A275R  NP_048629 E Yes Unknown function Uncategorized 
A277La  NP_048631 L No Ser/Thr protein kinase Signaling 
A278La NP_048632 L No Ser/Thr protein kinase Signaling 
A282La NP_048636 L No Ser/Thr protein kinase  Signaling 
A284La,b NP_048638 EL Yes Amidase Miscellaneous 
A286R  NP_048640 L No Unknown function Uncategorized 
A287R  NP_048641 EL No GIY-YIG endonuclease Integration and Transposition 
A289La  NP_048643 EL Yes Ser/Thr protein kinase Signaling 
A292La NP_048646 L No Chitosanase Cell Wall Degradation 
A295La NP_048649 EL No Fucose synthase Sugar Manipulation 
A296R   NP_048650 L Yes Unknown function Uncategorized 
A297L NP_048651 L Yes Fructose-2,6 biphosphatase Sugar  Metabolism 
A298L  NP_048652 E No Unknown function Uncategorized 
A301L  NP_048655 E Yes Unknown function Uncategorized 
A304R  NP_048658 L Yes Unknown function Uncategorized 
A305L NP_048659 L No Dual specificity phosphatase Signaling 
A306L  NP_048660 EL Yes Unknown function Uncategorized 
A308L  NP_048663 E Yes Unknown function Uncategorized 
A310L  NP_048665 L No Unknown function Uncategorized 
A312L  NP_048667 EL Yes Unknown function Uncategorized 
A313L  NP_048669 L No Unknown function Uncategorized 
A314R   NP_048670 L No Unknown function Uncategorized 
A315L  NP_048671 EL Yes GIY-YIG endonuclease Integration and Transposition 
A316R  NP_048672 L Yes Unknown function Uncategorized 
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A318R   NP_048674 L No Unknown function Uncategorized 
A320R   NP_048676 L No Unknown function Uncategorized 
A321R  NP_048677 L No Unknown function Uncategorized 
A322L   NP_048678 L Yes Unknown function Uncategorized 
A324L  NP_048680 L No Unknown function Uncategorized 
A326L NP_048682 L No NTP pyrophosphohydrolase Nucleotide Metabolism 
A328L  NP_048684 N/A Yes Unknown function Uncategorized 
A329R  NP_048685 L No Unknown function Uncategorized 
A330R  NP_048686 EL No Unknown function Uncategorized 
A333L  NP_048689 EL No Unknown function Uncategorized 
A337Lb NP_048693 EL No Unknown function Uncategorized 
A339Lb  NP_048695 EL No Unknown function Uncategorized 
A341L  NP_048697 E Yes Unknown function Uncategorized 
A342Lb   NP_048699 EL No Unknown function Uncategorized 
A348R  NP_048705 E Yes Unknown function Uncategorized 
A349Lb   NP_048706 EL No Unknown function Uncategorized 
A351L NP_048708 E Yes GIY-YIG endonuclease Integration and Transposition 
A352L   NP_048709 L No Unknown function Uncategorized 
A354R  NP_048711 EL No HNH endonuclease Integration and Transposition 
A357L  NP_048714 EL Yes Unknown function Uncategorized 
A360R  NP_048717 L No Unknown function Uncategorized 
A361Rb   NP_048718 EL No Unknown function Uncategorized 
A363R  NP_048720 L No Superfamily II helicase Transcription 
A366L  NP_048723 EL No Transposase Integration and Transposition 
A368L  NP_048725 E Yes Unknown function Uncategorized 
A373R  NP_048730 EL Yes Unknown function Uncategorized 
A375Rb  NP_048732 EL Yes Unknown function Uncategorized 
A378L   NP_048735 L No Unknown function Uncategorized 
A379L  NP_048736 E Yes Unknown function Uncategorized 
A382R  NP_048739 L No Unknown function Uncategorized 
A383R  NP_048740 L Yes Unknown function Uncategorized 
A384Lb   NP_048741 EL Yes Unknown function Uncategorized 
A390L   NP_048747 L No Unknown function Uncategorized 
A392R  NP_048749 L No ATPase (DNA packaging) DNA Replication, Recombination, and Repair 
A394Rb NP_048751 EL No Unknown function Uncategorized 
A395R  NP_048752 EL Yes Unknown function Uncategorized 
A396L  NP_048753 EL No Unknown function Uncategorized 
A397R  NP_048754 E Yes Unknown function Uncategorized 
A398L   NP_048755 L No Unknown function Uncategorized 
A399R  NP_048756 E No Rnase H DNA Replication, Recombination, and Repair 
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A400R  NP_048757 EL Yes Unknown function Uncategorized 
A401R  NP_048758 EL No Unknown function Uncategorized 
A402R  NP_048759 L No Lipoprotein lipase Lipid Manipulation 
A403R  NP_048760 EL Yes Unknown function Uncategorized 
A404R   NP_048761 L No Unknown function Uncategorized 
A405R   NP_048762 L No Unknown function Uncategorized 
A407L   NP_048764 L No Unknown function Uncategorized 
A408L  NP_048765 EL No Unknown function Uncategorized 
A410L  NP_048767 E Yes Unknown function Uncategorized 
A411R  NP_048768 L No Unknown function Uncategorized 
A412R  NP_048769 E Yes Unknown function Uncategorized 
A413L   NP_048770 L No Unknown function Uncategorized 
A414R   NP_048771 L No Unknown function Uncategorized 
A416R NP_048773 L No Deoxynucleoside kinase Nucleotide Metabolism 
A417L  NP_048774 L No Replication factor C DNA Replication, Recombination, and Repair 
A420L  NP_048777 L No Unknown function Uncategorized 
A421R  NP_048778 L No Unknown function Uncategorized 
A422Rb NP_048779 EL No HNH endonuclease Integration and Transposition 
A423R  NP_048780 L No Unknown function Uncategorized 
A424R  NP_048781 L Yes Unknown function Uncategorized 
A426R NP_048783 L No Unknown function Uncategorized 
A427L NP_048784 E Yes Thioredoxin Nucleotide Metabolism 
A428L  NP_048785 EL Yes Unknown function Uncategorized 
A429L  NP_048786 E Yes Unknown function Uncategorized 
A430L  NP_048787 L Yes Major capsid Structural Protein 
A431L  NP_048788 E Yes Unknown function Uncategorized 
A432R  NP_048789 L No Unknown function Uncategorized 
A435R  NP_048793 E Yes Unknown function Uncategorized 
A437L NP_048794 L No DNA binding protein DNA Replication, Recombination, and Repair 
A438La NP_048795 EL No Glutaredoxin Nucleotide Metabolism 
A439R  NP_048796 E Yes Unknown function Uncategorized 
A440L  NP_048797 E Yes Unknown function Uncategorized 
A441L  NP_048798 E Yes Unknown function Uncategorized 
A443R   NP_048800 E No Unknown function Uncategorized 
A444L  NP_048801 L No Unknown function Uncategorized 
A445L NP_048802 E Yes ABC Transporter Miscellaneous 
A448L NP_048805 L No Protein disulfide isomerase  Protein Synthesis, Modification, and Degradation 
A449Ra NP_048806 E Yes RNA triphosphatase Transcription 
A450R  NP_048807 E Yes Unknown function Uncategorized 
A452L  NP_048809 E Yes Unknown function Uncategorized 
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A454L   NP_048811 EL Yes Unknown function Uncategorized 
A456L NP_048813 E Yes Helicase -Superfamily III DNA Replication, Recombination, and Repair 
A462Rb NP_048818 EL No Unknown function Uncategorized 
A464Ra NP_048820 E Yes RNAse III Transcription 
A465Rb  NP_048821 EL No Thiol oxidoreductase Protein Synthesis, Modification, and Degradation 
A467L  NP_048823 EL Yes Unknown function Uncategorized 
A468R  NP_048824 EL No Archaeo-eukaryotic primase DNA Replication, Recombination, and Repair 
A470R  NP_048826 L No Unknown function Uncategorized 
A471R  NP_048827 L No Unknown function Uncategorized 
A473L NP_048829 E Yes Glycosyltransferase Sugar Metabolism 
A476R NP_048832 EL No Ribo. Reductase Nucleotide Metabolism 
A478L  NP_048834 EL Yes HNH endonuclease Integration and Transposition 
A480L  NP_048836 L No Unknown function Uncategorized 
A481L  NP_048837 E Yes SCF-E3 ubiquitin ligase Protein Synthesis, Modification, and Degradation 
A482R  NP_048838 N/A Yes Unknown function Uncategorized 
A484Lb   NP_048840 EL No Unknown function Uncategorized 
A485R  NP_048841 L No Unknown function Uncategorized 
A486L  NP_048842 E Yes Unknown function Uncategorized 
A488R   NP_048844 L No Unknown function Uncategorized 
A490L NP_048846 EL No HNH endonuclease Integration and Transposition 
A491R  NP_048847 L No Unknown function Uncategorized 
A492L  NP_048848 E Yes Unknown function Uncategorized 
A493L  NP_048849 E No Unknown function Uncategorized 
A494R  NP_048850 EL No Unknown function Uncategorized 
A495R  NP_048851 EL Yes GIY-YIG endonuclease Integration and Transposition 
A497R   NP_048853 L No Unknown function Uncategorized 
A501L   NP_048857 L Yes Unknown function Uncategorized 
A502L   NP_048858 L No Unknown function Uncategorized 
A503L  NP_048859 E No Unknown function Uncategorized 
A505L  NP_048861 E Yes Unknown function Uncategorized 
A512R  NP_048868 E Yes Unknown function Uncategorized 
A517L  NP_048873 E Yes Cytosine methyltransferase DNA Restriction/Modification 
A519L  NP_048875 L No Unknown function Uncategorized 
A520L  NP_048876 L No Unknown function Uncategorized 
A521Lb NP_048877 EL Yes Unknown function Uncategorized 
A523R NP_048879 L No Unknown function Uncategorized 
A526R NP_048882 L No Unknown function Uncategorized 
A527R  NP_048883 L No Unknown function Uncategorized 
A530R  NP_048886 L No Cytosine methyltransferase DNA Restriction/Modification 
A531L  NP_048887 L No Unknown function Uncategorized 
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A532L  NP_048888 L No Unknown function Uncategorized 
A533R  NP_048889 EL No Unknown function Uncategorized 
A535Lb   NP_048891 EL No Unknown function Uncategorized 
A536Lb NP_048892 EL No Unknown function Uncategorized 
A537L  NP_048893 E No Unknown function Uncategorized 
A539R NP_048895 E Yes GIY-YIG endonuclease Integration and Transposition 
A540L   NP_048896 L No Unknown function Uncategorized 
A543L  NP_048899 L No Unknown function Uncategorized 
A544R NP_048900 L No ATP-dependent ligase DNA Replication, Recombination, and Repair 
A546L  NP_048902 E No Glycosyltransferase Sugar Metabolism 
A548L NP_048904 E Yes SWI/SNF helicase Transcription 
A551La NP_048907 E Yes dUTP pyrophosphatase Nucleotide Metabolism 
A552R  NP_048908 E Yes Transcription factor TFIID Transcription 
A554/556/557L  NP_048910 E Yes ATPase (PP-loop) DNA Replication, Recombination, and Repair 
A558L   NP_048914 EL No Unknown function Uncategorized 
A559L   NP_048915 L No Unknown function Uncategorized 
A561L NP_048917 L Yes ATPase (DNA repair) DNA Replication, Recombination, and Repair 
A564L  NP_048920 EL Yes Unknown function Uncategorized 
A565Rb  NP_048921 EL Yes ATPase (Chromosome segregation)  DNA Replication, Recombination, and Repair 
A567L  NP_048923 EL No Unknown function Uncategorized 
A568L  NP_048924 E Yes Unknown function Uncategorized 
A570L  NP_048926 L Yes Unknown function Uncategorized 
A571R  NP_048927 L No Unknown function Uncategorized 
A572R   NP_048928 L No Unknown function Uncategorized 
A574L NP_048930 E Yes PCNA DNA Replication, Recombination, and Repair 
A575L  NP_048931 E Yes Unknown function Uncategorized 
A577L  NP_048933 L No Unknown function Uncategorized 
A579La  NP_048935 L No DNA restriction endonuclease DNA Restriction/Modification 
A581Ra  NP_048937 E Yes DNA methyltransferase DNA Restriction/Modification 
A583La NP_048939 E Yes DNA Topoisomerase II DNA Replication, Recombination, and Repair 
A590Lb  NP_048946 EL No Unknown function Uncategorized 
A592R  NP_048948 EL No Unknown function Uncategorized 
A594R  NP_048950 E Yes Unknown function Uncategorized 
A596Ra NP_048952 EL Yes dCMP deaminase Nucleotide Metabolism 
A598L  NP_048954 EL Yes Histidine decarboxylase Miscellaneous 
A601R  NP_048957 EL No Unknown function Uncategorized 
A602L  NP_048958 E Yes Unknown function Uncategorized 
A603R  NP_048959 E Yes Unknown function Uncategorized 
A604L NP_048960 E Yes Zn metallopeptidase Protein Synthesis, Modification, and Degradation 
A605Lb   NP_048961 EL No Unknown function Uncategorized 
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A607R  NP_048963 E Yes Unknown function Uncategorized 
A608R  NP_048964 E Yes Unknown function Uncategorized 
A609La NP_048965 E Yes UDP-glucose 6-dehydrogenase Sugar Metabolism 
A612La NP_048968 L No Histone H3, Lys27 methylase  Transcription 
A614La NP_048970 L No Ser/Thr protein kinase Signaling 
A617Ra NP_048973 EL Yes Ser/Thr protein kinase Signaling 
A618L  NP_048974 L Yes Unknown function Uncategorized 
A619L  NP_048975 L No Unknown function Uncategorized 
A620L  NP_048976 L No Unknown function Uncategorized 
A621L   NP_048977 L No Unknown function Uncategorized 
A622L   NP_048978 L No Unknown function Uncategorized 
A623L  NP_048979 E No Unknown function Uncategorized 
A624R   NP_048980 L No Unknown function Uncategorized 
A625R NP_048981 L Yes Transposase Integration and Transposition 
A627R   NP_048983 L Yes Unknown function Uncategorized 
A628L  NP_048984 E Yes Unknown function Uncategorized 
A629R NP_048985 EL Yes Ribo. Reductase (Large subunit) Nucleotide Metabolism 
A633R   NP_048989 L Yes Unknown function Uncategorized 
A634L  NP_048990 E Yes Unknown function Uncategorized 
A635R  NP_048991 L Yes Unknown function Uncategorized 
A636R  NP_048992 L No Unknown function Uncategorized 
A637R  NP_048993 E Yes Unknown function Uncategorized 
A638Ra NP_048994 E Yes Agmatine iminohydrolase Miscellaneous 
A642Rb   NP_048998 EL No Unknown function Uncategorized 
A643R   NP_048999 L No Unknown function Uncategorized 
A644R   NP_049000 L No Unknown function Uncategorized 
A645R  NP_049001 E Yes Unknown function Uncategorized 
A646L  NP_049002 N/A Yes Unknown function Uncategorized 
A647R  NP_049003 E Yes Unknown function Uncategorized 
A649R  NP_049005 E Yes Unknown function Uncategorized 
A651L NP_049007 EL Yes GIY-YIG endonuclease Integration and Transposition 
A654L NP_049010 E Yes N-Acetyltransferase Lipid Metabolism 
A656L  NP_049012 E Yes Unknown function Uncategorized 
A658R  NP_049014 L No Unknown function Uncategorized 
A659L  NP_049015 L No Unknown function Uncategorized 
A662L  NP_049018 EL Yes Unknown function Uncategorized 
A664L  NP_049020 E Yes Unknown function Uncategorized 
A665L  NP_049021 E Yes Unknown function Uncategorized 
A666L NP_049022 E Yes Translation elongation factor -3 Protein Synthesis, Modification, and Degradation 
A672R  NP_049028 E Yes Unknown function Uncategorized 
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A674Ra NP_049030 E Yes Thymidylate synthase X Nucleotide Metabolism 
A676R   NP_049032 L No Unknown function Uncategorized 
A678R   NP_049034 L Yes Unknown function Uncategorized 
A682L  NP_049038 E Yes Unknown function Uncategorized 
A683L NP_049039 EL Yes Cytosine methyltransferase DNA Restriction/Modification 
A686L  NP_049042 E Yes Unknown function Uncategorized 
A687R  NP_049043 E Yes Unknown function Uncategorized 
A689L  NP_049045 N/A N/A Unknown function Uncategorized 
a Recombinant proteins have been characterized for these CDSs  
b Non-continuous transcription was detected for these CDSs  
c E = Early genes; EL = Early/Late genes; L = Late genes; N/A = Not Available  
d COG = Cluster of Orthologus Group 
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Chlorella viruses (Family Phycodnaviridae, genus Chlorovirus) are large, 
icosahedral, plaque-forming, dsDNA-containing viruses that infect and replicate in 
certain isolates of chlorella-like green algae.  The 330-kb genome of the prototype virus, 
Paramecium bursaria chlorella virus 1 (PBCV-1), was sequenced and annotated more 
than 10 years ago [1].  The virus contains 366 putative protein-encoding genes and a 
polycistronic gene that encodes 11 tRNAs [1, 2].  Approximately 40% of its predicted 
gene products resemble proteins of known function and many are unexpected for a virus.  
Currently, three species are included in the genus Chlorovirus: i) Viruses that infect 
Chlorella NC64A (NC64A viruses), ii) viruses that infect Chlorella Pbi (Pbi viruses) and 
iii) viruses that infect symbiotic zoochlorella in the coelenterate Hydra viridis [3].  
Chlorella NC64A and Chlorella Pbi are normally endosymbionts of the protozoan 
Paramecium bursaria, but they can be cultured independently of the protozoan.  The 
current study involves three chlorella viruses whose genomes have been sequenced: 
viruses PBCV-1 and NY-2A [4] are NC64A viruses with 330-kb and 369-kb genomes, 




PBCV-1 infects its host by attaching rapidly to the external surface of the algal 
cell wall [6].  Attachment occurs at a unique virus vertex [7] and is followed by digestion 
of the cell wall at the attachment point.  Following host wall degradation, the PBCV-1 
internal membrane presumably fuses with the host membrane, which leads to the entry of 
virus DNA and probably associated proteins into the host.  An empty capsid remains on 
the host surface.  Circumstantial evidence suggests that the infecting PBCV-1 DNA, and 
DNA associated proteins, rapidly move to the nucleus to initiate virus transcription [2].  
Support for this hypothesis includes the fact that neither PBCV-1 nor any of the chlorella 
viruses encode a recognizable RNA polymerase or RNA polymerase subunit.  
Furthermore, RNA polymerase activity was not detected in PBCV-1 virions (Rohozinski 
and Van Etten, unpublished results).  Consequently, assuming that the infecting viral 
DNA moves to the nucleus, it must FRPPDQGHHU RQH RI WKH KRVW¶V 51$ SRO\PHUDVHV
(probably RNA polymerase II) to initiate viral transcription [2].  Therefore, the host 
polymerase(s), possibly in combination with a virus protein(s), must recognize some 
virus DNA promoter sequence(s) to initiate transcription.  This process occurs rapidly 
because early PBCV-1 transcripts can be detected within 5 to 10 min post-infection (p.i.) 
[8].  Virus DNA replication starts 60 to 90 min p.i., followed by transcription of late virus 
genes.  Nascent virus capsids begin to assemble in localized regions of the cytoplasm, 
called virus assembly centers, at 2 to 4 hr p.i.  By 5 to 6 hr p.i. the cytoplasm contains 
many progeny viruses and by 6 to 8 hr p.i. the cell lyses and releases progeny viruses 
(~1,000 particles/cell). 
Thus, PBCV-WUDQVFULSWLRQLVWHPSRUDOO\SURJUDPPHG*HQHVGHILQHGDV³HDUO\´




of de novo protein synthesis [8] (Yanai-Balser et al., unpublished results).  Transcripts of 
JHQHVGHILQHGDV³ODWH´EHJLQWRDSSHDU-90 min p.i.; their appearance probably requires 
translation of early viral genes. However, some early gene transcripts can also be 
detected in later stages of infection.  The PBCV-1 genes are not spatially clustered on the 
genome by either temporal or functional class.  Therefore, temporal regulation of 
transcription must occur via cis- and possibly trans-acting regulatory elements. 
The purpose of the current study is to identify conserved DNA sequences that 
might be involved in activation and regulation of viral transcription by using 
bioinformatic procedures. We identified three conserved nucleotide sequences that appear 
within 150 nucleotides of the ATG translation start codon of many virus open reading 
frames (ORFs).  One of these motifs is associated predominately with early viral gene 




Figure 1. Genomic locations of homologous genes between NY-2A and either PBCV-1 
or MT325.  When a homologous gene is detected between NY-2A and another genome a 
line is drawn.  If the gene is transcribed in the same direction the line is blue.  If the gene 




2. MATERIALS AND METHODS 
2.1. Bioinformatics. The genome sequences and annotations for viruses PBCV-1, NY-
2A, and MT325 are available from GenBank under accession numbers U42580, 
DQ491002, and DQ491001, respectively. The same material is also located at 
http://greengene.uml.edu.  For this study, the promoter region was defined as the region 
encompassing 150 nucleotides upstream of the ATG translation initiation codon and 50 
nucleotides downstream of the ATG translation start codon.   
AlignAce software [9] was used to identify conserved motifs in the promoter 
regions of the 366 PBCV-1 genes.  Three conserved sequences were initially identified 
(Fig. 2).  Two of the sequences were 10-mers and one was a 12-mer.  These sequences 
were optimized and shortened (from each end) one base at a time by trial and error to 
generate the highest ratio of sequence hits in the promoter region relative to total 
sequence hits in the PBCV-1 genome (Table 1).  The PBCV-1, NY-2A, and MT325 
genomes were then searched for the occurrence of the three optimized sequences under 
complete stringency; the locations of the sequences within the promoter region were 
identified for each gene.  The position of each sequence was then plotted with respect to 
the ATG translation initiation codon (Fig. 3).  In addition, the PBCV-1 genome was 
searched for the three conserved sequences allowing one nucleotide mismatch and 
plotted. 
 
2.2 RNA isolation. Infected chlorella cells (m.o.i. of 5) were collected at 20, 40, 60, 90, 
120, 240, and 360 min p.i.  Cells were disrupted with glass beads in the presence of 




Miniprep kit (Stratagene, LaJolla, CA), according WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV
RNA integrity was verified in denaturing 1% agarose gels where intact host cytoplasmic 
and chloroplast rRNAs were visualized.  
 
 
Figure 2.  AlignAce results for the three conserved nucleotide sequences that 
frequently occur in the virus PBCV-1 promoter regions.  The black line indicates a 
potential groove of DNA. 
 
2.3 Microarrays fabrication and hybridization. A microarray containing 50-mer 
oligonucleotide probes representing each ORF in the PBCV-1 genome was constructed 
by MWG Biotech (Ebersberg, Germany) and the Microarray Core Facility (University of 
Nebraska Medical Center). For each time point, 20 mg of total RNA was reverse-
transcribed using oligo(dT) as primers and cDNA was labeled with Cy3 or Cy5-dUTP 
(GE Healthcare, Piscataway, NJ) with the aid of a SuperScript Indirect cDNA Labeling 




hybridization experiments were conducted for each time point against a pool of 
transcripts representing every gene isolated in the time course. 
 
2.4 Microarrays analysis. Results from three independent biological hybridizations were 
analyzed using the GenePix Pro v.6.0 software (Molecular Devices, Sunnyvale, CA) and 
TIGR microarray software suite (TM4) [10].  Many transformations were performed to 
eliminate low quality data, to normalize the measured intensities using Lowess algorithm, 
and to regularize the standard deviation of the intensity of the Cy3/Cy5 ratio across the 
blocks. Genes that displayed statistically significant modulation were identified by a one-
way analysis of variance, using P values of <0.01 as a cutoff.  Genes with similar 
expression profiles were grouped into 10 different clusters using a K-means algorithm.  
 
3. RESULTS and DISCUSSION 
3.1. Viruses analyzed and criteria used to define genes and promoter regions in this 
study. The three chlorella viruses chosen for this study are PBCV-1, NY-2A, and MT325 
that have 366, 404, and 329 putative protein-encoding genes, respectively.  
Approximately 80% of the genes are present in all three viruses.  PBCV-1 and NY-2A 
infect the same host, Chlorella NC64A, and presumably are more closely related, in 
terms of evolutionary distance, to each other than to MT325, which infects Chlorella Pbi.  
However, the two NC64A viruses are among the most diverse of the NC64A viruses.  
The average amino acid identity between PBCV-1 and NY-2A homologs is ~75% [4], 




Most PBCV-1 and NY-2A gene homologs are located co-linearly; in contrast, 
homologous genes in PBCV-1 and MT325 have almost no co-linearity with each other 
(Fig. 1).  Thus, the promoter elements of the two NC64A viruses might be expected to be 
more similar to each other than between NC64A and Pbi viruses. 
 
Table 1.  Promoter motif optimization based on generating the motif that has the most 
occurrences in the promoter region relative to the total number of occurrences in the 
PBCV-1 genome.   
 
*Shown is the total number of times the motif occurred in the promoter regions.  Note the 
same motif can occur multiple times within the same promoter region.  For example, 
there are 91 unique genes that contain the promoter sequence ARNTTAANA; 84 of these 




The following criteria were originally used to define genes in the three viruses: i) 
a minimal size of 65 codons initiated by an ATG codon, ii) when genes overlapped, the 
largest gene was chosen and iii) genes typically contain A+T-rich (>70%) regions in the 
50 nucleotides upstream of the ATG translation start codon [1].  For this study, promoter 
regions were defined as encompassing a 200 bp region (150 bp upstream and 50 bp 
downstream of the ATG translation start site) of each viral encoded gene.  However, the 
intergenic regions between PBCV-1 genes have an average size of 81 nucleotides with a 
standard deviation of 83 nucleotides (excluding the two-tailed 5% most extreme data 
points).   In fact, 260 of the 366 PBCV-1 genes have less than 100 nucleotides between 
them.  Using this definition, many of the putative viral promoter regions are located in an 
adjacent gene.  
 
3.2. Three conserved sequences occur in the chlorella virus promoter regions. Using 
AlignAce software, three highly conserved nucleotide sequences were identified in the 
PBCV-1 promoter regions (Fig. 2).  These sequences were optimized as described in the 
Materials and Methods section to generate three sequences that range in size from 7 to 9 
nucleotides (Table 1); one or more degenerate positions occur in two of the three 
sequences. Some promoter regions contain more than one copy of either the same or 
different conserved sequences.  As reported in Fig. 3, most of the sequences occurred in 





Sequence ARNTTAANA. The sequence ARNTTAANA occurs in the promoter region in 
91 of the 366 PBCV-1 genes (25%), in 90 of the 404 virus NY-2A genes (22%), and in 
40 of the 329 MT325 genes (12%) (Table 2).  Relative to the entire genome, this 
sequence is present within the 200-nucleotide promoter region 44% of the time in PBCV-
1, 49% of the time in NY-2A, and 37% of the time in MT325.  Furthermore, the location 
of the sequence is biased to nucleotide position -15 to -45, relative to the ATG translation 
start codon (64% in PBCV-1, 66% in NY-2A, and 65% in MT325) (Fig. 3A).  Thus the 
region between nucleotides -15 and -45 is a hotspot for the ARNTTAANA sequence. 
 
Sequence AATGACA. The sequence AATGACA occurs in the promoter region in 60 of 
the 366 PBCV-1 genes (16%), in 74 of the 404 NY-2A genes (18%), and 25 of the 329 
MT325 genes (8%) (Table 2).  Relative to the entire genome, this sequence is present 
within the 200-nucleotide promoter region in 54% of the PBCV-1 genes, 53% of the NY-
2A genes, and 25% of the MT325 genes.  Furthermore, the AATGACA sequence is 
biased to nucleotide position -60 to -90, relative to the ATG initiation codon  (44% in 
PBCV-1, 37% in NY-2A, and 33% in MT325) (Fig. 3B).  These results indicate that the 
region between nucleotides -60 and -90 is a hotspot for the AATGACA sequence.  This 
sequence resembles the consensus -35 element (TTGACA) in E. coli promoters. 
 
Sequence GTNGATAYR. The sequence GTNGATAYR occurs in the promoter region in 
49 of the 366 PBCV-1 genes (13%), 58 of the 404 NY-2A genes (14%), and 36 of the 




specifically within the 200-nucleotide promoter region in 28% of the PBCV-1 genes, 
22% of the NY-2A genes, and 21% of the MT325 genes.  The location of the sequence is 
biased to nucleotide positions -50 to -80, relative to the ATG initiation codon (39% in 
PBCV-1, 38% in NY-2A, and 70% in MT325) (Fig. 3C).  These results indicate that the 
region between nucleotides -50 and -80 is a hotspot for the GTNGATAYR sequence. 
 
Table 2. General characteristics of three conserved, putative promoter elements in 
three chlorella viruses. 
 
 
3.3. Occurrence of conserved sequences in PBCV-1 allowing a one base mismatch. 
The presence of these three conserved sequences in the promoter regions was also 
determined with one base mismatch in PBCV-1.  Under complete stringency, 48% of the 
366 PBCV-1 gene promoter regions contain at least one of the three conserved 
sequences.  With one base-pair mismatch, ARNTTAANA occurs in 306 (84%) of the 
gene promoter regions, AATGACA occurs in 204 (56%) of the gene promoter regions, 
and GTNGATAYR occurs in 155 (42%) of the PBCV-1 366 promoter regions.  [Note: 
some of the genes have two sequences located one or more times in the same promoter 
region (supplement 1).]  Allowing a one base mismatch, one of these three motifs is 





















































































Figure 3. The positional distributions of three conserved nucleotide sequences in the 
gene promoter region of chlorella viruses PBCV-1, NY-2A, and MT325 with respect to 




sequences with one base pair mismatch relative to the ATG translation start codon are 
similar to the locations under complete stringency (results not shown). 
 
3.4. The conserved motifs are not specific to direction or location within the genome. 
None of the three conserved sequences exhibit a preference for direction or location 
within the three viral genomes.  This finding is not surprising because genes classified as 
early or late occur throughout the PBCV-1 genome (Yanai-Balser et al., unpublished 
results) and they are approximately equally positioned in both orientations. 
 
3.5. Homologous virus genes often share similar motif patterns at conserved 
locations. Viruses PBCV-1, NY-2A, and MT325 share many homologs (~80% of the 
genes are conserved among the three viruses).  Therefore, we examined the occurrence of 
the conserved sequences among homologs in the three viruses.  Homologous gene 
products often share similar motif patterns at conserved locations relative to the ATG 
translation start site (supplement 1).  For example, a putative VLTF2-type transcription 
factor is a gene product encoded by all three viruses.  Homologs in each of the viruses 
have the same motif (ARNTTAANA) in a similar location (-32, -31, and -33 nucleotides 
from the ATG translation start codon in viruses PBCV-1, NY-2A and MT325, 
respectively).  Furthermore, if a specific motif occurs outside of the expected promoter 
region (e.g. outside of the -50 and -80 region for GTNGATAYR), homologous genes 
contain the motif in a similar location.  For example, a gene encoding a putative PBCV-1 




beginning at -146.  The homologous gene in NY-2A contains the same sequence 
beginning at nucleotide ±142.  This sequence is not present in the MT325 replication 
factor C gene homolog.   
 
3.6. Conserved sequences in the promoter region of homologous genes often contain 
identical nucleotides at degenerate positions. In addition to conserved sequences in 
their promoter regions, homologous genes often have similar nucleotide preferences at 
degenerate nucleotide positions within those sequences.  Two of the three conserved 
nucleotide sequences (ARNTTAANA and GTNGATAYR) have degenerate nucleotide 
positions, and conserved nucleotide preferences occur among homologs for each of these 
two sequences.  For example, the promoter region of the ribonucleotide reductase large 
subunit gene (a629r in PBCV-1 and b832r in NY-2A) contains the sequence 
*71*$7$<5 D VHTXHQFH ZLWK WKUHH GHJHQHUDWH QXFOHRWLGH SRVLWLRQV  $W WKH µ1¶
position, the PBCV-1 and NY-$ KRPRORJV FRQWDLQ D F\WLGLQH UHVLGXH  $W WKH µ<¶
position, botKYLUDOJHQRPHVFRQWDLQDF\WLGLQHUHVLGXHDQGDWWKHµ5¶SRVLWLRQERWKYLUDO
genomes contain an adenine residue (Table 3).  Not surprisingly, the nucleotide 
conservation at degenerate positions is more frequent between PBCV-1 and NY-2A than 
between either of these viruses and MT325.   
 
3.7. Motif AATGACA is strongly associated with PBCV-1 early gene expression. To 
determine if there is a correlation between time of expression and the presence of a 




























Figure 4. Distribution of three putative promoter motifs relative to when PBCV-1 genes 
are expressed.  Transcripts of genes classified as early/late are detected prior to the 
beginning of DNA replication and are present after DNA synthesis begins.   
 
containing probes from each gene in the genome.  Competitive hybridization experiments 
were conducted employing cDNA from poly A-containing viral RNAs obtained from 
cells at 20, 40, 60, 90, 120, 240, and 360 min p.i., which allows us to follow global 
transcription of PBCV-1 replication. 
The microarray results established that PBCV-1 transcripts fall into two groups: 
(i) early genes (59%), expressed before 60 min p.i. (the beginning of DNA synthesis) and 
(ii) late genes (41%), expressed after 60 min p.i.  However, transcripts of 42% of the 
early genes are also present at late times after infection, referred to as early/late genes in 
Fig. 4 (Yanai-Balser et al., unpublished results). 
Most of the genes with the AATGACA sequence are expressed early during 
infection (83%); transcripts from 24% of these early genes are also present after virus 
DNA synthesis begins (Fig. 4).  The remaining 17% of the genes containing the 
AATGACA sequence are expressed late. 
The other two sequences, ARNTTAANA and GTNGATAYR, have a no 
correlation with expression time.  Sixty percent of the genes with the sequence 
ARNTTAANA are transcribed early; transcripts from 56% of these early genes are also 
present after virus DNA synthesis begins.  The remaining 40% of the genes with the 




sequence GTNGATAYR in the promoter region are transcribed early and 25% of these 
genes produce transcripts that are also detected late during infection.  The remaining 40% 
of the genes containing the GTNGATAYR sequence are expressed late.  However, since 
60% of the total genes are expressed early and 40% of the total genes are expressed late, 
there is no correlation with time of expression and these two sequences.   
 
Table 3. Examples of homologous proteins of known function containing promoter motifs 
with conserved nucleotides at degenerate positions. 
 
Bold nucleotides represent non-degenerate positions. A (-) denotes either a 
homolog does not exist or a homologous protein does not contain the motif.  Degenerate 





3.8. Promoter elements in related viruses. This is the first attempt to identify promoter 
elements by bioinformatic procedures in the phycodnaviruses.  However, two previous 
reports described conserved nucleotide sequences in promoter regions that are associated 
either with a single chlorella virus gene, a gene encoding a potassium ion channel protein 
[11], or with 23 immediate early expressed genes in chlorella virus CVK2 [12].  The 
motif identified in the immediate early genes by Kawasaki et al. (ATGACAA) is similar 
to a motif identified in this manuscript (AATGACA), which also correlated with early 
transcripts.  
 The phycodnaviruses probably share a common evolutionary ancestry with the 
poxviruses, iridoviruses, asfarviruses, and the mimivirus [13, 14, 15].  All of these 
viruses have nine gene products in common and at least two of these viral families have 
an additional 41 homologous ORFs [14].  Collectively, these large dsDNA viruses are 
referred to as nucleocytoplasmic large DNA viruses [13]. 
 A bioinformatics study on mimivirus identified an eight-nucleotide sequence, 
AAAATTGA, which occurs in the putative promoter regions (-150 to 0) of 403 of the 
911 (45%) mimivirus ORFs [16].  This element is specific to the mimivirus lineage and 
the authors suggest that the element may correspond to an ancestral promoter structure 
predating the radiation of the eukaryotic kingdom. 
 In the iridovirus, Chilo iridescent virus (CIV), 5 nucleotides (AAAAT) located 
between   -19 and -15 have been described as essential for promoter activity [17].  
Interestingly, this promoter sequence is not only in the putative promoter regions of other 




promoter regions of the poxviruses [18] and the asfarvirus, African swine fever virus 
[19], have also been reported.   
 
4. CONCLUSIONS 
This study identified three conserved 7 to 9 nucleotide sequences that probably 
function as promoter elements in the chlorella viruses. One of these sequences is 
associated primarily with early viral gene transcription and is likely to serve as a 
promoter for early genes.  One way to test these predictions is to place one or more of 
these suspected early gene promoter regions in front of a late virus gene and determine if 
the "late" gene is now expressed early.  Unfortunately, these experiments are not possible 
at the present time because procedures for manipulating the chlorella virus genomes are 









5.1. Supplement Table 1.  Putative PBCV-1, NY-2A and MT325 genes are grouped by 
their functional categories.  If a conserved nucleotide motif has been identified within the 
promoter region of the gene, the sequence and location are noted. 
 
DNA Replication, Recombination and Repair 
  PBCV-1 NY-2A MT325 
  Gene Sequence Location Gene Sequence Location Gene Sequence Location 
į'1$SRO\PHUDVH a185r      b249r     m019l     
Archaeo-eukaryotic primase 
a468r      b633r GTCGATATG -85 m664l     
      b633r AATGACA -71       
PCNA 
a193l  AACTTAAGA -33 b261l AACTTAAGA -29 m014r     
a574l      b767l     m697l     
Replication factor C 
a417l  AGATTAAAA -49 b571l GTCGATATG -142 m430l     
a417l  GTCGATACG -146             
RNase H a399r      b547r     m570l GTCGATATA -61 
Helicase-Superfamily III a456l      b623l GTCGATATG -83 m674r     
DNA Topoisomerase II a583l      b781l     m546r     
ATP-dependent DNA ligase 
a544r  AACTTAATA -28 b734r GTCGATACA -13       
      b734r AATGACA 0       
      b734r AATGACA 7       
ATPase (PP-loop) a554/556/557l      b744l     m389r AATGACA 37 
ATPase (DNA packaging) a392r      b536r     m586l     
Pyrimidine dimer-specific 
glycosylase a050l      b076l     m627l     
Exonuclease a166r  AACTTAACA -29 b214r     m215r     
          
Transcription 
  PBCV-1 NY-2A MT325 
  Gene Sequence Location Gene Sequence Location Gene Sequence Location 
Transcription factor TFIIB a107l  AATGACA -86 b154l AATGACA -25 m139l     
Transcription factor TFIID 
a552r  AATTTAAAA -147 b743r AATTTAAAA -7 m266r GTCGATATA -78 
      b743r GTCGATATG -73       
Transcription factor TFIIS 
a125l      b175l     m163l AGATTAATA -33 
            m163l GTCGATATA -62 
VLTF2-type transcription factor a482r  AATTTAAGA -32 b647r AATTTAAGA -31 m635r AACTTAACA -33 
Superfamily II helicase 
a153r  AAATTAAGA 38 b203r AACTTAATA -9 m201r     
a241r  AATGACA -61 b203r AAATTAAGA 38 m225l GTCGATATA -60 
a241r  AAATTAAAA -8 b316r     m372r     
a241r  GTCGATACG -75 b508r           
a363r                  
mRNA guanylyltransferase a103r  AATGACA -56 b148r AATGACA -84 m133r AGCTTAAAA -44 
RNA triphosphatase a449r  AACTTAACA -30 b612r AACTTAACA -36 m399l AGCTTAACA -41 
Histone H3, Lys 27 methylase 
a612l  AATGACA 7 b268l     m727l AATGACA 10 
a612l  GTGGATATG 41 b813l           
SWI/SNF chromatin remodeling 
complex a189/192r      b258r     m015l     
SWI/SNF helicase 
a548l  AATGACA -147 b738l AATGACA -70 m272l     
a548l  AATGACA -140 b738l AATGACA -63       




a548l  AATGACA -126             
a548l  AATGACA -119             
a548l  AATGACA -112             
RNase III 
a464r  AATTTAAGA -7 b628r AATTTAAGA -27 m672l AACTTAATA 13 
            m672l GTCGATATG -27 
Cytosine deaminase 
a200r  AATGACA -75 b271r AATGACA -20 m010l     
a200r  AATGACA 0 b271r AATGACA 0       
          
Sugar Manipulation 
  PBCV-1 NY-2A MT325 
  Gene Sequence Location Gene Sequence Location Gene Sequence Location 
D-lactate dehydrogenase a053r            m026l     
GDP-D-mannose dehydratase 
a118r  AACTTAACA -28 b163r AACTTAACA -28       
      b163r AATGACA 0       
Fucose synthase a295l  AATTTAAGA -22 b395l AACTTAAGA -28       
UDP-glucose 6-dehydrogenase a609l  AGATTAACA -101 b465r AATTTAACA -131 m719l     
Glucosamine synthetase a100r      b143r     m037r     
Hyaluronan synthase a098r            m128r     
Chitin synthase 
      b139r           
      b472r AAATTAAAA -16       
Cellulase precursor             m354r     
Polysaccaride deacetylase       b469l           
Glycosyltransferase 
a064r      b159r     m186r AATGACA -28 
a111/114r  AAGTTAATA -83 b618r     m467r GTCGATATA -78 
a219/222/226r      b736l AACTTAAGA -31 m467r GTTGATACA -52 
a473l  GTCGATATG -88       m491r     
a546l  AACTTAAGA -90       m721l     
dTDP glucose pyrophosphorylase             m174l     
          
Lipid Manipulation 
  PBCV-1 NY-2A MT325 
  Gene Sequence Location Gene Sequence Location Gene Sequence Location 
Acetyltransferase a254r  GTTGATACG -60             
N-acetyltransferase a654l      b853l     m758r     
Glycerophosphoryl diesterase a049l      b075l           
Lipoprotein lipase a402r AGCTTAACA -32 b550r AGCTTAACA -16 m564l     
Lysophospholipase a271l      b354l           
Patatin-like phospholipase a173l      b226l     m219l     
          
Cell Wall Degradation 
  PBCV-1 NY-2A MT325 
  Gene Sequence Location Gene Sequence Location Gene Sequence Location 
Chitinase 
a181/182r  AATTTAAAA -28 b239r GTCGATACG -56 m085r     
a260r  GTCGATATG -68       m791r     
a260r  GTTGATATG -57             
Chitosanase a292l      b393l     m091r     
ȕ	ĮOLQNHGJOXFXURQLFO\DVH 
a215l      b288l     m289r GTCGATATA -101 
      b468r           
ȕ-1,3-glucanase 
a094l  AATGACA -90 b137l AATGACA -14 m124l     
a094l  AATGACA -83 b137l AATGACA 0       
a094l  AATGACA -76             
a094l  AATGACA -69             
a094l  AATGACA -62             
a094l  AATGACA -55             
          
Signaling 




  Gene Sequence Location Gene Sequence Location Gene Sequence Location 
Aquaglyceroporin             m030r     
Potassium channel protein a250r      b336r     m183r     
Ligand-gated channel protein a163r  AGTTTAAGA -36             
Glutamate receptor a162l                  
Ca2+ transporting ATPase             m535l     
Dual specificity phosphatase a305l      b430l     m313l AAATTAAAA -28 
Serine/Threonine protein kinase 
a034r      b331r GTCGATATG -13 m143l AATTTAATA -21 
a248r  AATGACA -80 b331r AATGACA 0 m221l     
a277l      b331r AATGACA 7 m543r AATGACA -76 
a278l      b365l AAATTAACA -55 m729l AAATTAAAA -23 
a282l      b368l     m729l AATTTAATA -9 
a289l      b388l GTCGATACG -74 m729l AATGACA -139 
a614l      b816l     m733r     
a617r      b818r     m794r     
          
Integration and Tranposition 
  PBCV-1 NY-2A MT325 
  Gene Sequence Location Gene Sequence Location Gene Sequence Location 
Transposase 
a625r      b080l AATTTAACA -37       
      b080l AATGACA -92       
      b334r AATGACA -73       
      b334r AATGACA 0       
      b378l AATTTAACA -37       
      b378l AATGACA -92       
      b702l AATGACA 0       
      b711l           
      b829r AATTTAAAA -144       
Resolvase 
      b083l AATTTAACA -42       
      b083l AATGACA -97       
      b381l AATTTAACA -42       
      b381l AATGACA -97       
      b715l AATTTAACA -42       
      b715l AATGACA -97       
Tlr 6Fp DNA mobile protein a121r     b168r AAATTAATA -25 m150r AACTTAACA -11 
GIY-YIG endonuclease 
a134l  AATTTAAGA -37 b039l     m032l     
a287r  AATGACA -80 b185l AACTTAAGA -36 m111r     
a315l      b185l GTCGATACA -47       
a351l  AATGACA -80 b206l     m180l     
a351l  AATGACA -73 b246r     m288l GTCGATATA -60 
a351l  GTTGATATA -100 b286r AAATTAATA -85 m370r AATGACA -143 
a495r      b286r GTCGATACG -71 m370r AATGACA -123 
a539r      b286r AATGACA -58 m370r AATGACA -103 
a651l  AATGACA -64 b346l GTCGATACA -145 m370r AATGACA -83 
a651l  AACTTAAAA -38 b346l AATGACA -77 m460r AGGTTAACA 41 
      b389r AATGACA 0 m465l AATTTAACA -90 
      b389r AATGACA 7 m465l GTCGATATA -61 
      b433l     m502l     
      b440l     m517r AATGACA -62 
      b497l AATTTAAAA -132 m683l     
      b497l GTCGATATA -142       
      b499l GTCGATATA -99       
      b602l           
      b629r AATGACA -46       
      b724r AATTTAATA -47       
      b724r AATGACA -53       
      b850l GTCGATATG -99       




a267l      b061r AATTTAATA -29 m093l     
a354r      b133r AATGACA -77 m578r GTCGATATA -60 
a422r      b165r     m622l GTCGATATA -59 
a478l      b173l AATGACA -37       
a490l      b173l AATGACA -25       
      b199r GTCGATACA -71       
      b199r AATGACA -58       
      b218r AATGACA -55       
      b324l           
      b370l AATGACA -70       
      b370l AATGACA -63       
      b424l           
      b446r AATGACA -55       
      b598l           
      b718l           
      b747l           
      b753l AATGACA -81       
      b798r AAATTAATA -82       
      b798r AATGACA -62       
      b805r           
      b878l           
          
Protein Synthesis, Modification and Degradation 
  PBCV-1 NY-2A MT325 
  Gene Sequence Location Gene Sequence Location Gene Sequence Location 
Translation elongation factor-3 
a646l  AAGTTAATA 29       m375r GTTGATATA -27 
a666l            m742r     
Prolyl-4-hydroxylase a085r  AATGACA 0 b126r AATGACA -29 m401r AATGACA -29 
Thiol oxidoreductase a465r      b630r     m670r     
Protein disulfide isomerase 
a448l  AATGACA -55 b611l GTTGATATA -88 m403r     
      b611l AATGACA -66       
SKP-1 protein 
a039l  AATGACA -76 b068l AATGACA -77 m807r     
      b068l AATGACA -64       
Ubiquitin       b699l           
Ring finger ubiquitin ligase 
a481l AAATTAAAA -88 b645l AAATTAAAA -45 m629l GTCGATATA -59 
a481l AACTTAAGA -29 b645l AACTTAAGA -28       
                
Ubiquitin C-terminal hydrolase a105l  AGCTTAACA -31 b150l AGTTTAACA -29 m137l     
Zn metallopeptidase 
a521l AACTTAATA -44 b685l     m496l AATTTAATA -20 
a604l  AATGACA -96 b803l AAATTAAGA -86       
a604l  AATGACA -89 b803l GTCGATATA -73       
a604l  GTTGATATA -111 b803l AATGACA -59       
Initiation factor 2 
            m488l AATGACA 12 
            m489r     
          
Nucleotide Metabolism 
  PBCV-1 NY-2A MT325 
  Gene Sequence Location Gene Sequence Location Gene Sequence Location 
Aspartate transcarbamylase a169r  GTCGATACG -80 b222r AATTTAACA -28       
Ribo. Reductase (small subunit) a476r      b641r     m653l AATGACA -97 
Ribo. Reductase (large subunit) 
a629r  AATTTAAAA -133 b832r GTGGATACA -105 m777l AATGACA -66 
a629r  GTCGATACA -96             
Deoxynucleoside kinase a416r            m425r     
dCMP deaminase a596r  AATTTAAAA -29 b795r AATTTAACA -33 m530l     
dUTP pyrophosphatase 
a551l  GTTGATACG -95 b741l AAATTAAAA -114 m264l GTCGATATA -78 
      b741l GTTGATATA -75       





a438l      b592l     m241l AGCTTAAAA -29 
            m423r     
Thioredoxin 
a427l  AATGACA -47 b581l AATGACA -47 m445l GTCGATATG -61 
a427l  AAATTAACA 32       m448l AATTTAAGA -30 
            m449l     
          
DNA Restriction/Modification 
  PBCV-1 NY-2A MT325 
  Gene Sequence Location Gene Sequence Location Gene Sequence Location 
Adenine methyltransferase 
a251r      b010r           
a581r  AAGTTAATA -55 b016l           
      b230l           
      b236l AAGTTAAAA 34       
      b359r           
      b399r AATTTAAAA -34       
      b416r           
      b418r           
      b543l           
      b567l           
      b774r           
Cytosine methyltransferase 
a517l  AGTTTAAGA -29 b008r AATTTAAGA 7 m359l     
a530r      b088r           
a683l      b411l AACTTAACA -27       
      b566r AACTTAACA 19       
      b681l AATTTAAGA -44       
      b681l AATGACA -60       
      b697r           
      b769r GTCGATATG -54       
DNA restriction endonuclease 
a252r  AATGACA 0 b361r           
a579l  AATGACA -17 b542r           
a579l  AACTTAAAA -29             
a579l  GTTGATATA -40             
          
Miscellaneous 
  PBCV-1 NY-2A MT325 
  Gene Sequence Location Gene Sequence Location Gene Sequence Location 
Ornithine/Arginine decarboxylase a207r      b278r     m307l     
Agmatine iminohydrolase a638r      b844r     m766l     
N-carbamoylput. amidohydrolase  a078r  GTTGATATG -75 b116r     m103l     
Homospermidine synthase a237r      b305r     m233l     
Histidine decarboxylase 
a598l  AAATTAATA -51 b796l AATTTAAGA -33 m601l     
      b796l GTCGATATA -70       
Monoamine oxidase 
a217l  AATGACA -20 b289l AATGACA -29 m283r     
a217l  AATGACA -10 b289l AATGACA 0       
a217l  AATGACA 0             
a217l  AATGACA 33             
Amidase a284l      b371l     m101r     
Cu/Zn-superoxide dismutase a245r  AAATTAACA -114       m099r     
O-methyltransferase a061l                  
FkbM Methyltransferase       b183l     m177l     
ABC transporter protein a445l      b606l GTCGATACG -147 m404r AATTTAATA -33 
ATPase (SequenceA+ class) 
a044l  AAATTAATA -40 b073l AATTTAAGA -29       
a044l  AACTTAAAA -32 b073l GTTGATACA -126       
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CONCLUSIONS AND FUTURE PROSPECTS 
1. OVERVIEW 
 Only recently, the role of viruses in the ecology of aqueous environments has 
begun to be appreciated [1, 2, 3, 4]. Viruses are major players in the mortality of aquatic 
microorganisms and, consequently, contribute to geochemical cycles as well as structure 
of microbial communities [4]. Research focusing on individual viruses infecting 
unicellular and multicellular algae has made progress in recent years, but the field of 
algal virology is still in its infancy [5, 6, 7, 8, 9, 10, 11]. Questions about the long-term 
effects of viral-mediated processes and their true biological potential in maintaining 
aquatic communities remain unanswered.   
 To help recognize the importance of viruses in freshwater, we investigate the 
virus PBCV-1 that infects the eukaryotic unicellular green alga, Chlorella NC64A. Since 
its discovery in the early 1980s [12], many fascinating characteristics about this virus 
have been found. For example, this virus has a large genome and it is predicted to encode 
~365 proteins. PBCV-1 CDSs resemble genes from all domains of life. Some of the 
PBCV-1 encoded proteins have been independently characterized by producing 
recombinant proteins. There was, however, a big gap in the understanding of how, where, 
and when viral gene expression occurs and if the 365 CDSs were transcribed. It was also 
not clear how the expression of each CDS is regulated, and ultimately, how virus proteins 
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take control of the host and drive the successful infection resulting in host cell lysis and 
spread of progeny virion. In an attempt to find answers as to which and when PBCV-1 
CDSs are expressed, we monitored virus transcription during the replication cycle in 
Chlorella NC64A by microarray analysis. This allowed us to group each CDS with 
respect to time of expression. The results from this study led to the following 
conclusions: (i) most PBCV-1 CDSs (99%) are expressed during the virus life cycle in 
laboratory conditions. However, many PBCV-1 CDSs are not essential for replication in 
vitro because PBCV-1 deletion mutants (with deletions up to ~37 kb) produce viable 
progeny [13]. Microarray analysis of other large DNA viruses also reveals expression of 
the majority of genes (e.g., poxviruses, iridoviruses). (ii) PBCV-1 temporally regulates 
the expression of each CDS and most late CDS expression depends on the onset of viral 
DNA synthesis. This pattern is common for other viral systems (e.g., poxviruses and 
iridoviruses). (iii) By classifying PBCV-1 CDSs according to time of expression and 
putative function, it was determined that many of the early CDSs were involved with 
virus DNA replication and many late CDSs were packaged in the virion.
 This transcriptional study contributes to our understanding of PBCV-1 infection, 
but it also raises many questions that are mentioned below.  
- Do PBCV-1 CDSs have additional promoters?  
 Although three sequences were found in many putative promoter regions of the 
PBCV-1 genome, only one of them (5’-AATGACA-3’) correlates with early expression 
of PBCV-1 CDSs (Chapter III). However, many early CDSs do not possess this sequence 
and more importantly, no conserved putative promoter sequences were found for CDSs 
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that are expressed early/late and late stages of infection. In Chapter III, the search for 
putative promoter sequences is described and it primarily focused on a specific region (-
150 to +50 from the translation start site), assuming promoter sequences are found within 
this range and also assuming they are ubiquitous. Rare promoter sequences are not easily 
identified since they cannot always be distinguished from random background noise 
using bioinformatics tools. Microarray results, as described in Chapter II, revealed that 
35% of the PBCV-1 CDSs are transcribed early, 27% are transcribed early/late, and 37% 
are transcribed late. The earliest time point analyzed was 20 min p.i., however, not all 
early CDSs were detected at 20 min p.i. The same phenomenon was observed for late 
CDS, not all late viral transcripts were detected at the same time post-infection. The 
pattern is even more complicated for early/late CDSs, as their transcripts are detected at 
different times, and sometimes, the transcript is present at an early time, then disappears, 
and reappears at a late time. This suggests that there are additional promoters elements in 
each transcriptional class that have not been identified. 
 Because ~80% of the PBCV-1 CDSs are conserved in other chloroviruses, it may 
be possible to compare, for example, the promoter regions of all early PBCV-1 CDSs to 
the promoter regions of their orthologs. Assuming CDSs with the same function are 
transcribed at the same time during infection, and also assuming the promoter sequence is 
conserved, it may be possible to find putative signals in this comparison
- Assuming PBCV-1 is dependent on host transcription machinery, do viral 
CDSs, promoters, and terminators resemble host genes? 
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Now that the genome sequence of the host Chlorella NC64A is available and 
assuming virus gene expression depends on host transcriptional machinery, it will be 
interesting to search for the putative promoter sequences identified in PBCV-1 genome 
and determine whether they are also found in the Chlorella NC64A genome. Also, if 
putative promoter sequences are found in Chlorella, they should also be compared to the 
putative promoter regions in the PBCV-1 genome.  An experiment using the yeast-two-
hybrid system could be carried out to test if transcription factors from the virus or host 
bind to the putative promoter sequences.  
- Are “minor” CDSs important for PBCV-1 replication? 
All of the PBCV-1 CDSs described in this work were considered “major” CDSs; 
i.e., protein encoding genes. “Minor” CDSs are also present in the virus genome and they 
are mostly ignored. A CDS is classified as minor in PBCV-1 if: (i) it resides inside a 
major CDS, regardless of orientation; (ii) if it overlaps within a major CDS, regardless of 
orientation. However, mass-spectrometry analysis of virion-associated proteins (D. 
Dunigan, unpublished results) has revealed several (~12) minor CDSs expressed and 
found to be virion-associated. This indicates that some minor CDSs might have important 
roles in PBCV-1 replication. In addition, preliminary analysis of the transcriptome 
sequence of uninfected cells and PBCV-1 infected cells at 20 min p.i. reveals that some 
of the minor CDSs are expressed.  
Minor CDS microarray probes were not used in this study, thus it would be 
interesting to check if they are expressed and when they are expressed. However, it is not 
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trivial to distinguish a minor from a major CDS especially when they are co-localized in 
the genome. Thus, the results from this type of experiment must be carefully interpreted. 
- Are predicted initiation and termination sites correct for PBCV-1 CDSs? Are 
there additional introns in PBCV-1 CDSs?
 In the microarray analysis, PBCV-1 CDSs were classified according to their 
expression time, i.e., when hybridization occurred with the corresponding 50 nucleotide-
long probe. The probes were designed to be specific and they correspond to various sites 
within each known CDS. Thus, microarrays do not provide any information regarding 
initiation and termination sites or intron regions. 
As mentioned above, transcriptome mapping of  PBCV-1 infected cells at 20 min 
p.i. shows transcription of a few CDSs starting before the predicted start codon and bases 
after the termination codon. The mapping also reveals the presence of introns that were 
not previously identified. It will be important to repeat this experiment in order to 
confirm these results.  
- Are some PBCV-1 messages are polycistronic?   
 We suspect that some of PBCV-1 messages are polycistronic because Northern 
blot analyses revealed RNA bands running larger than their expected sizes from 
denaturing agarose gels electrophoresis. However, a comprehensive characterization of 
PBCV-1 transcripts and processing is lacking. We expect most CDSs to be monocistronic 
because microarray analysis shows very few clusters with nearby genes showing the 
same expression pattern.   
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- Where does PBCV-1 transcription occur? 
 It has been assumed that PBCV-1 DNA and some virion-associated proteins are 
directed to the nucleus upon infection. This is in part because the virus lacks a 
recognizable RNA polymerase gene and the assumption is that the virus uses the host 
transcription machinery for expression of viral messages. Although a few viral proteins 
(e.g. restriction endonucleases) likely go to the nucleus, there is no direct evidence that 
the virus DNA goes to the nucleus.
 The results obtained by the microarray analysis do not provide any evidence as to 
where transcription occurs. However, if it is shown that virus promoters are similar to 
host promoters, then this will probably indicate that the virus uses transcription 
machinery from the host and consequently goes to the cell nucleus.
- How does PBCV-1 transcription time correlate to translation time? 
The presence of a transcript as indicated by the microarray may or may not 
directly correlate with the presence of translation products. Western blots of a few 
PBCV-1 proteins have shown a ~30 min lag after expression of the mRNA. However, 
translation of the majority of PBCV-1 CDSs have not been analyzed.
- Are mRNAs packaged in the virion? 
 Since virus transcription begins almost immediately after infection (within 2-5 
min p.i.), it is possible that some messages required very early are packaged in the virion. 
It is possible to test this hypothesis using the PBCV-1 microarray. Disrupted virus 
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particles can be used for cDNA synthesis, and the product can later be fluorescently 
labeled and hybridized with the probes in the microarray. It will not be surprising if some 
mRNAs are packaged in the virion since viral messages can be detected as early as 5 min 
p.i. [14]. However, recent calculations of transcription rates in vivo reveal that 
transcription can occur as fast as 4.4 kb/min and the average PBCV-1 average CDS size 
is 0.9 kb, which means it could be synthesized in ~ 15 seconds.    
- How is viral mRNA degradation carried out during infection? 
PBCV-1 microarray analysis classified each viral CDSs according to the presence 
of the transcript in the time points investigated. The presence of specific transcription 
classes also indicates that the infected cell has a very efficient process for degrading virus 
mRNAs. It is not known how this is regulated by the virus.
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CHLORELLA VIRUSES CONTAIN GENES ENCODING A 
COMPLETE POLYAMINE BIOSYNTHETIC PATHWAY 
1. OVERVIEW 
Polyamines are small cationic organic molecules of vital importance for all living 
organisms. The primary polyamines in eukaryotes are putrescine and the putrescine-
derived spermidine and spermine (Fig. 1A). Putrescine is formed either directly by the 
decarboxylation of ornithine by ornithine decarboxylase (ODC) or indirectly from 
arginine by the sequential action of arginine decarboxylase (ADC), agmatine 
iminohydrolase (AIH, also known as agmatine deiminase), and N-carbamoylputrescine 
amidohydrolase (CPA). Both pathways occur in plants although the model plant 
Arabidopsis thaliana lacks an ODC gene [1] and is therefore completely dependent on the 
ADC pathway. Putrescine is converted to spermidine by spermidine synthase (SPDS) and 
S-adenosylmethionine decarboxylase; the latter enzyme produces decarboxylated S-
adenosylmethionine (dcSAM) which serves as the aminopropyl donor for SPDS. 
Spermine is synthesized in a similar way from spermidine and dcSAM by spermine 
synthase. Although putrescine, spermidine,and spermine are the main polyamines in 
eukaryotes, many other polyamines have been identified in nature that are either derived 
from the putrescine pathway, such as 1,3-diaminopropane and homospermidine, or from 
other precursors,e.g. cadaverine is derived from lysine [2]. 
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Figure 1. Polyamine biosynthesis pathways. (A) Overview. (B) Details of the reactions 
catalyzed by agmatine iminohydrolase and N-carbamoylputrescine amidohydrolase. 
ADC, arginine decarboxylase; AIH, agmatine iminohydrolase; CPA, N-
carbamoylputrescine amidohydrolase; HSS, homospermidine synthase, ODC, ornithine 
decarboxylase; SAMDC, S-adenosylmethionine decarboxylase; SPDS, spermidine 
synthase; SPMS, spermine synthase. 
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Polyamines are not only essential for living cells butthey also occur in the capsids 
of many viruses and, in some cases, are important for virus multiplication (reviewed in 
[3, 4]). In other systems, host polyamines are important for resistance against viruses 
(reviewed in [4]).
The relationship between viruses and polyamines took a new turn with the 
discovery that chlorella virus Paramecium bursaria chlorella virus (PBCV-1) (family 
Phycodnaviridae) has genes encoding the two polyamine biosynthetic enzymes, ODC [5] 
and homospermidine synthase (HSS) [7]. HSS synthesizes the rare polyamine 
homospermidine from two molecules of putrescine (Fig. 1A). Although PBCV-1 ODC is 
able to directly convert ornithine to putrescine, its preferred substrate is arginine [8]; 
consequently the PBCV-1 enzyme is referred to as ODC/ADC. 
 PBCV-1, the prototype chlorella virus, has a 331-kb dsDNA genome that 
contains 366 putative protein-encoding genes and a polycistronic gene that encodes 11 
tRNAs [9, 10]. PBCV-1 and another virus used in this study, NY-2A (370 kb genome), 
infect Chlorella NC64A (NC64A viruses), which is an endosymbiont of the protozoan P. 
bursaria that was originally isolated in North America. Other viruses, such as MT325 
(314 kb genome) infect Chlorella Pbi (Pbi viruses), an endosymbiont of P. bursaria that 
was isolated in Europe [11, 12].
The genes for the polyamine biosynthetic enzymes AIH and CPA from A. 
thaliana were recently identified [12, 13, 14]. This identification was due to their 
similarity to the corresponding enzymes from Pseudomonas aeruginosa PAO1, which 
were identified previously [15, 16]. Database searches revealed that homologs of both 
enzymes are also encoded by PBCV-1. Here we report the characterization of these genes 
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and their products from PBCV-1, as wellas from chlorella viruses NY-2A and MT325. 
Our results establish that chlorella viruses encode a complete polyamine biosynthetic 
pathway that allows the formation of homospermidine from arginine via agmatine, N-
carbamoylputrescine, and putrescine.  
2. MATERIALS AND METHODS  
2.1 Cloning of viral genes for AIH and CPA. Isolation of viral DNAs has been 
described [17]. The ORFs for the AIH and CPA proteins were amplified by PCR using 
the DyNAazyme EXT DNA polymerase (Finnzymes, Espoo, Finland). Each forward 
primer begins with an NdeI restriction site including an in frame start codon (CATATG), 
the reverse primers omit the stop codon and end with XhoI restriction sites for in frame 
cloning with the (His)6-tag of the pET-21b(+) vector (Novagen, Nottingham, UK). If 
XhoI sites were present in the ORF, XhoI-compatible SalI restriction sites were used 
instead. PCR products were T/A cloned into pGEM-T (Promega, Madison, WI). After 
establishing that the PCR products were free of error by sequencing (MWG Biotech, 
Ebersberg, Germany), the ORFs were cloned into the NdeI and XhoI sites of pET-21b(+).
The accession numbers for the virus genomes are U42580, DQ491002, 
DQ491003, DQ491001, and DQ890022 for viruses PBCV-1, NY-2A, AR158, MT325, 
and FR483, respectively. The DNA sequences can also be found at http://greengene.uml. 
edu.
2.1 Expression of viral proteins in E. coli and purification of the (His)6-tagged 
proteins. The proteins were expressed in E. coli strain CodonPlus (DE3) RIL 
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(Stratagene, La Jolla, CA). Pre-cultures were grown overnight in 2YT medium [18] 
containing ampicillin (100 μgmlí 1)and chloramphenicol (30 μgmlí 1)in an orbital 
shaker (220 rpm) at 37 °C. The expression cultures were inoculated 1:10 in 2YT medium 
(including ampicillin and chloramphenicol) with the pre-cultures. Optimized expression 
conditions to produce the recombinant proteins are described in the Supplementary Table 
S3.
Table1. Characteristics of AIH and CPA proteins from chlorella viruses in comparison 
to the enzymes from Arabidopsis thaliana and Pseudomonas aeruginosa PAO1 
Bacteria were harvested by centrifugation and stored frozen at í80 °C. For protein 
purification the cell pellets were resuspended in 1/10 of the culture volume of lysis buffer 
(50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 5 mM 2mercaptoethanol, 1 mg mlí 1 
lysozyme) and incubated for 15 min on ice. Cell lysis was completed by sonification with 
an ultrasound tip for 4×1 min at 50 W (Sonifier B17, Branson, USA). After removing the 
insoluble material by centrifugation (Sorvall GSA rotor, 10,000 rpm, 10 min), the 
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supernatant was loaded onto a Ni2+-NTA agarose (Qiagen, Hilden, Germany) column 
(bed volume 2 ml), which was equilibrated in 50 mM sodium phosphate, pH 8.0, 300 
mM NaCl, 10 mM imidazole. The column was washed with 50 mM sodium phosphate, 
pH 8.0, 300 mM NaCl, 30 mM imidazole, and bound proteins were eluted in a total 
volume of 2.5 ml with 50 mM sodium phosphate, pH 8.0, 300 mM NaCl, and 250 mM 
imidazole. After desalting on PD-10 columns (GE Healthcare, Freiburg, Germany) into 
50 mM potassium phosphate, pH 8.0 and 1 mM DTT (for the CPA proteins) or 50 mM 
potassium phosphate, pH 8.0 and 0.5 mM DTT (for AIH proteins), the purified 
recombinant proteins were frozen in 0.5 ml aliquots in liquid nitrogen and stored at í80
°C. Under these conditions the enzymes were stable for at least 2 months.  
2.3 Enzyme assays. Enzymes assays were conducted in triplicates with a background 
control in which the protein was inactivated by boiling for 10 min. The typical CPA assay 
was performed in 50 mM MES, pH 6.0, 1 mM DTT, 1 mM N-carbamoylpu-trescine and 
1μg ofprotein in a totalvolume of0.5 ml at 37 °C. The AIH assays consisted of 50 mM 
potassium phosphate, pH 7.5, 0.5 mM DTT, 1mM agmatine and1μg protein in a total 
volume of 1 ml and were incubated at 30 °C. 
Activity was measured as the release of ammonia from the substrates (Fig. 1B). 
Ammonia was detected with the indophenol blue method: a 100 μl aliquot of sample was 
mixed with 100 μlof 0.33 Msodium phenolate, 0.02 Msodium hypochlorite (prepared 
fresh daily), and 0.01% (w/v) sodium nitroprusside. The reaction was incubated for 3 min 
in a boiling water bath and then 600 μlof water was added. The absorbance at 640 nm 
was determined and compared to a calibration curve made with NH4Cl.  
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Thin-layer chromatography was conducted on silica plates (PolygramSIL 201 
G/UV254, Macherey-Nagel,Düren, Germany) that were developed in ethanol/NH4OH 
(25%) 1:1. About 5 to 10 μlof sample was applied to the plates. Amines were detected by 
spraying with ninhydrin (0.2% in ethanol).
Figure 2. Expression and purification of (His)6-tagged PBCV-1 AIH and CPA from E. 
coli. About 10 μl each of bacterial crude extracts (CE) and the column flowthrough (FT) 
were loaded on the gel. 2and 10 μlofthe AIH and CPAeluates (E) were loaded, 
respectively. M: low-molecular weight markers. 
2.4 RNA isolation. Infected chlorella cells (m.o.i. of 5) were collected at 20, 40, 60, 90, 
120, 240, 360 min p.i. Cells were disrupted with glass beads in the presence of Trizol 
(Invitrogen, Carlsbad, CA) and RNA was isolated using an Absolutely RNA Miniprep 
Kit (Stratagene, LaJolla, CA) according to the manufacturer's instructions. RNA integrity 
was verified in denaturing 1% agarose gels where intact host cytoplasmic and chloroplast 
rRNAs were visualized.
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2.5 Microarray and dot blot analyses. A microarray containing 50-mer probes 
representing each ORF in the PBCV-1 genome was constructed by MWG Biotech 
(Ebersberg, Germany) and the Microarray Core Facility (University of Nebraska Medical 
Center). Four replicas of the entire genome are present in each array. For each time point, 
20 μgof total RNA was reverse-tr anscribed using oligo(dT) as primers and cDNA was 
labeled with Cy3 or Cy5-dUTP (GE Healthcare, Piscataway, NJ) with the aid of a 
SuperScript Indirect cDNA Labeling System (Invitrogen, Carlsbad, CA) following the 
supplier's directions. Competitive hybridization experiments were conducted for each 
time point against a pool of transcripts representing every gene present in the time course.  
Results from three independent biological hybridizations were analyzed using the 
GenePix Pro v.6.0 software (Molecular Devices, Sunnyvale, CA) and TIGR microarray 
software suite (TM4) [19]. A number of transformations were performed in order to 
eliminate low quality data, to normalize the measured intensities using the Lowess 
algorithm, and to regularize the standard deviation of the intensity of the Cy3/Cy5 ratio 
across the blocks. Genes that displayed statistically significant modulation were 
identified by a one-way analysis of variance, using P values of <0.01 as a cutoff. Genes 
with similar expression profiles were grouped into 10 different clusters using a K-means 
algorithm.  
Viral DNAs used for dotblots were denatured, applied to nylon membranes fixed 
by UV cross-linking, and hybridized with 32Plabelled gene probes as described 
previously [20].
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Figure 3. Enzymatic activities of PBCV-1 AIH and CPA. The release of ammonia  (A) 
as well as the turnover of the substrates to the products (B) were analyzed. Agmatine (1 
mM) was incubated with PBCV-1 AIH (20 μg) for 90 min, then 15 μgof PBCV-1 CPAwas 
added. C, Cƍ: controls with heat denatured enzyme after 10 and 240 min incubation, 
respectively; M: standard mixture of 2mMeach of agmatine (Agm), N-
carbamoylputrescine (N-CP) and putrescine (Put). 
2.6 Phylogenetic analysis. The amino acid sequences of PBCV-1 polyamine 
biosynthesis enzymes were used to search the “non-redundant” dataset of GenBank using 
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BLASTP [21]. All sequences showing similarities greater than 50% over the full 
sequence were collected (between 30 and 130 entries) and multiple entries from the same 
species were discarded. The remaining 30–70 sequences were aligned using the 
DNAMAN program (version 5.2.2, Lynnon Corp., Vaudreuil-Dorion, Canada) and 
sequences which obviously altered the alignment were discarded. A new alignment was 
produced with the remaining sequences, extremely diverse N-and C-terminal sequences 
were deleted, and neighbor-joining trees using Kimura distances and 1000 bootstrap 
replicates were constructed with the DNAMAN software. These trees were used to 
discard additional sequences in overrepresented monophyletic clades with high bootstrap 
support. To root the trees paralogous sequences were included (arginine deiminase for the 
AIH sequences and N-carbamoyl-ȕ-alanine amidohydrolase for the CPA sequences). 
Again a new alignment was created with the remaining sequences (43 and 57 for the 
AIHs and CPAs, respectively). From these alignments phylogenetic inference was 
performed by Bayesian analysis using the MrBayes software (version 3.1.2; [22]) 
(gamma rates, model: mixed, 250,000 generations, burn-in: 25% of saved trees). 
4. RESULTS 
 In the following sections we only show results obtained with recombinant AIH 
and CPA proteins from PBCV-1 genes; results obtained with recombinant AIH and CPA 
proteins from viruses NY-2A and MT325 will be mentioned in the text or, where 
appropriate, listed in the tables.
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Table 2. Enzymatic properties of AIH and CPA proteins from chlorella viruses, 
Arabidopsis thaliana, and Pseudomonas aeruginosa PAO1
a Not determined (see text). 
b From [13]. 
C From [16]. 
d From [14]. 
3.1 Identification of aih and cpa genes in chlorovirus genomes. BLAST [21] searches 
using the AIH and CPA sequences from A. thaliana revealed homologous genes encoding 
both enzymes in the virus PBCV-1 genome. The predicted gene products from PBCV-1 
open reading frames (ORF) A638R and A78R have 48% and 49% amino acid identity to 
AtAIH and AtCPA, respectively (Table 1). Two other chlorella viruses have been 
sequenced recently [23, 24], virus NY-2A that infects the same host as PBCV-1 
(Chlorella NC64A) and virus MT325 that infects Chlorella Pbi. Both of these viruses also 
contain putative AIH and CPA encoding genes (Table 1) as well as PBCV-1 ODC/ ADC 
and HSS homologs (Table 3). The PBCV-1 AIH has 97% and 63% amino acid identity to 
its NY-2A and MT325 homologs, respectively. Similar amino acid identities occur 
between PBCV-1 CPA and its homologs from NY-2A and MT325 (97% and 68%amino 
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acid identity, respectively). These values are similar to the amino acid identities of 
PBCV-1 ODC/ ADC (86% and 63%) and HSS (93% and 69%) to their respective NY-2A 
and MT325 homologs (see also Supplementary Fig. S1). The viral AIH proteins are 5 to 
24 amino acids shorter than the enzymes from P. aeruginosa and A. thaliana, while all of 
the CPA proteins are of similar size.  
3.2 Chlorella virus AIH and CPA proteins are functional enzymes. We amplified the 
aih and cpa genes from PBCV-1, NY-2A and MT325 genomes by PCR. Recombinant 
proteins were expressed in Escherichia coli with C-terminal (His)6-tags and were 
subsequently purified by metal affinity chromatography (Fig. 2). AIH proteins from 
PBCV-1 and NY-2A were obtained as soluble proteins in large amounts (up to 20 mg 
from 100 ml bacterial cultures), whereas the CPA proteins were expressed in lower 
amounts (up to 1 mg from 300 ml cultures). In contrast, only small amounts of soluble 
proteins were obtained from both MT325 genes (about 200 μg per 300 ml culture) 
because most of the expressed proteins appeared in inclusion bodies.  
A colorimetric ammonia assay was used to test the recombinant proteins for 
activity because AIH and CPA each release ammonia from their presumed substrates in 
stoichiometric amounts with their products (Fig. 1B). In addition, thin-layer 
chromatography was used to verify the products of the two reactions as N-
carbamoylputrescine (for AIH) and putrescine (for CPA). PBCV-1 AIH produced 
ammonia from agmatine, while at the same time N-carbamoylputrescine was formed 
(Figs. 3A, B, 0–90 min). This N-carbamoylputrescine was subsequently converted to 
putrescine with a concomitant release of more ammonia after addition of PBCV-1 CPA 
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(Figs. 3A, B, 90–240 min). Thus, PBCV-1 AIH and CPAwere both functional enzymes 
displaying their predicted activities. Similar results were obtained with recombinant 
proteins from 
NY-2A and MT325 (results not shown). When PBCV-1 AIH was heat-denatured 
before assaying, no release of ammonia and no conversion of agmatine occurred, even 
after prolonged incubation (Fig. 3B, lane Cƍ). This experiment also establishes that 
agmatine is not a substrate for PBCV-1 CPA. 
3.3 Enzyme characterization. The properties of both enzymes (pH and temperature 
optima, m and kcat)were determined and the results are summarized in Table 2. The pH 
optima of the viral AIH enzymes (pH 7.5)were similar to those from A. thaliana and P. 
aeruginosa. In contrast, the viral CPA enzymes had highest activities in slightly acidic 
conditions (pH 5.5–6.5), when compared to the CPA enzymes from A. thaliana and P. 
aeruginosa (pH 8.0–9.0). The temperature optima for both enzymes from the Pbi virus 
MT325 (20 °C for AIH and 30 °C for CPA) were slightly lower than the two enzymes 
from the NC64A viruses and from A. thaliana and P. aeruginosa (Table 2).
The Km values were similar within each group of enzymes with the exception of 
the P. aeruginosa enzymes, which had higher Km values for both enzymes. The protein 
concentrations of the purified MT325 enzymes were so low that they could not be 
reliably determined; therefore, we did not calculate kcat values for these two enzymes. 
The kcat values for the other viral enzymes were similar to those obtained from A. 
thaliana and P. aeruginosa enzymes. 
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Figure 4. Release of ammonia from agmatine and arcaine by PBCV-1 AIH. 40 μg of 
protein was incubated with 1mM of the substrates and the released ammonia was 
quantified at the indicated time points. In the second arcaine sample (third set of 
columns) the protein was heat inactivated after 30 min (indicated with an arrow). The 
dotted line shows the 1 mM level. 
3.4 Substrate specificities. We tested the structurally similar compounds arginine, 
arginine methyl ester, argininamide, and arcaine (1,4-diguani-dinobutane), which is a 
derivative of agmatine (1-amino-4-guandinobutane), as possible substrates for PBCV-1 
AIH. Under standard conditions (0.5 μg protein/ml, 1mM substrate, 30 °C, 30 min), no 
ammonia was released from arginine, arginine methyl ester or argininamide. However, 
increased amounts of enzyme (80 μg/ml) and prolonged incubation (1 and 2 h), resulted 
in very weak activity with arginine methyl ester (0.2 nkat/mg protein). In contrast, 
arcaine was a relatively good substrate for the viral AIH enzymes (Fig. 4); the specific 
activity of PBCV-1 AIH with arcaine was only 4-fold less than with agmatine (results not 
shown). Arcaine has been reported to inhibit plant AIH enzymes [25, 26]. These authors 
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reported about 28% to 50% inhibition of maize AIH with 1 or 2 mM arcaine; 2 mM 
arcaine inhibited A. thaliana recombinant AIH by 39% (Janowitz and Piotrowski, 
unpublished results). Therefore, we were surprised that arcaine was a substrate for the 
viral AIHs. We tested the plant AtAIH and also observed release of ammonia from 
arcaine by this enzyme (results not shown). Although arcaine has two guanidino groups, 
only one molecule of ammonia per molecule of arcaine is released initially by the viral 
enzymes. However, prolonged incubation with the enzyme results in the release of 
ammonia that clearly exceeds the molar amount of arcaine (Fig. 4). This result can be 
explained if the product of the first reaction, 1-carbamoyl-4-guanidinobutane, is also a 
substrate for the viral AIH but the specific activity of the enzyme for this substrate is 
lower.  
Figure 5. Expression of PBCV-1 polyamine biosynthesis genes during the infection 
cycle as revealed by microarray analyses. Color code represents the log2 (Cy5/ Cy3) 
ratio for each time point and has Cy3 as a reference.
We tested N-carbamoyl-D, L-aspartic acid, N-carbamoyl-ȕ-alanine, and L-
citrulline as substrates for the viral CPA enzymes. However, no ammonia was released 
from any of these compounds indicating that they are not substrates for the viral CPA 
enzymes.  
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3.5 Expression of PBCV-1 polyamine biosynthesis genes during infection. The 
expression of the PBCV-1 aih and cpa genes during virus replication was monitored by 
Northern blot (results not shown) and by microarray analyses (Fig. 5). Both genes are 
expressed only within the first 20 to 40 min of infection. Since PBCV-1 DNA replication 
begins between 60 and 90 min p.i. [27], aih and cpa are early expressed genes. Their 
expression overlaps with expression of the PBCV-1 odc/ adc gene (ORF A207R) that is 
also expressed early (Fig. 5 and [5]). However, the PBCV-1 odc/adc gene is also 
expressed late (from 90 to 360 min) and, therefore, also overlaps with expression of the 
hss gene (ORF A237R) that is a typical late gene (Fig. 5). The aih and cpa transcripts are 
each about 1600 nt in size as revealed by Northern blot analyses (results not shown). 
These are appropriate sizes for the AIH and CPA proteins, which are 359 and 298 amino 
acids, respectively.
Immediate early genes (detectable expression within the first 5 to 10min after 
infection) often have ATGACAA sequences in their predicted promoter regions [28]. 
However, this sequence was absent in the putative promoter regions of aih and cpa genes 
from all three viruses (data not shown).
3.6 Occurrence of aih and cpa genes in other chlorella viruses. To determine if the aih 
and cpa genes are common among the chlorella viruses, a638r and a78r were hybridized 
to DNA isolated from 37 additional viruses that infect Chlorella NC64A and 5 viruses 
that infect Chlorella Pbi. The a638r (aih) probe hybridized to some extent with all 37 
NC64A viruses (Fig. 6A). The a78r (cpa) probe hybridized to 33 of the NC64A viruses 
(Fig. 6B). Neither probe hybridized to the host DNA or to the 5 Pbi virus DNAs. These 
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results suggest that the aih gene is common in all of the NC64A viruses and that the cpa 
gene might be absent in a few NC64A viruses, i.e. NYs-1, IL-5-2s1, MA-1D, and NY-
2B, or that the nucleotide sequence is sufficiently different from the PBCV-1 cpa gene so 
that hybridization is not detected. The lack of hybridization to the 5 Pbi viruses by both 
genes is very likely due to differences in their nucleotide sequences.
Table 3. Polyamine biosynthesis ORFs in several chlorella viruses
New sequencing projects have identified aih and cpa genes, as well as odc/adc 
and hss genes, in the NC64A virus AR158 [24] and in a new chlorella virus, ATCV-1, 
that infects endosymbiontic chlorella from the heliozoon Acanthocystis turfacea [29] 
(Table 3, unpublished results). However, a newly sequenced Pbi virus, FR483, lacks the 
aih gene, but contains the other three polyamine biosynthetic genes [23].  
3.7 Phylogenetic analysis of viral polyamine biosynthesis genes. Neighbor-joining 
phylogenetic analyses of the polyamine biosynthetic gene products (ADC/ODC, AIH, 
CPA, and HSS) of PBCV-1, NY-2A, AR158, MT325, and FR483 and of 30–60 
homologs from other species resulted in four trees in which the virus sequences formed 
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monophyletic clades with bootstrap support of 100%, indicating that the last common 
ancestor of the NC64A and Pbi viruses already contained these genes. Additionally, all 
four trees supported the monophylly of the NC64A and the Pbi viruses with 100% 
bootstrap support (data not shown and Supplementary Fig. S2).  
Previous studies indicate that the PBCV-1 HSS enzyme is bacterial-like [6] and 
phylogenetic analyses depict the PBCV-1 ODC/ADC protein arising near the ancestral 
origin of the ODC clade [5, 7]. Aih and cpa genes are common in bacteria and plants; in 
Pseudomonas aeruginosa PAO1 both genes are organized in an operon [15] and they are 
also clustered in many other bacteria (Supplementary Fig. S2). However, determining the 
ancestors of the viral aih and cpa genes was difficult because of apparent horizontal gene 
transfer events, indicated by the unusual groupings of sequences from distant bacterial 
species (e.g. Firmicutes together with Ȗ-Proteobacteria), and by the absence of a clear 
plant–bacteria split (Supplementary Fig. S2). Therefore, we cannot unequivocally 
determine if the viral aih and cpa genes are of bacterial or plant origin.
Polyamine biosynthesis genes have only been found in chlorella viruses and are 
absent in viruses from the other five Phycodnaviridae genera. Therefore, the chlorella 
viruses either acquired these genes after separation from the other phycodnaviruses or the 
genes were lost by the other phycodnaviruses during evolution. It is interesting that the 
G+C content of the four genes encoding the polyamine biosynthetic enzymes is always 
higher than the mean G+C content of their respective viral genomes (Table 4). This 
higher G+C content is especially striking for the cpa gene. Deviation of the G+C content 
of a gene from the mean G+C is often interpreted as a sign of a recent horizontal gene 
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transfer [30]. Therefore, maybe the chlorovirus polyamine biosynthesis genes were 
acquired after separation from the other phycodnaviruses.
Figure 6. Hybridization of the PBCV-1 aih gene (A) and cpa gene (B) to DNAs isolated 
from the host Chlorella NC64A, 37 NC64A viruses and 5 Pbi viruses (CVA-1, CVB-1, 
CVG-1, CVM-1, and CVR-1). The DNAs were hybridized with a 
32
P-labelled a638r 
(aih)gene probe (A) or a a78r (cpa)gene probe (B). The blots in each row contain 1, 0.5, 
0.25, and 0.12 μgof DNA from left to right, respectively.
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4. DISCUSSION AND CONCLUSIONS 
The importance of polyamines in virus replication has often been discussed in the 
literature (reviewed in [3, 31]) and these discussions can be summarized as follows: i) 
Polyamines, primarily putrescine, spermidine and spermine, are present in large amounts 
in the capsids of some viruses where they can neutralize up to 50% of the viral nucleic 
acid (e.g. [3, 32, 33, 34]). In contrast, other viruses are devoid of polyamines (e.g. [35]). 
ii) Virus infection often leads to an increase in polyamine biosynthesis and consequently, 
in the polyamine content of infected cells [36, 37]. iii) Depletion of intracellular 
polyamine pools (e.g. by using inhibitors of polyamine biosynthesis) inhibits the 
replication of some viruses but not others (e.g. [38, 39, 40, 41]).
These previous studies assumed that the polyamines associated with virus 
replication are synthesized by host enzymes. However, this assumption is no longer valid 
for all viruses because two genes encoding functional polyamine biosynthetic enzymes 
were recently discovered in the chlorella virus PBCV-1, an ODC/ADC [5, 7] and a HSS 
[6]. As reported here, PBCV-1 and at least two other chlorella viruses, NY-2A and 
MT325, have two additional genes that encode functional AIH and CPA enzymes. Thus, 
PBCV-1, and most likely NY-2A and MT325, encode a complete ADC pathway that 
converts arginine to putrescine (ODC/ADC proteins from NY-2A and MT325 have not 
been tested for activity). Consequently, these viruses are not dependent on their hosts for 
polyamine biosynthesis. 
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Table 4. G+C content of the chlorella virus genes encoding polyamine biosynthetic 
enzymes.
The fact that all four polyamine biosynthetic encoding genes are present in most 
chloroviruses, as shown by Southern blot analyses (Fig. 6; [5, 6]) and genome-
sequencing projects (Table 3), suggests that these proteins are important for chlorella 
virus replication. However, at least one chlorella virus, FR483, which infects Chlorella 
Pbi lacks an aih gene [23]. The other three genes encoding polyamine biosynthetic 
enzymes are present in all chlorella viruses sequenced to date. Chlorovirus is the only 
genus within the family Phycodnaviridae, currently consisting of 6 genera [42], with 
genes encoding polyamine biosynthetic enzymes; thus, either polyamines are especially 
important for chlorella virus replication or the chlorella host, in contrast to other algal 
hosts, is unable to provide the necessary amounts of polyamines for virus replication. The 
results also indicate that the chlorella viruses either acquired these enzymes after 
separation from the other phycodnaviruses or that all of the phycodnaviruses originally 
had the polyamine biosynthetic genes and that they have been selectively lost by the other 
phycodnaviruses during evolution. However, one should keep in mind that only a few 
other phycodnavirus genomes have been sequenced [43] and so the concept that only 
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chlorella viruses encode these enzymes could change as more algal virus genomes are 
sequenced. It may not be relevant, but one distinction between the chlorella viruses and 
members of the five other phycodnavirus genera is that the chlorella viruses exist in fresh 
water and the other viruses occur in marine environments.  
Unfortunately, not much is known about polyamine metabolism in chlorellae. 
ADC and ODC activities were reported in Chlorella vulgaris Beijerinck [44, 45]. The 
related green alga Chlamydomonas reinhardtii only uses the ODC pathway to synthesize 
putrescine [46]. However, although Chlamydomonas lacks an adc gene it has aih and cpa 
genes (available at: http:// genome.jgi-psf.org/Chlre3/Chlre3.home.html), but, according 
to EST data, they are not expressed. It is unknown if Chlorella NC64A and Chlorella Pbi 
possess a complete ADC pathway consisting of ADC, AIH and CPA; if they do the host 
chlorella AIH may functionally replace the absent viral AIH in FR483 during infection. 
The genome of Chlorella NC64A, the host for PBCV-1 and NY-2A, is currently being 
sequenced and annotation of its sequence will provide information on its polyamine 
biosynthetic capability. However, it is unlikely that the four PBCV-1 polyamine 
biosynthetic genes are acquired from Chlorella NC64A because none of the four virus 
genes hybridize with Chlorella NC64A DNA (Fig. 6A, B; [5, 6]).
PBCV-1 aih and cpa genes are transcribed as early genes, appearing within the 
first 20 min p.i. Their expression overlaps with transcription of the PBCV-1 odc/adc gene 
so that all three putrescine biosynthetic enzymes are presumably present early in 
infection. Therefore, one might expect the polyamine levels to increase during the first 60 
min of PBCV-1 infection. However, little change occurs in either the polyamine 
concentration or its composition (putrescine, cadaverine, spermidine, and 
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homospermidine are present) during the first 60 min of virus infection [6]. By 240 min 
p.i., the concentration of putrescine increases about 3.5 times, whereas the other 
polyamines decrease duringthis time. The net result is that the total polyamine 
concentration decreases slightly during virus replication [6]. It is unlikely that polyamines 
play a role in the neutralization of PBCV-1 DNA in the capsid because the number of 
polyamine molecules per PBCV-1 virion is so low that they can only neutralize ׽0.2% of 
the virus phosphate residues [6]. Furthermore, the physiological significance of the 
polyamines in the PBCV-1 particles must be limited because they are only loosely 
associated with the virions, i.e. they can be replaced by Tris or displaced by washing the 
particles in a polyamine-free buffer without affecting virus infectivity [6].
The dual expression pattern (early and late) of the viral genes encoding the 
polyamine biosynthetic enzymes may indicate that putrescine (early in viral replication) 
and homospermidine (late in viral replication) have different functions in virus 
replication. It should be mentioned that the HSS protein, but not the other three 
polyamine biosynthetic enzymes, is a major component of PBCV-1 virions (Dunigan et 
al., manuscript in preparation). Therefore, the HSS protein may also serve a structural 
role in the virus life cycle.  
In summary, most of the chlorella viruses have four genes that encode functional 
enzymes involved in polyamine biosynthesis. However, the biological function(s) of 
these enzymes and their products is currently an enigma. 
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APPENDIX II 
CHLORELLA VIRUSES ENCODE MOST, IF NOT ALL, OF THE 
MACHINERY TO GLYCOSYLATE THEIR GLYCOPROTEINS
INDEPENDENT OF THE ENDOPLASMIC RETICULUM AND GOLGI 
1. VIRUS ENCODED GLYCOSYLTRANSFERASES  
Structural proteins of many viruses, such as rhabdoviruses, herpesviruses, 
poxviruses, and paramyxoviruses are glycosylated. Most virus glycoproteins, which can 
have very complex glycans, are linked to Asn via N-acetylglucosamine, although some 
viruses have O-linked sugars attached to Ser or Thr residues via an amino sugar, usually 
acetylglucosamine or acetylgalactosamine. Typically, viruses use host-encoded 
glycosyltransferases and glycosidases located in the endoplasmic reticulum (ER) and 
Golgi apparatus to add and remove N-linked sugar residues from virus glycoproteins 
either co-translationally or shortly after translation of the protein.  This post-translational 
processing aids in protein folding and involves other host-encoded enzymes such as 
protein disulfide isomerase.  After folding and assembly, virus glycoproteins are 
transported by host sorting and membrane transport functions to virus specified regions in 
host membranes where they displace host glycoproteins.  Progeny viruses then bud 
through these virus-specific target membranes, which is usually the final step in the 
assembly of infectious virions [1-4].  Thus, nascent viruses only become infectious by 
budding through the membrane, usually the plasma membrane, as they are released from 
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the cell.  Consequently, the glycan portion of virus glycoproteins is host-specific.  The 
theme that emerges from these studies is that virus glycoproteins are synthesized and 
glycosylated by the same mechanisms as host glycoproteins.  Therefore, the only way to 
alter glycosylation of virus proteins is to either grow the virus in a different host or have a 
mutation in the virus protein that alters the protein glycosylation site. 
One outcome of this scenario is that, in general, viruses lack genes encoding 
glycosyltransferases.  However, a few virus-encoded glycosyltransferases have been 
reported in the last few years (see review [5]).  Sometimes these virus-encoded 
glycosyltransferases add sugars to compounds other than proteins.  For instance, some 
phage-encoded glycosyltransferases modify virus DNA to protect it from host restriction 
endonucleases [e.g., 6-8], and a glycosyltransferase encoded by baculoviruses modifies a 
host insect ecdysteroid hormone leading to its inactivation [9].  Bovine herpesvirus-4 
encodes aҏ E-1,6-N-acetyl-glucosaminyltransferase that is localized in the Golgi and is 
probably involved in post-translational modification of virus structural proteins [10-12].  
Additional putative virus encoded glycosyltransferases of unknown function include 
certain pox viruses [13, 14], Ectocarpus siliculosus virus 1 [15], Ostreococus virus OsV5 
[16], Acanthamoeba polyphaga Mimivirus [17], and two Archaea viruses, Acidianus 
filamentous virus 3 [18], and Sulfolobus virus STSV1 [19].  With the rapid increase in 
sequencing virus genomes, additional virus encoded glycosyltransferases will 
undoubtedly be discovered. 
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Figure 1. A ribbon diagram of the crystal structure of the virus PBCV-1 major capsid 
protein, Vp54, monomer with strategic amino acids labeled.  The carbohydrate moieties 
(yellow) and glycosylated Asn and Ser residues (blue and gray, respectively) are shown 
as space-filling atoms. The green and red regions indicate the consecutive "jelly roll" 
domains of the protein.  The arrow shows the orientation of the protein from the inside to 
the outside of the virus.  Reproduced from [62]. 
One group of viruses that differs from the scenario that viruses use the host 
machinery located in the ER and Golgi to glycosylate their glycoproteins is the 
chloroviruses (family Phycodnaviridae) that infects eukaryotic algae. Phycodnaviruses 
are large (150 to 190 nm in diameter) polyhedral, dsDNA-containing viruses with an 
internal lipid membrane (genomes of 170 to 560 kb) [20-23]. They are present in aqueous 
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environments throughout the world and play dynamic, albeit largely unknown, roles in 
regulating algal communities in aqueous environments, such as the termination of 
massive algal blooms commonly referred to as red and brown tides [e.g., 24-27].  Some 
phycodnaviruses encode as many as 600 proteins, which is more protein-encoding genes 
than in the smallest bacteria.  
The phycodnaviruses probably have a common ancestor with the poxviruses, 
iridoviruses, African swine fever virus, and Mimivirus [e.g., 28-30], and accumulating 
evidence indicates that the phycodnaviruses have a long evolutionary history, possibly 
dating from the time eukaryotes arose from prokaryotes (2-3 billion years ago) [e.g., 30-
32]. Some algal virus genes encode commercially important enzymes such as DNA 
restriction endonucleases [e.g., 33, 34], whereas other viral genes encode proteins that are 
the smallest in their class and may represent the minimal catalytic unit. Consequently, 
these ‘small’ proteins serve as models for mechanistic and structural studies (e.g., DNA 
topoisomerase type II [35] and a K+ ion channel protein [36]).
Phycodnavirus members in the genus Chlorovirus are plaque-forming viruses that 
infect certain isolates of unicellular, chlorella-like green algae. The prototype chlorella 
virus Paramecium bursaria chlorella virus (PBCV-1) infects a host, Chlorella NC64A, 
that is normally a symbiont in the protozoan P. bursaria. The 330 kb PBCV-1 genome 
has ~690 potential open reading frames (ORFs) of 65 codons or larger [20].  About 365 
of these ORFs are predicted to encode proteins (CDSs) and the functions of 35-40% of 
these CDSs have been tentatively identified.  Pertinent to this review is that 17 of the 
PBCV-1 genes encode enzymes that manipulate sugars, many of which have never been 
found previously in a virus (Table 1). At least five of the enzymes are putative 
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glycosyltransferases, presumably involved in glycosylation of the PBCV-1 major capsid 
protein Vp54.  [Note: in our original report on the annotation of the PBCV-1 genome we 
identified 7 PBCV-1 encoded glycosyltransferases [37].  However, two of these CDSs, 
which were co-linear with an adjacent glycosyltransferase, were the result of sequencing 
errors and are part of the adjacent glycosyltransferase.]    
Figure 2. A ribbon diagram of the crystal structure of the glycosyltransferase domain 
from virus PBCV-1 CDS A64R. Bound Mn2+ and citrate ions are shown in a ball-and-
stick representation.  Alpha (purple) and beta sheets (pink) are color coded.  Reproduced 
from reference [70] with permission. 
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2. CHLOROVIRUS ENCODED SUGAR ENZYMES 
Three PBCV-1 encoded enzymes are involved in the synthesis of the extracellular 
matrix polysaccharide hyaluronan (also referred to as hyaluronic acid), including the 
glycosyltransferase hyaluronan synthase (HAS) [38, 39].  Hyaluronan, a ubiquitous 
constituent of the extracellular matrix in vertebrates, consists of ~20,000 alternating E-
1,4-glucuronic acid and E-1,3-N-acetylglucosamine residues [40].  Hyaluronan synthesis 
occurs at the plasma membrane and is simultaneously extruded through the membrane to 
the exterior of the cell.  Until the has gene was discovered in PBCV-1, hyaluronan was 
thought to only occur in vertebrates and a few pathogenic bacteria, where it forms an 
extracellular capsule, presumably to avoid the immune system [40, 41].
PBCV-1 also encodes two enzymes involved in the biosynthesis of hyaluronan 
precursors, glutamine:fructose-6-phosphate amidotransferase and UDP-glucose 
dehydrogenase [42].  All three genes are expressed early during PBCV-1 infection.  
These results led to the discovery that hyaluronan lyase-sensitive hair-like fibers begin to 
accumulate on the surface of PBCV-1 infected host cells by 15 min post infection (p.i.).  
By 4 hr p.i., the infected cells are covered with a dense fibrous hyaluronan network [39]. 
The has gene is present in many, but not all, chloroviruses isolated from diverse 
geographical regions [39].  Surprisingly, many chloroviruses that lack a has gene have a 
gene encoding a functional chitin synthase (CHS).  Furthermore, cells infected with these 
viruses produce chitin fibers on their external surface [43].  Chitin, an insoluble linear 
homopolymer of -1,4-linked N-acetyl-glucosamine residues, is a common component 
of insect exoskeletons, shells of crustaceans and fungal cell walls [44]. 
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A few chloroviruses contain both has and chs genes, and form both hyaluronan 
and chitin on the surface of their infected cells [43, 45].  Finally, a few chloroviruses 
probably lack both genes because no extracellular polysaccharides are formed on the 
surface of cells infected with these viruses [39].  The fact that many chloroviruses encode 
enzymes involved in extracellular polysaccharide biosynthesis suggests that the 
polysaccharides, which require a huge expenditure of ATP for their synthesis, are 
important in the virus life cycle.  However, at present this function(s) is unknown. 
Table 1.  Virus PBCV-1 encoded enzymes involved in sugar manipulation.
1The time the genes were expressed was determined by microarray analysis (Yanai-Balser, G.M. et al., 
manuscript in preparation). 
2Another name is GDP-4-keto-6-deoxy-D-mannose epimerase reductase. 
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The chloroviruses encode additional enzymes involved in nucleotide sugar 
metabolism.  Two enzymes encoded by virus PBCV-1, GDP-D-mannose 4,6 dehydratase 
(GMD) and a GDP-4-keto-6-deoxy-D-mannose epimerase reductase (GMER) comprise 
the highly conserved pathway that converts GDP-D-mannose to GDP-L-fucose.  In vitro 
reconstruction of the biosynthetic pathway using recombinant PBCV-1 GMD and GMER 
synthesized GDP-L-fucose [46, 47].  Unexpectedly, however, the PBCV-1 GMD also 
catalyzes the NADPH-dependent reduction of the intermediate GDP-4-keto-6-deoxy-D-
mannose, forming GDP-D-rhamnose.  Both fucose and rhamnose are constituents of the 
glycans attached to the PBCV-1 major capsid protein Vp54 (see below).  Therefore, the 
virus might encode the enzymes to meet this need.  Other chloroviruses encode additional 
sugar metabolizing enzymes including a putative mannose-6-phosphate isomerase and a 
UDP-glucose 4,6 dehydratase [48] (Tonetti, M. et al., unpublished data). 
At least five PBCV-1-encoded enzymes are involved in polysaccharide 
degradation, including 2 chitinases, a chitosanase, a -1,3-glucanase, and a - and -
1,4-linked glucuronic acid lyase (summarized in [21], [49-51]).  Finally, one enzyme is a 
glycosylase that initiates pyrimidine photodimer excision [52, 53].  
3. GLYCOSYLATION OF VIRUS PBCV-1 MAJOR CAPSID PROTEIN VP54 
The major capsid protein of PBCV-1, Vp54 (comprises ~40% of total virus 
protein), is a glycoprotein with a molecular weight of 53,790 (Table 2).  Glycosylation of 
Vp54 and two minor structural proteins Vp280 (~1% of the total virus protein) and 
Vp260 (~0.1% of total virus protein) differs from other viruses.  CDS A430L encodes 
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Vp54 with a predicted molecular weight of 48,165 Da. This protein undergoes additional 
post-translational modifications in addition to being glycosylated. The amino terminal 
Met is removed [54] and the protein is myristylated in the carboxyl-terminal portion of 
the protein, probably at an internal Lys or Arg [55]. Vp260 is coded by CDS A122/123R, 
a protein of 138 kDa.  Since the protein migrates on SDS-PAGE with a weight of ~260 
kDa, it probably consists of more than 40% carbohydrate. The CDS encoding Vp280 is 
unknown.
Cryo-electron microscopy and three-dimensional (3-D) icosahedral image 
reconstruction of the PBCV-1 virion indicate that the outer capsid is icosahedral and 
covers a lipid bilayered membrane [56, 57]. The capsid shell consists of 1,680 donut-
shaped trimeric capsomers plus 12 pentameric capsomers at each icosahedral vertex.  The 
trimeric capsomers are arranged into 20 triangular facets (trisymmerons, each containing 
66 trimers) and 12 pentagonal facets (pentasymmetrons, each containing 30 trimers and 
one pentamer at the icosahedral vertices).  Trisymmetrons and pentasymmetrons are 
made up of trimeric capsomers, with each doughnut shaped capsomer composed of 3 
monomers of Vp54.  The trimeric capsomers are easy to isolate because heating PBCV-1 
to 65oC for a few minutes leads to solubilization of the trimers.  However, the monomer 
form of Vp54 is insoluble.  
Recent five-fold symmetry, rather than icosahedral, averaging of cryoelectron 
microscopy data has produced some exciting results on the structure of PBCV-1 [58].  
PBCV-1 has a unique pentameric vertex with a 250 Å long and 50 Å wide cylindrical 
spike that connects to a large pocket between the capsid and the enveloped nucleocapsid.  
Circumstantial evidence suggests that Vp260 may be a component of the spike structure, 
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which presumably is involved in virus attachment. 
The conclusion that the PBCV-1 proteins are glycosylated by a different 
mechanism than those used by other viruses originally arose from antibody studies.  
Polyclonal antiserum prepared against intact PBCV-1 virions inhibits virus plaque 
formation by agglutinating particles. Spontaneously derived, antiserum-resistant, plaque-
forming variants of PBCV-1 occur at a frequency of 10-5 to 10-6.  These antiserum-
resistant variants fall into four serologically distinct classes (Table 2) [59].  Polyclonal 
antisera prepared against members of each of these antigenic classes react exclusively or 
predominately with the Vp54 (and Vp280 and Vp260) equivalents from the viruses in the 
class used for the immunization.  While each of the three glycoproteins from the 
antigenic variants migrate faster on SDS-PAGE than those of the strains from which they 
are derived, all of the major capsid proteins co-migrate after deglycosylation.  Western 
blot analyses of Vp54 proteins isolated from the variants, before and after removing the 
glycans with trifluoromethane-sulfonic acid or altering the glycan with periodic acid, 
established that the antigenic variants reflect differences in the Vp54 glycans. In addition, 
the ratio of the seven neutral sugars [glucose, fucose, galactose, mannose, xylose, 
rhamnose and arabinose [59] attached to PBCV-1 Vp54 and the variants change in a 
manner that correlates with antigenicity and Vp54 migration on SDS-PAGE (Table 3). 
Variants from different classes can complement and recombine in dual infection 
experiments to produce wild-type progeny, indicating that the enzymes involved in 
glycosylation reside in different virus-encoded complementation groups [60]. 
Additional observations indicate that Vp54 glycosylation is unusual: i) Unlike 
viruses that acquire their glycoprotein(s) by budding through a plasma membrane, intact 
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infectious PBCV-1 particles accumulate inside the host 30-40 min before virus release 
[61].  ii) The nucleotide sequence of the Vp54 gene (a430l) in each of the variants is 
identical to wild type PBCV-1, thus the peptide portion of Vp54 is not altered in the 
mutants [59].  iii) All of the antigenic variants are grown in the same host so the 
differences cannot be attributed to the host.  iv) Polyclonal antibodies to Vp54 do not 
react with host glycoproteins.  v) Neither N-acetylglucosamine (GlcNAc) nor N-
acetylgalactosamine were detected in Vp54 glycans, sugars commonly found in Asn-
linked (N-linked) and many Ser/Thr-linked (O-linked) glycoproteins produced via the 
cellular ER-Golgi pathway (Table 3) [59]. vi) Unlike most glycoproteins that exhibit size 
microheterogeneity, Vp54 appears homogeneous on SDS-PAGE; in addition, mass 
spectrometry analysis only reveals one satellite peak that differs in molecular weight by 
140 Da, the approximate weight of either one arabinose, xylose, fucose or rhamnose 
sugar (Cerny, R. and Van Etten, J.L., unpublished data).  vii) The ability to easily 
crystallize Vp54 as a homotrimer provides additional evidence that the protein is 
essentially homogeneous (Fig. 1) [62]. 
The glycans are not linked to the major capsid proteins by a traditional N-linkage 
because: i) treatment of Vp54 with the enzymes endo-E-N-acetylglucosaminidase F or N-
glucosidase F, which cleave glycans from N-linked glycoproteins [63], does not alter 
Vp54 migration on SDS-PAGE (Chaney, W.G. and Van Etten, J.L., unpublished data).  
ii) The drug tunicamycin, which inhibits synthesis of N-linked glycoproteins [64], has no 
effect on PBCV-1 replication nor Vp54 electrophoretic mobility, even at concentrations 
three times that required to inhibit host chlorella growth [55].  Finally, an antibody 
(provided by Felix Wieland) to a Eglucose Asn linkage present in bacterial 
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glycoproteins [65] reacts strongly with Vp54 (Gurnon, J.R. and Van Etten, J.L., 
unpublished data), suggesting that one or more of the Asn linked glycans in Vp54 have 
this linkage.  This same linkage exists in the B2 chain of mammalian laminin, a major 
basement membrane glycoprotein [66].  
Table 2. Properties of antigenic classes of viruses derived from PBCV-1. 
a Calculated by subtracting the deduced peptide mass minus the N-terminal initiating Met residue (48,017) 
and the mass of one myristate (228.4) from the MW determined by mass spectrometry.  All the protein 
backbones are identical.  
b nd, not determined.  
Modified from [60]. 
We originally suggested that Vp54 had a single ~30mer glycan or two-15mer 
glycans attached to it [60].  However, the Vp54 crystal structure revealed sugars attached 
to six amino acids in the protein (Fig. 1) [62].  Comparison of  the molecular mass of 
Vp54 (53,790 Da) with its predicted molecular weight from the amino acid sequence 
(48,165 Da) indicates that the protein contains 30-35 sugar moieties, of which 20 could 
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be detected, but not identified, in the crystal density map.  At a minimum, single sugars 
were found attached to Ser57 and Ser387; six and seven-branched chain sugar moieties 
were found attached to Asn280 and Asn302, respectively, as well as three and two sugar 
residues were located at Asn399 and Asn406, respectively.  As predicted from the antibody 
results, the four N-linked glycans are on the external surface of the virus.  GlcNAc fits 
the carbohydrate electron density at residues Asn280, Asn302, and Asn399.  However, the 
inability to detect GlcNAc in Vp54 suggests that another modified sugar might be in this 
position, e.g., glucose with an O-linked acetate. 
The identification of the glycan-linked Asn residues in Vp54 provided additional 
evidence that Vp54 glycosylation does not involve host glycosyltransferases.  Asn302,
Asn399, and Asn406 occur in the amino acid sequence (A/G)NTXT, and Asn280 occurs in 
an ANIPG sequence.  None of these Asn residues reside in a NX(T/S) sequence 
commonly recognized by ER located glycosyltransferases [67].  These findings also 
explain why previous enzymatic tests for N-glycosylation were negative.  Finally, the 
major capsid protein, like the glycosyltransferases, lacks an ER or Golgi signal peptide.  
Therefore, taken together, the results suggest that PBCV-1 encodes some, if not all, of the 
enzymes involved in constructing the glycans attached to Vp54. 
4. PBCV-1 ENCODED GLYCOSYLTRANSFERASES 
As mentioned above, five putative glycosyltransferase-encoding genes have been 
found in PBCV-1, which are scattered throughout the PBCV-1 genome (Table 1). None
of these PBCV-1 encoded glycosyltransferases have an identifiable signal peptide that 
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would target them to the ER.  Furthermore, the cellular protein localization program 
PSORT predicts that all of these proteins, with the exception of A473L, are located in the 
cytoplasm.  A473L is predicted to contain one transmembrane domain.  
The genes for all five PBCV-1 encoded glycosyltransferases are expressed early 
during PBCV-1 infection (Yanai-Balser, G.M. et al., manuscript in preparation).  Thus, 
assuming the proteins are stable, the enzymes should be available for either adding sugars 
to the Vp54 glycans or transferring the glycans.  The a430l gene is expressed late.
PBCV-1 a64r gene.  The PBCV-1 a64r gene encodes a 638 amino acid protein 
with 4 motifs that are conserved in the "fringe-class" of glycosyltransferases [68, 69].  
Five conserved domains, designated 1-5, have been identified in this class of enzymes 
[69].  Domains 3 and 5 contain the proposed catalytic amino acids, the "DXD" sequence 
in domain 3 and the first "D" residue in domain 5.  The A64R protein contains domains 
2-5 although the spacing between some of the domains differs from that of fringe-
glycosyltransferases. As mentioned above, the A64R protein lacks both an identifiable 
signal peptide that would target the protein to the ER and a membrane-spanning domain 
in contrast to fringe glycosyltransferases. 
Analysis of 13 PBCV-1 antigenic variants revealed mutations in a64r that 
correlated with a specific antigenic class, EPA-1 (Table 2).  The a64r gene in six of these 
antigenic variants was sequenced to determine if mutations in a64r correlated with the 
EPA-1 antigenic variation [60].  The a64r sequences from mutants EPA-1, EPA-3, and 
P31 have single nucleotide substitutions, which produce a single amino acid substitution 
in the A64R protein.  Two of the amino acid substitutions occur in the DXD motif 
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(domain 3) and the other one is in domain 4.  A fourth variant has an extra base in the 
coding sequence, which creates a frame shift mutation in the gene.  Finally, the entire 
gene is deleted in the other two antigenic variants.
Dual infection experiments with the different antigenic variants indicate that 
viruses containing wild-type a64r complement and recombine with viruses that contain 
variant a64r to form wild-type virus.  Therefore, we concluded that a64r encodes a 
glycosyltransferase involved in the synthesis of the Vp54 glycan [60]. 
5. STRUCTURE OF PBCV-1 ENCODED A64R GLYCOSYLTRANSFERASE  
Blast searches with the 638 amino acid A64R protein established that the 
glycosyltransferase domains are located in the amino-terminal 211 amino acids.  The 
A64R carboxyl terminus resembles several bacterial proteins of unknown function.
 The amino-terminal A64R glycosyltransferase domain (residues 1-211) was 
expressed in a bacterial system for crystallization studies.  The crystal structure of the 
peptide was solved at 1.6 Å resolution (Fig. 2) [70].  The peptide has a mixed / fold 
containing a central, six-stranded  sheet flanked by ҏhelices.  The overall fold is 
similar to catalytic domains of glycosyltransferases in the GT-A group, retaining 
glycosyltransferase family 34, although the amino acid similarity between them is low 
(less than 14% for equivalent C atoms).  Crystal structures of A64R complexed with 
UDP, CMP, or GDP, established that only UDP bound to A64R in the presence of Mn2+,
consistent with its high structural similarity to glycosyltransferases that use UDP as the 
sugar carrier.  The structure of the A64R, UDP-glucose, and Mn2+ complex showed that 
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the largest conformational change occurred when hydrogen bonds were formed with the 
ligands.  Unlike UDP-glucose, UDP-galactose and UDP-GlcNAc did not bind to A64R, 
suggesting a selective binding of UDP-glucose.  Thus UDP-glucose is most likely the 
sugar donor for A64R, consistent with glucose occurring in the virus major capsid protein 
glycans (Table 3). 
However, no enzymology has been conducted on the A64R peptide, or any of the 
other virus encoded glycosyltransferases because the structure of the Vp54 glycans are 
unknown. Consequently, the substrate(s) for A64R or any of the putative viral 
glycosyltransferases are unknown. 
Table 3. Sugar composition of the glycoproteins from PBCV-1 serotypes. 
Values are normalized to that of glucose. The mutants are arranged so that the major capsid protein 
decreases in size from PBCV-1 to P100.  Viruses EPA-1 and P31 and viruses P41 and E11 are 
serologically similar even though they are separate isolates. Viruses P91, EPA-1, P31 and P41 are derived 
from PBCV-1; virus E11 is derived from EPA-1; and virus P100 is from P31. Ara/Rham, 
arabinose/rhamnose. (Reproduced from [59]).  
*Subsequent experiments established that both Ara and Rham are present in the PBCV-1 major capsid 
protein. 
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6. WHERE DOES VP54 ACQUIRE ITS GLYCANS? 
A brief description of the PBCV-1 life cycle follows.  PBCV-1 infects its host 
Chlorella NC64A by attaching rapidly, probably at a unique virus vertex [71, 58] via one 
of its vertices, to the algal cell wall, followed by degradation of the wall at the point of 
attachment [72].  After digestion of the wall, the PBCV-1 internal membrane presumably 
fuses with the host membrane to translocate virus DNA and probably some virus 
associated proteins to the inside of the host, leaving an empty capsid on the surface.   
Two observations suggest that upon infection PBCV-1 DNA and probably DNA-
associated proteins quickly move to the nucleus and commandeer at least some of the 
host transcription machinery to initiate early viral RNA synthesis; early virus transcripts 
can be detected within 5-10 min p.i. [73, 74].  i) PBCV-1 does not encode a recognizable 
RNA polymerase gene(s) nor is RNA polymerase activity detected in isolated virions 
(Rohozinski, J. and Van Etten, J.L., unpublished data). ii) A small intron with splice-site 
sequences characteristic of nuclear-spliced mRNAs exists in the PBCV-1 DNA 
polymerase gene [75].  Presumably, this intron is excised in the cell nucleus. 
Viral DNA synthesis begins between 60 and 90 min p.i., followed by late viral 
transcription [76, 73].  Virus assembly begins ~3 hr p.i. in localized regions of the 
cytoplasm called virus assembly centers.  By 6-8 hr p.i., virus induced host cell lysis 
occurs and results in the release of progeny viruses (~1000 virus particles per cell of 
which ~25% are infectious) [72]. 
The intracellular location of virus protein glycosylation is unknown, although 
gold-labelled Vp54 antibody only reacts with proteins in the virus assembly centers 
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(Graves, M.V., Gurnon, J.R. and Van Etten, J.L., unpublished data).  This finding 
suggests that Vp54 might acquire its glycans in the virus assembly centers.
Table 4.  Glycosyltransferase-like genes encoded by six viruses that infect three 
Chlorella species*. 
*CDS’s listed in the source line across are considered to be orthologs.  The amino acid sequences of each 
of them are available at http://GreenGene.uml.edu.  Viruses PBCV-1, NY-2A and AR158 infect Chlorella 
NC64A, viruses MT325 and FR483 infect Chlorella Pbi and virus ATCV-1 infects Chlorella SAG 3.83. 
7. HOW ARE SUGARS ADDED TO VP54? 
The structures of the glycans attached to Vp54 are unknown and we are happy to 
collaborate with anyone who wants to solve their structures.  The prediction is that the 
glycan structures differ from typical glycans because it is unlikely that the host ER and 
Golgi apparatus are involved in adding sugars to PBCV-1 Vp54.  Vp54 lacks a 
recognizable ER signal peptide and so presumably, it does not enter the ER.  However, 
one can ask the question: Are the sugars added to Vp54 either sequentially or are they 
synthesized independently of Vp54, possibly on a lipid carrier, and then attached to the 
protein in a single step?   A slight variation of these two possibilities is to synthesize a 
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core glycan(s) independently of the protein and attach it to Vp54.  This core glycan(s), 
which could be either larger or smaller than the final product, is processed further after 
attachment to the protein.  
To distinguish between these possibilities [2,6-3H]-galactose was added to cells at 
the time of PBCV-1 infection and cells collected at various times p.i.  [We are aware that 
galactose can be converted to other products.]  After disrupting the cells, SDS-soluble 
materials were separated on SDS-PAGE, and labeled material viewed via fluorography 
(Fig. 3) (Graves, M.V. and Van Etten, J.L., unpublished data).  Vp54 first appears 
between 60 and 90 min p.i. and is a tight homogeneous band suggesting that the fully 
synthesized glycans are transferred to the Vp54 peptide "en mass" [Note: the Vp54 
equivalent from antigenic variant EPA-1 is easily distinguished from wild type Vp54 
even though it is only 2,230 Da smaller; the slightly smaller variant Vp54 from mutant 
E11 can be distinguished as well (Fig. 3)]  It is interesting that a slowly migrating 
radioactive smear is present at the top of the gel first appearing between 15 and 30 min 
p.i., prior to the appearance of Vp54; the smear increases in intensity to 90 min p.i. and 
then becomes less intense as Vp54 intensifies.  Could this "smear" be an intermediate(s) 
in the synthesis of the Vp54 glycan?  Interestingly, the appearance of this smear 
correlates with the expression of A64R, as well as the other putative glycosyltransferases; 
each of the glycosyltransferase gene transcripts begin to be detected at 20 to 40 min p.i. 
(Table 3; [Yanai-Balser, G.M. et al., manuscript in preparation]).  Note: the smear is 
absent in normal cells even after 5 hr of continuous labeling (Fig. 3, lane U). 
Assuming the Vp54 glycan precursors are transferred "en mass", one predicts that 
they are attached to a lipid carrier such as either undecaprenol-phosphate, which is the 
202 
carrier for bacterial peptidoglycans and cell surface polysaccharides [77], or 
dolicholdiphosphate, which is the carrier in eukaryotic cells [67].  It is unlikely that 
dolicholphosphate is the carrier because tunicamycin, which interferes with the transfer 
of UDP-N-acetylglucoseamine to dolicholphosphate [64], has no effect on either PBCV-1 
replication or Vp54 synthesis, even at concentrations three times that required to inhibit 
host chlorella growth [55].
8. GLYCOSYLTRANSFERASES CODED BY OTHER CHLORELLA VIRUSES  
Polyconal antibodies to wild type PBCV-1 and its antigenic variants do not react 
with many other independent virus isolates that infect Chlorella NC64A (NC64A 
viruses).  This lack of cross-reactivity suggests that the major capsid proteins from these 
non-reacting viruses have different glycans and as such these viruses code unique 
glycosyltransferases.  In addition, two other related virus/chlorella systems are available 
for study, viruses that infect Chlorella Pbi (Pbi viruses) and Chlorella SAG 3.83 (SAG 
viruses).  None of the Pbi viruses or SAG viruses react with PBCV-1 antiserum. 
We recently sequenced and annotated five additional chlorella viruses, two more 
NC64A viruses [78], two Pbi viruses [79], and one SAG virus [48].  These newly 
sequenced viruses encode from 3 to 6 putative glycosyltransferases (Table 4).  The 
PBCV-1 glycosyltransferase A111/114R is the only protein with an ortholog in all of the 
viruses.  The orthologs B618R and C559R from NC64A viruses NY-2A and AR158, 
respectively, produce a high Blast score with N-acetyglucosaminyltransferases, 
suggesting that N-acetylglucosamine might be present in their major capsid proteins.  The 
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major capsid proteins from NY-2A and AR158 clearly differ from PBCV-1 Vp54 
because neither virus reacts with antibodies to PBCV-1 or any of its antigenic variants.  
The sugar components of the major capsid proteins have not been determined for any of 
these 5 newly sequenced viruses.  The prediction is that the sugars will probably differ 
both qualitatively and quantitatively from PBCV-1.  
Figure 3. Total proteins isolated from virus PBCV-1 infected Chlorella NC64A at the 
indicated times (min) p.i.  The infection was done in the presence of [3H]-galactose.  
Uninfected (lane U) cells were labeled for 300 min.  Lanes labeled EPA and E11 contain 
total proteins from cells at 120 min after infection with antigenic variant viruses EPA-1 
and E11.  The slower migrating "smear" described in the text is indicated by the bracket.   
Proteins were separated on a 7.5% SDS-PAGE, and labeled proteins visualized by 
autoradiography (Graves, M.V. and Van Etten, J.L., unpublished data). 
9. IMPLICATIONS 
The chlorella viruses contain genes encoding a variety of glycosyltransferases,
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most of which, if not all, lack a recognizable ER signal peptide.  Furthermore, hundreds 
of these viruses can be isolated easily from natural sources. We assume that different 
glycosyltransferases use different sugars and form distinct linkages.  Because all of the 
virus-encoded glycosyltransferases lack ER signaling domains and most of them lack 
transmembrane domains, the virus encoded recombinant glycosyltransferases are likely to 
be soluble, which makes them easier to purify and use as reagents for adding sugars to 
proteins.
10. CONCLUSION 
Collectively, the results indicate that glycosylation of the PBCV-1 major capsid 
protein differs from that of other viruses and that glycosylation probably occurs 
independently of the ER and Golgi apparatus.  Furthermore, most, if not all, of the 
machinery to carry out this glycosylation is encoded by the virus.  These conclusions lead 
to many questions including: i) Could Vp54 glycosylation reflect an ancestral pathway 
that existed prior to ER and Golgi formation in eukaryotic cells?  ii) Is PBCV-1 
glycosylation similar to that of O-antigen-containing bacteria, which add a precise 
number of sugars to the basal core polysaccharide [80].  iii) Are the Vp54 glycan 
precursors synthesized and assembled on a lipid carrier?  iv) How much diversity in the 
number of glycosyltransferases and glycan structures exists among chlorella viruses?  v) 
What is the ultimate function of the capsid protein glycan? 
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